10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 001-37757

Adient plc
(exact name of Registrant as specified in its charter)

Ireland	98-1328821
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
25-28 North Wall Quay, IFSC, Dublin 1, Ireland D01 H104
(Address of principal executive offices)
734-254-5000
(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading symbol	Name of exchange on which registered
Ordinary Shares, par value $0.001	ADNT	New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☑  No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☑  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☑	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes  ☐  No  ☑

At June 30, 2022, 94,813,661 ordinary shares were outstanding.

Adient plc

Form 10-Q

For the Three Months Ended June 30, 2022

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION
Item 1.	Unaudited Financial Statements	3
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	32
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	47
Item 4.	Controls and Procedures	47
PART II - OTHER INFORMATION
Item 1.	Legal Proceedings	48
Item 1A.	Risk Factors	48
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	49
Item 3.	Defaults Upon Senior Securities	49
Item 4.	Mine Safety Disclosures	49
Item 5.	Other Information	49
Item 6.	Exhibits	50
	Signatures	51

Adient plc | Form 10-Q | 2

PART I - FINANCIAL INFORMATION

Item 1. Unaudited Financial Statements

Adient plc

Consolidated Statements of Income (Loss)

(unaudited)

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions, except per share data)	2022		2021		2022		2021
Net sales	$	3,485	$	3,242	$	10,471	$	10,909
Cost of sales	3,312		3,092		9,947		10,120
Gross profit	173		150		524		789
Selling, general and administrative expenses	142		136		439		433
Restructuring and impairment costs	12		8		20		20
Equity income (loss)	16		38		56		220
Earnings (loss) before interest and income taxes	35		44		121		556
Net financing charges	39		87		172		256
Other pension expense (income)	(4)		(4)		(6)		(8)
Income (loss) before income taxes	—		(39)		(45)		308
Income tax provision (benefit)	20		10		65		90
Net income (loss)	(20)		(49)		(110)		218
Income (loss) attributable to noncontrolling interests	10		22		55		70
Net income (loss) attributable to Adient	$	(30)	$	(71)	$	(165)	$	148
Earnings (loss) per share:
Basic	$	(0.32)	$	(0.75)	$	(1.74)	$	1.57
Diluted	$	(0.32)	$	(0.75)	$	(1.74)	$	1.55
Shares used in computing earnings per share:
Basic	94.8		94.2		94.7		94.1
Diluted	94.8		94.2		94.7		95.6

The accompanying notes are an integral part of the consolidated financial statements.

Adient plc | Form 10-Q | 3

Adient plc

Consolidated Statements of Comprehensive Income (Loss)

(unaudited)

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Net income (loss)	$	(20)	$	(49)	$	(110)	$	218
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(155)		25		(122)		62
Realized and unrealized gains (losses) on derivatives	(7)		17		(5)		34
Other comprehensive income (loss)	(162)		42		(127)		96
Total comprehensive income (loss)	(182)		(7)		(237)		314
Comprehensive income (loss) attributable to noncontrolling interests	(10)		23		43		79
Comprehensive income (loss) attributable to Adient	$	(172)	$	(30)	$	(280)	$	235

The accompanying notes are an integral part of the consolidated financial statements.

Adient plc | Form 10-Q | 4

Adient plc

Consolidated Statements of Financial Position

(unaudited)

(in millions, except share and per share data)	June 30, 2022		September 30, 2021
Assets
Cash and cash equivalents	$	892	$	1,521
Accounts receivable - net	1,761		1,426
Inventories	953		976
Assets held for sale	—		49
Other current assets	456		1,114
Current assets	4,062		5,086
Property, plant and equipment - net	1,443		1,607
Goodwill	2,122		2,212
Other intangible assets - net	504		555
Investments in partially-owned affiliates	348		335
Assets held for sale	7		25
Other noncurrent assets	829		958
Total assets	$	9,315	$	10,778
Liabilities and Shareholders' Equity
Short-term debt	$	9	$	17
Current portion of long-term debt	11		167
Accounts payable	2,361		2,130
Accrued compensation and benefits	336		389
Liabilities held for sale	—		16
Restructuring reserve	70		115
Other current liabilities	600		677
Current liabilities	3,387		3,511
Long-term debt	2,707		3,512
Liabilities held for sale	—		—
Pension and postretirement benefits	110		128
Other noncurrent liabilities	613		669
Long-term liabilities	3,430		4,309
Commitments and Contingencies (Note 17)
Redeemable noncontrolling interests	45		240
Preferred shares issued, par value $0.001; 100,000,000 shares authorized, Zero shares issued and outstanding at June 30, 2022	—		—
Ordinary shares issued, par value $0.001; 500,000,000 shares authorized, 94,813,661 shares issued and outstanding at June 30, 2022	—		—
Additional paid-in capital	4,018		3,991
Accumulated deficit	(1,153)		(988)
Accumulated other comprehensive income (loss)	(742)		(627)
Shareholders' equity attributable to Adient	2,123		2,376
Noncontrolling interests	330		342
Total shareholders' equity	2,453		2,718
Total liabilities and shareholders' equity	$	9,315	$	10,778

The accompanying notes are an integral part of the consolidated financial statements.

Adient plc | Form 10-Q | 5

Adient plc

Consolidated Statements of Cash Flows

(unaudited)

	Nine Months Ended June 30,
(in millions)	2022		2021
Operating Activities
Net income (loss) attributable to Adient	$	(165)	$	148
Income attributable to noncontrolling interests	55		70
Net income (loss)	(110)		218
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities:
Depreciation	223		210
Amortization of intangibles	40		29
Pension and postretirement expense (benefit)	(1)		(1)
Pension and postretirement contributions, net	(17)		(18)
Equity in earnings of partially-owned affiliates, net of dividends received (includes purchase accounting amortization of $1 and $3, respectively)	(38)		106
Impairment/(gain) on sale of nonconsolidated partially-owned affiliates	8		(33)
Premium and transaction costs paid on repurchase of debt	34		50
Retrospective recoveries of Brazil indirect tax credits	—		(38)
Derivative loss on the 2021 Yanfeng Transaction	3		24
Deferred income taxes	5		(5)
Non-cash impairment charges	12		11
Equity-based compensation	21		36
Other	14		16
Changes in assets and liabilities:
Receivables	(415)		195
Inventories	(26)		(158)
Other assets	62		(63)
Restructuring reserves	(49)		(118)
Accounts payable and accrued liabilities	283		(142)
Accrued income taxes	(11)		43
Cash provided (used) by operating activities	38		362
Investing Activities
Capital expenditures	(170)		(186)
Sale of property, plant and equipment	18		23
Settlement of derivatives	(30)		—
Advance payment for business acquisitions	(19)		(271)
Proceeds from business divestitures	740		72
Loans to affiliates	—		15
Cash provided (used) by investing activities	539		(347)
Financing Activities
Increase (decrease) in short-term debt	(8)		36
Increase (decrease) in long-term debt	—		214
Repayment of long-term debt	(888)		(890)
Debt financing costs	(1)		(8)
Cash paid to acquire a noncontrolling interest	(153)		—
Dividends paid to noncontrolling interests	(102)		(66)
Other	(12)		(4)
Cash provided (used) by financing activities	(1,164)		(718)
Effect of exchange rate changes on cash and cash equivalents	(42)		12
Increase (decrease) in cash and cash equivalents, including cash classified within current assets held for sale	(629)		(691)
Change in cash classified within current assets held for sale	—		(1)
Increase (decrease) in cash and cash equivalents	(629)		(692)
Cash and cash equivalents at beginning of period	1,521		1,692
Cash and cash equivalents at end of period	$	892	$	1,000

The accompanying notes are an integral part of the consolidated financial statements.

Adient plc | Form 10-Q | 6

Adient plc

Notes to Consolidated Financial Statements

(unaudited)

1. Basis of Presentation and Summary of Significant Accounting Policies

Adient is a global leader in the automotive seating supplier industry. Adient has a leading market position in the Americas, Europe and China, and has longstanding relationships with the largest global original equipment manufacturers, or OEMs, in the automotive space. Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests and trim covers. Adient is an independent seat supplier with global scale and the capability to design, develop, engineer, manufacture, and deliver complete seat systems and components in every major automotive producing region in the world.

Basis of Presentation

The consolidated financial statements of Adient have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"). During the second half of fiscal 2021 and continuing into the first nine months of fiscal 2022, Adient faced, along with the entire global automotive industry, widespread supply chain disruptions primarily related to semiconductor chip shortages. Although Adient’s seating products are not highly dependent directly on semiconductor chips, Adient is directly impacted by the lower production levels at OEM’s as a direct result of these supply chain disruptions. These disruptions have led to unplanned down time at Adient’s production facilities, often with very little warning, which creates operating inefficiencies and limits Adient’s ability to adequately mitigate such inefficiencies. Further, the Russia/Ukraine conflict has created additional risks to the macroeconomic environment of the global automotive industry by restricting availabilities of certain key raw material components. Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information on the impacts from the Russia/Ukraine conflict.

The automotive industry has also experienced price increases for commodities, utilities and shipping costs throughout fiscal 2022 which have negatively impacted Adient's results. These cost increases may continue into the future as demand increases and supply may remain constrained, which has resulted in, and may continue to result in, increased costs for Adient that may not be, or may only be partially, offset. Adient has also experienced wage inflationary pressures as a result of constrained labor availability in fiscal 2022.

Additionally, the impact of COVID-19, and related variants and sub-variants, continues to be present throughout the world, including in all global and regional markets served by Adient. The elevated COVID-19 rates in China led to widespread lockdowns during the second and third quarters of fiscal 2022, negatively impacting the automotive production levels in that region, along with creating further supply chain disruptions. Although vaccines have been introduced that are expected to have the result of reducing the effect of COVID-19 and COVID-19 has waned in certain geographic areas, governmental authorities continue to implement numerous measures attempting to contain and mitigate the effects of COVID-19, including travel bans and restrictions, quarantines, social distancing orders, shelter in place orders and shutdowns of non-essential activities. Adient's manufacturing facilities are located in areas that continue to be affected by the pandemic.

Principles of Consolidation

Adient consolidates its wholly-owned subsidiaries and those entities in which it has a controlling interest. Investments in partially-owned affiliates are accounted for by the equity method when Adient's interest exceeds 20% and does not have a controlling interest.

Consolidated VIEs

Based upon the criteria set forth in the Financial Accounting Standards Board (the FASB) Accounting Standards Codification (ASC) 810, "Consolidation," Adient has determined that it was the primary beneficiary in two variable interest entities (VIEs) for the reporting periods ended June 30, 2022, and September 30, 2021, respectively, as Adient absorbs significant economics of the entities and has the power to direct the activities that are considered most significant to the entities.

The two VIEs manufacture seating products in North America for the automotive industry. Adient funds the entities' short-term liquidity needs through revolving credit facilities and has the power to direct the activities that are considered most significant to the entities through its key customer supply relationships.

The carrying amounts and classification of assets (none of which is restricted) and liabilities included in Adient's consolidated statements of financial position for the consolidated VIEs are as follows:

Adient plc | Form 10-Q | 7

(in millions)	June 30, 2022		September 30, 2021
Current assets	$	223	$	158
Noncurrent assets	105		88
Total assets	$	328	$	246
Current liabilities	$	193	$	143
Noncurrent liabilities	13		8
Total liabilities	$	206	$	151

Earnings Per Share

The following table shows the computation of basic and diluted earnings (loss) per share:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions, except per share data)	2022		2021		2022		2021
Numerator:
Net income (loss) attributable to Adient	$	(30)	$	(71)	$	(165)	$	148
Denominator:
Shares outstanding	94.8		94.2		94.7		94.1
Effect of dilutive securities	—		—		—		1.5
Diluted shares	94.8		94.2		94.7		95.6
Earnings (loss) per share:
Basic	$	(0.32)	$	(0.75)	$	(1.74)	$	1.57
Diluted	$	(0.32)	$	(0.75)	$	(1.74)	$	1.55

The effect of common stock equivalents which would have been anti-dilutive was excluded from the calculation of diluted earnings per share for the nine months ended June 30, 2021. Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings per share which for the three and nine months ended June 30, 2022 and for the three months ended June 30, 2021 is a result of being in a loss position.

New Accounting Pronouncements

Standards Adopted During Fiscal 2022

On October 1, 2021, Adient adopted Accounting Standards Codification (ASU) 2018-14 Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20). ASU 20218-14 eliminates, adds, and modifies certain disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The guidance is to be applied on a retrospective basis. The adoption of this guidance on October 1, 2021 did not significantly impact Adient's consolidated financial statements for the nine months ended June 30, 2022.

On October 1, 2021, Adient adopted ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 modifies ASC 740, Income Taxes, by simplifying accounting for income taxes. As part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements, the FASB’s amendments may impact both interim and annual reporting periods. The adoption of this guidance on October 1, 2021 did not significantly impact Adient's consolidated financial statements for the nine months ended June 30, 2022.

Standards Effective After Fiscal 2022

Adient plc | Form 10-Q | 8

Adient has considered the ASUs summarized below, effective after fiscal 2022, none of which are expected to significantly impact the consolidated financial statements:

Standard Adopted	Description	Date Effective
ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40)	ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity by reducing the number of accounting models for convertible debt and convertible preferred stock.	October 1, 2022
ASU 2021-10, Government Assistance (Topic 832) - Disclosures by Business Entities about Government Assistance	The ASU requires annual disclosures of: i) information about the nature of government assistance transactions and the related accounting policy used to account for the transactions, ii) the balance sheet and income statement line items affected by the transactions, and the amounts for each financial statement line item, and iii) significant transaction terms and conditions.	October 1, 2022

2. Revenue Recognition

Adient generates revenue through the sale of automotive seating solutions, including complete seating systems and the components of complete seating systems. Adient provides production and service parts to its customers under awarded multi-year programs. The duration of a program is generally consistent with the life cycle of a vehicle, however, the program can be canceled at any time without cause by the customer. Programs awarded to Adient to supply parts to its customers do not contain a firm commitment by the customer for volume or price and do not reach the level of a performance obligation until Adient receives either a purchase order and/or a materials release from the customer for a specific number of parts at a specified price, at which point an enforceable contract exists. Sales revenue is generally recognized at the point in time when parts are shipped and control has transferred to the customer, at which point an enforceable right to payment exists. Contracts may provide for annual price reductions over the production life of the awarded program, and prices are adjusted on an ongoing basis to reflect changes in product content/cost and other commercial factors. The amount of revenue recognized reflects the consideration that Adient expects to be entitled to in exchange for such products based on purchase orders, annual price reductions and ongoing price adjustments (some of which are accounted for as variable consideration and subject to being constrained), net of the impact, if any, of consideration paid to the customer.

In a typical arrangement with the customer, purchase orders are issued for pre-production activities which consist of engineering, design and development, tooling and prototypes for the manufacture and delivery of component parts. Adient has concluded that these activities are not in the scope of ASC 606.

Adient has elected to include shipping and handling fees billed to customers in revenue, while including costs of shipping and handling in cost of sales. Taxes collected from customers are excluded from revenue and credited directly to obligations to the appropriate government agencies. Payment terms with customers are established based on customary industry and regional practices. Adient has evaluated the terms of its arrangements and determined that they do not contain significant financing components.

Contract assets primarily relate to the right to consideration for work completed, but not billed at the reporting date on contracts with customers. The contracts assets are transferred to receivables when the rights become unconditional. Contract liabilities primarily relate to contracts where advance payments or deposits have been received, but performance obligations have not yet been satisfied and revenue has not been recognized. No significant contract assets or liabilities were identified at September 30, 2021 or at June 30, 2022. As described above, the issuance of a purchase order and/or a materials release by the customer represents the point at which an enforceable contract with the customer exists. Therefore, Adient has elected to apply the practical expedient in ASC 606, paragraph 606-10-50-14 and does not disclose information about the remaining performance obligations that have an original expected duration of one year or less. Refer to Note 15, "Segment Information," of the notes to consolidated financial statements for disaggregated revenue by geographical market.

Adient plc | Form 10-Q | 9

3. Acquisitions and Divestitures

2021 Yanfeng Transaction

On March 12, 2021, Adient, Yanfeng Automotive Trim Systems Company Ltd. (“Yanfeng”), Yanfeng Adient Seating Co., Ltd. (“YFAS”), a joint venture owned, directly or indirectly, by Yanfeng (50.01%) and Adient (49.99%), and KEIPER Seating Mechanisms Co., Ltd. (f/k/a Adient Yanfeng Seating Mechanisms Co., Ltd. (“AYM” or "KEIPER"), a joint venture owned, directly or indirectly, by Yanfeng (50%) and Adient (50%), entered into a Master Agreement (the “2021 Agreement”), pursuant to which the parties agreed to, among other things, the following transactions (collectively, the “2021 Yanfeng Transaction”). The 2021 Yanfeng Transaction closed on September 30, 2021 (“Closing Date”).

a.Adient transferred all of the issued and outstanding equity interest in YFAS held by Adient, which represents 49.99% of YFAS’s total issued and outstanding equity interest, to Yanfeng pursuant to the Equity Transfer Agreement, dated as of March 12, 2021, by and between Yanfeng and Adient, for CNY ¥8,064 million ($1,210 million), of which ¥3,446 million ($519 million) was paid by Yanfeng to Adient on the Closing Date, and ¥4,618 million ($691 million) was paid by Yanfeng to Adient in December 2021, and;

b.YFAS transferred all of the issued and outstanding equity interests in Yanfeng Adient Automotive Components Co., Ltd. ("CQADNT") and Adient (Langfang) Seating Co., Ltd. ("LFADNT") held directly or indirectly by YFAS to Adient for a price of ¥1,754 million ($271 million) (the “YFAS JVs Acquisition”). The YFAS JVs Acquisition was funded, in part, by annual cash dividends from YFAS and KEIPER, paid to shareholders of YFAS and KEIPER;

c.YFAS transferred all of the issued and outstanding equity interest in Yanfeng Adient Founder Motor Co., Ltd. (“YFM”) held, directly or indirectly, by YFAS, which represented 70% of YFM’s total issued and outstanding equity interest, to KEIPER for ¥71 million ($11 million) (the “YFM Sale”);

d.YFAS transferred all of the issued and outstanding equity interest in Nantong Yanfeng Adient Seating Trim Co., Ltd. (“YFAT”) held, directly or indirectly, by YFAS, which represented 75% of YFAT’s total issued and outstanding equity interest, to KEIPER for ¥113 million ($17 million) (the “YFAT Sale”);

e.Adient granted to Yanfeng a license of intellectual property for use on a non-exclusive and perpetual basis for a payment of ¥385 million ($59 million), and Yanfeng/YFAS granted to Adient a royalty-free, non-exclusive and perpetual intellectual property license of the Yanfeng/YFAS intellectual property; and

f.YFAS declared and distributed dividends in the amounts and at the times as set forth in the 2021 Agreement to its shareholders (proportionately to their ownership interest, namely 50.01% to Yanfeng and 49.99% to Adient) of approximately ¥4,168 million ($635 million) in the aggregate. YFAS paid an aggregate dividend of ¥2,809 million ($436 million) during the third quarter of fiscal 2021, and ¥1,359 million ($199 million) was distributed on the Closing Date.

In addition, on March 12, 2021, Adient, YFAS, Yanfeng and KEIPER, entered into an Ancillary Master Agreement (the “Ancillary Master Agreement”), pursuant to which the parties have agreed to, among other things, the following transactions (collectively, the “Ancillary Transactions”). The Ancillary Transactions were also completed on the Closing Date.

a.Adient and Yanfeng amended the KEIPER Equity Joint Venture Contract, dated as of January 31, 2020, as amended, and the Articles of Association of KEIPER, dated as of September 9, 2013, as amended, to, among other things, (i) provide that KEIPER would declare and pay certain annual dividends to KEIPER’s shareholders with respect to each of its 2021 to 2023 fiscal years and (ii) upon closing of the earlier of the YFAT Sales (as defined below) or YFM Sale, because of KEIPER’s ownership of YFAT and YFM, certain amendments relating thereto, including modifying the scope of KEIPER’s business to include the manufacture and sale of automotive seat trim products and micro-motors; and

b.KEIPER and Yanfeng and KEIPER and Adient each entered into a long-term supply agreement.

In conjunction with the 2021 Yanfeng Transaction, Adient entered into an agreement (the “Boxun Agreement”) with Chongqing Boxun Industrial Co., Ltd. (“Boxun”). Pursuant to such agreement, upon consummation of the YFAS JVs Acquisition, Adient provided Boxun with the right to sell and, if exercised, Adient agreed to purchase, all of the issued and outstanding equity interest in CQADNT held by Boxun, which represents 25% of CQADNT’s total issued and outstanding equity interest (the “Boxun Equity Purchase”). On October 29, 2021, Boxun exercised its right to sell its equity interest to

Adient plc | Form 10-Q | 10

Adient. In January 2022, Boxun and Adient closed the transaction. The total payment to Boxun from Adient was approximately $200 million, of which $15 million of historical dividends were paid in December 2021, and $185 million, including $32 million of historical dividends, was paid in the second quarter of fiscal 2022. At September 30, 2021, $194 million had been reflected as redeemable noncontrolling interest. With the acquisitions of Boxun’s 25% and YFAS’s 50% interest of CQADNT, Adient owns 100% of CQADNT effective January 2022.

In addition, in conjunction with the 2021 Yanfeng Transaction, Adient entered into agreements, whereby, Adient would: (i) transfer all of the issued and outstanding equity interest in YFAT held, directly or indirectly, by Adient, which represents 25% of YFAT’s total issued and outstanding equity interest, to KEIPER for ¥38 million ($6 million) (the “Adient YFAT Sale” and together with the YFAT Sale, the “YFAT Sales”); (ii) transfer all of the issued and outstanding equity interest in Guangzhou Dongfeng Adient Seating Co., Ltd. (“GZDFAS”) held by Adient, which represents 25% of GZDFAS’s total issued and outstanding equity interest, to YFAS for ¥371 million ($56 million) (the “GZDFAS Sale”) and (iii) transfer all of the issued and outstanding equity interest in Hefei Adient Yunhe Automotive Seating Co., Ltd. (“YHAS”) held by Adient, which represents 10% of YHAS’s total issued and outstanding equity interest, to YFAS for ¥13 million ($2 million) (the “YHAS Sale,” together with the Adient YFAT Sale and GZDFAS Sale, each an “Additional Equity Sale” and collectively, the “Additional Equity Sales”). The Additional Equity Sales were completed on the Closing Date.

As a result of the 2021 Agreement, Adient received $41 million in November 2021 representing the remaining balance of proceeds from the sale of its interest in Yanfeng Global Automotive Interior Systems Co. ("YFAI"), a joint venture previously owned, directly or indirectly, by Yanfeng (70%) and Adient (30%), which was part of the 2020 Yanfeng Transaction (as defined and described in Form 10-K for the fiscal year ended September 30, 2021).

Upon completion of the 2021 Yanfeng Transaction on September 30, 2021, Adient started consolidating CQADNT and LFADNT. The net purchase consideration of $271 million consisted of net cash consideration of $211 million, net of $60 million acquired. The acquisition was accounted for using the acquisition method, and the operating results and cash flows of CQADNT and LFADNT will be included in Adient's consolidated financial statements starting from October 1, 2021. The acquisitions are expected to provide substantial synergies through vertical integration, purchasing and logistics improvements. The acquisitions also provide for an immediate manufacturing presence in strategic locations in China.

Adient recorded a purchase price allocation for the assets acquired and liabilities assumed based on their estimated fair values as of the September 30, 2021 acquisition date. The preliminary purchase price adjustments and allocation is as follows:

	Fair value allocation
(in millions)	CQADNT		LFADNT
Cash	$	55	$	5
Accounts receivable	296		2
Inventory	37		5
Property, plant and equipment	86		8
Other assets	46		2
Goodwill	180		8
Intangible assets	234		6
Accounts payable	(252)		(19)
Other liabilities	(127)		(4)
Subtotal	555		13
Less: Interest already owned	103		—
Less: Redeemable noncontrolling interest	194		—
Total purchase consideration	258		13
Less: cash acquired	55		5
Net cash paid	$	203	$	8

The values allocated to CQADNT and LFADNT’s intangible assets of $234 million and $6 million, respectively, primarily consisted of customer relationships and patented technologies which are being amortized on a straight line basis over estimated useful lives of 3 to 12 years. The assets were valued using a combination of an income approach and a relief from royalty

Adient plc | Form 10-Q | 11

approach. These values were considered level 3 measurements under the U.S. GAAP fair value hierarchy. Key assumptions used in the valuation of customer relationships included a rate of return of 13.5% and the life of the relationship of approximately 12 years. Key assumptions used in the valuation of patented technologies included a rate of return of 13.5% and the life of the technologies of approximately 10 years.

The allocation of the purchase price was based on the valuations performed to determine the fair value of the net assets as of the acquisition date. The amounts allocated to goodwill and intangible assets along with fair value adjustments on property, plant and equipment and inventory reflected preliminary valuations.

In April 2022, Adient entered into an agreement whereby Adient would purchase all of the issued and outstanding equity interest in YFAT held by KEIPER for ¥150 million ($24 million). Adient made an initial deposit of ¥37 million ($6 million) (reflected within other current assets as of June 30, 2022), and a second deposit of ¥37 million ($6 million) in April 2022, which represents 50% of the estimated purchase price. The transaction is subject to a public bidding process and other customary regulatory approvals, and is expected to be completed in the second half of calendar year 2022. The remaining 50% of the estimated purchase price will be paid at the time of completion of the transaction.

Also, Adient has entered into agreements whereby Adient would transfer all of the issued and outstanding equity interests in two joint ventures in China held directly by Adient, each of which represents 25% of their total issued and outstanding equity interests, to Yanfeng for $3 million. As a result, Adient concluded that indicators of other-than-temporary impairment were present related to the investments in these joint ventures, and recorded a non-cash impairment charge of $3 million during the second quarter of fiscal 2022. The transactions are expected to be completed during the second half of fiscal 2022.

SJA

On March 31, 2021, Adient sold its 50% equity interest in Shenyang Jinbei Adient Automotive Components Co., Ltd. ("SJA") to the joint venture partner for $58 million, which resulted in a $33 million one-time gain recognized during the second quarter of fiscal 2021. The receivable was recorded as part of other current assets on March 31, 2021, and the net proceeds of $53 million were received on April 1, 2021.

Russia/Ukraine conflict

Following Russia's invasion of Ukraine in February 2022, Adient has determined to withdraw from the Russian market. Adient recorded a charge of $3 million during the second quarter of fiscal 2022, which included a $2 million impairment of Adient's Russian entity and $1 million of allowance for doubtful accounts in EMEA. Adient's Russian operation, which primarily produces automotive seating trim products for the domestic market, recorded $7 million of net sales and de minimis amount of net income in fiscal 2021. In July 2022, Adient entered into a sale agreement and finalized the sale transaction of its Russian operation for one ruble. In conjunction with the sale transaction, Adient will record an additional charge of $3 million related to accumulated foreign currency translation losses that are reflected in accumulated other comprehensive income (loss) under shareholders' equity on Adient's consolidated statements of financial position as of June 30, 2022.

Assets held for sale

During the first quarter of fiscal 2022, Adient committed to sell certain assets in EMEA. As a result, these assets were classified as assets held for sale and were required to be adjusted to the lower of fair value less cost to sell or carrying value. This resulted in an impairment charge of $7 million. The impairment was measured using third party sales pricing to determine fair values of the assets. The inputs utilized in the analyses are classified as Level 3 inputs within the fair value hierarchy as defined in ASC 820, "Fair Value Measurement." During the third quarter of fiscal 2022, the impairment charge was reduced by $1 million as the finalized sale agreement indicated a higher sale price than the originally estimated fair value.

During the second quarter of fiscal 2022, Adient collected the final portion of proceeds from the sale of certain assets in Turkey, which had been classified as assets held for sale during fiscal 2021. The finalization of the transaction resulted in a loss on sale of $2 million, recorded within selling, general and administrative costs on the consolidated statement of income (loss) in the second quarter of fiscal 2022.

During fiscal 2021, Adient committed to sell certain assets in France and Turkey. As a result, these assets were classified as assets held for sale (including an allocation of $11 million of goodwill) and were required to be adjusted to the lower of fair value less cost to sell or carrying value. This resulted in Adient recording an impairment charge of $9 million within restructuring and impairment costs on the consolidated statement of income (loss) related to the assets in France. The impairment was measured using third party sales pricing to determine fair values of the assets. The inputs utilized in the analyses are classified as Level 3 inputs within the fair value hierarchy as defined in ASC 820, "Fair Value Measurement." The

Adient plc | Form 10-Q | 12

sale of the assets in France was completed during the third quarter of fiscal 2021 for minimal proceeds while the sale of the assets in Turkey was completed in October 2021 for total proceeds of $46 million, of which $36 million was collected at closing, and $10 million was collected in the second quarter of fiscal 2022.

4. Inventories

Inventories consisted of the following:

(in millions)	June 30, 2022		September 30, 2021
Raw materials and supplies	$	765	$	750
Work-in-process	24		29
Finished goods	164		197
Inventories	$	953	$	976

5. Goodwill and Other Intangible Assets

The changes in the carrying amount of goodwill are as follows:

(in millions)	Americas		EMEA		Asia		Total
Balance at September 30, 2021	$	607	$	354	$	1,251	$	2,212
Currency translation and other	1		(38)		(53)		(90)
Balance at June 30, 2022	$	608	$	316	$	1,198	$	2,122

Refer to Note 15, "Segment Information," of the notes to consolidated financial statements for more information on Adient's reportable segments.

Adient's other intangible assets, primarily from business acquisitions valued based on independent appraisals, consisted of:

	June 30, 2022						September 30, 2021
(in millions)	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Intangible assets
Patented technology	$	86	$	(24)	$	62	$	86	$	(19)	$	67
Customer relationships	627		(201)		426		649		(178)		471
Trademarks	18		(16)		2		26		(21)		5
Miscellaneous	26		(12)		14		24		(12)		12
Total intangible assets	$	757	$	(253)	$	504	$	785	$	(230)	$	555

Amortization of other intangible assets for the nine months ended June 30, 2022 and 2021 was $40 million and $29 million, respectively.

Refer to Note 15, "Segment Information," of the notes to consolidated financial statements for more information on Adient's reportable segments.

Adient plc | Form 10-Q | 13

6. Product Warranties

Adient offers warranties to its customers depending upon the specific product and terms of the customer purchase agreement. A typical warranty program requires that Adient replace defective products within a specified time period from the date of sale. Adient records an estimate for future warranty-related costs based on actual historical return rates and other known factors. Based on analysis of return rates and other factors, Adient's warranty provisions are adjusted as necessary. Adient monitors its warranty activity and adjusts its reserve estimates when it is probable that future warranty costs will be different than those estimates. Adient's product warranty liability is recorded in the consolidated statements of financial position in other current liabilities.

The changes in Adient's total product warranty liability are as follows:

	Nine Months Ended June 30,
(in millions)	2022		2021
Balance at beginning of period	$	23	$	24
Accruals for warranties issued during the period	7		7
Changes in accruals related to pre-existing warranties (including changes in estimates)	—		(1)
Settlements made (in cash or in kind) during the period	(7)		(6)
Currency translation	(1)		—
Balance at end of period	$	22	$	24

7. Leases

Adient's lease portfolio consists of operating leases for real estate including production facilities, warehouses and administrative offices, equipment such as forklifts and computer servers and laptops, and fleet vehicles.

The components of lease costs included in the consolidated statement of income (loss) for the three and nine months ended June 30, 2022 and 2021 were as follows:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Operating lease cost	$	32	$	32	$	90	$	94
Short-term lease cost	2		4		14		16
Total lease cost	$	34	$	36	$	104	$	110

Operating lease right-of-use assets and lease liabilities included in the consolidated statement of financial position were as follows:

Adient plc | Form 10-Q | 14

(in millions)		June 30, 2022			September 30, 2021
Operating leases:
Operating lease right-of-use assets	Other noncurrent assets	$	293		$	335
Operating lease liabilities - current	Other current liabilities	$	85		$	89
Operating lease liabilities - noncurrent	Other noncurrent liabilities	209			246
		$	294		$	335
Weighted average remaining lease term:
Operating leases		6 years			6 years
Weighted average discount rate:
Operating leases		5.4		%	5.2		%

Maturities of operating lease liabilities and minimum payments for operating leases having initial or remaining non-cancelable terms in excess of one year as of June 30, 2022 are as follows:

	Operating leases
Fiscal years (in millions)	June 30, 2022
2022 (excluding the nine months ended June 30, 2022)	$	26
2023	89
2024	66
2025	47
2026	31
Thereafter	81
Total lease payments	340
Less: imputed interest	(46)
Present value of lease liabilities	$	294

Supplemental cash flow information related to leases is as follows:

	Nine Months Ended June 30,
(in millions)	2022		2021
Right-of-use assets obtained in exchange for lease obligations:
Operating leases (non-cash activity)	$	38	$	102
Operating cash flows:
Cash paid for amounts included in the measurement of lease liabilities	$	89	$	96

Adient plc | Form 10-Q | 15

8. Debt and Financing Arrangements

Debt consisted of the following:

(in millions)	June 30, 2022		September 30, 2021
Long-term debt:
Term Loan B - LIBOR plus 3.25% due in 2028	$	990	$	998
4.875% Notes due in 2026	795		795
3.50% Notes due in 2024	860		1,161
9.00% Notes due in 2025	92		600
European Investment Bank Loan - EURIBOR plus 1.58% due in 2022	—		156
Finance lease obligations	1		1
Less: debt issuance costs	(20)		(32)
Gross long-term debt	2,718		3,679
Less: current portion	11		167
Net long-term debt	$	2,707	$	3,512
Short-term debt:
Other bank borrowings	$	9	$	17
Total short-term debt	$	9	$	17

Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintains an asset-based revolving credit facility (the “ABL Credit Facility”), which provides for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity and certain other restrictions, including a minimum fixed charge coverage ratio. The ABL Credit Facility will mature on May 6, 2024, subject to a springing maturity date 91 days earlier if certain amounts remain outstanding at that time under the Term Loan B Agreement (defined below). Adient will pay a commitment fee of 0.25% to 0.375% on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the ABL Credit Facility then in effect. Subject to certain conditions, the ABL Credit Facility may be expanded by up to $250 million in additional commitments. Loans under the ABL Credit Facility may be denominated, at the option of Adient, in U.S. dollars, Euros, Pounds Sterling or Swedish Kroner. The ABL Credit Agreement is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. On November 24, 2021, Adient entered into an amendment to its ABL Credit Facility (the “ABL Amendment”) to amend certain terms and provisions, including to (i) change the interest rate benchmark rates applicable under the ABL Credit Facility for borrowings denominated in euro, Swedish krona and pounds sterling to EURIBOR, STIBOR, and SONIA, in each case subject to certain adjustments, and (ii) update the provisions in our ABL Credit Facility by which U.S. dollar LIBOR will eventually be replaced with SOFR or another interest rate benchmark, in each case, to reflect the most recent standards and practices used in the industry. Interest is payable on the ABL Credit Facility at a fluctuating rate of interest determined by reference to LIBOR, in the case of amounts outstanding in dollars, EURIBOR, in the case of amounts outstanding in euros, STIBOR, in the case of amounts outstanding in Swedish krona and SONIA, in the case of amounts outstanding in pounds sterling, in each case, plus an applicable margin of 1.50% to 2.00%. As of June 30, 2022, Adient had not drawn down on the ABL Credit Facility and had availability under this facility of $780 million (net of $42 million of letters of credit).

In addition, Adient US and Adient Global Holdings S.à r.l., a wholly-owned subsidiary of Adient, maintain a term loan credit agreement (the “Term Loan B Agreement”) that initially provided for a 5-year $800 million senior secured term loan facility that was fully drawn on closing. The Term Loan B Agreement amortizes in equal quarterly installments at a rate of 1.00% per annum of the original principal amount thereof, with the remaining balance originally due at final maturity on May 6, 2024. Interest on the Term Loan B Agreement accrues at the Eurodollar rate plus an applicable margin originally equal to 4.25% (with one 0.25% step down based on achievement of a specific secured net leverage level starting with the fiscal quarter ending December 31, 2019). The Term Loan B Agreement also permits Adient to incur incremental term loans in an aggregate amount not to exceed the greater of $750 million and an unlimited amount subject to a pro forma first lien secured net leverage ratio of

Adient plc | Form 10-Q | 16

not greater than 1.75 to 1.00 and certain other conditions. In April 2021, Adient amended the Term Loan B Agreement ("Amended Agreement") which, among other changes (i) extended the maturity date for loans outstanding to April 8, 2028, (ii) reduced the interest rate margin applicable thereunder by 0.75% to 3.50%, in the case of Eurodollar Rate loans, and 2.50% (in the case of Base Rate loans) (in each case, with one 0.25% step down based on achievement of a specified first lien secured net leverage level starting with the fiscal quarter ending December 31, 2021) and (iii) made certain other negative covenant and mandatory prepayment changes in connection therewith. The amendment also established incremental term loans in an aggregate principal amount of $214 million resulting in total loans outstanding under the Amended Agreement of $1.0 billion. Adient paid $7 million related to the Amended Agreement and wrote off $8 million of previously deferred financing costs as a result of the debt extinguishment during the third quarter of fiscal 2021.

Adient US was also a party to an indenture relating to the issuance of $800 million aggregate principal amount of Senior First Lien Notes. The notes originally mature on May 15, 2026 and bore interest at a rate of 7.00% per annum. Interest on these notes was payable semi-annually in arrears on November 15 and May 15 of each year, commencing on November 15, 2019. During the second quarter of fiscal 2021, Adient repurchased $640 million of the outstanding balance of the Senior First Lien Notes at a price of 107% of the principal plus $17 million of accrued and unpaid interest. As a result, $9 million of previously deferred financing costs was written off to net financing charges. During the third quarter of fiscal 2021, Adient redeemed the $160 million of remaining balance of the Senior First Lien Notes at a price of 103% of the principal plus $4 million of accrued and unpaid interest, and wrote off $3 million of previously deferred financing costs as a result of the debt extinguishment.

The ABL Credit Facility, Term Loan B Agreement and the Senior First Lien Notes due 2026 contain covenants that are usual and customary for facilities and debt instruments of this type and that, among other things, restrict the ability of Adient and its restricted subsidiaries to: create certain liens and enter into sale and lease-back transactions; create, assume, incur or guarantee certain indebtedness; pay dividends or make other distributions on, or repurchase or redeem, Adient’s capital stock or certain other debt; make other restricted payments; and consolidate or merge with, or convey, transfer or lease all or substantially all of Adient’s and its restricted subsidiaries’ assets, to another person. These covenants are subject to a number of other limitations and exceptions set forth in the agreements. The agreements also provide for customary events of default, including, but not limited to, cross-default clauses with other debt arrangements, failure to pay principal and interest, failure to comply with covenants, agreements or conditions, and certain events of bankruptcy or insolvency involving Adient and its significant subsidiaries.

Adient Global Holdings Ltd. ("AGH"), a wholly-owned subsidiary of Adient, previously maintained $900 million aggregate principal amount of 4.875% USD-denominated unsecured notes due 2026. During the fourth quarter of fiscal 2020, Adient redeemed $103 million of face value of these notes, resulting in a remaining balance of $797 million as of September 30, 2020. Adient further redeemed $2 million of the notes during fiscal 2021, resulting in a remaining balance of $795 million as of June 30, 2022 and September 30, 2021. AGH also previously maintained €1.0 billion aggregate principal amount of 3.50% unsecured notes due 2024. In February 2022, Adient repurchased €177 million ($198 million) of the 3.50% unsecured notes due 2024 at a price of 102% of the principal plus €17 million ($19 million) of accrued and unpaid interest, and wrote off €1 million ($1 million) of previously deferred financing costs to net financing charges. As of June 30, 2022, the remaining balance of this debt was €823 million ($860 million).

Adient Germany Ltd. & Co. KG, a wholly owned subsidiary of Adient, previously maintained €135 million ($150 million) in an unsecured term loan from the European Investment Bank ("EIB") due in 2022. The loan bore interest at the 6-month EURIBOR rate plus 158 basis points. During the first quarter of fiscal 2021, Adient repaid $16 million of the EIB loan, triggered in part by the redemption of debt in the prior year. Adient repaid $20 million of the EIB loan in May 2021, triggered by the prior year sale of the fabrics business. Adient fully repaid the remaining balance of the EIB loan in May 2022 upon its maturity.

On April 20, 2020, Adient US issued $600 million (net proceeds of $591 million) aggregate principal amount of 9.00% Senior First Lien Notes due 2025. These notes will mature on April 15, 2025, provided that if AGH has not refinanced (or otherwise redeemed) in whole its outstanding 3.50% unsecured notes due 2024 or any refinancing indebtedness thereof that matures earlier than 91 days prior to the maturity date of the Senior First Lien Notes due 2025 on or prior to May 15, 2024, these notes will mature on May 15, 2024. Interest on these notes is due on April 15 and October 15 each year, beginning on October 15, 2020. These notes contain covenants that are usual and customary, similar to the covenants on the Senior First Lien Notes due 2026 as described above. Adient incurred $10 million of debt issuance cost associated with this new debt in fiscal 2020. In February 2022, Adient repurchased $508 million of 9.00% Senior First Lien Notes due 2025 at a price of 105.875% of the principal plus $15 million of accrued and unpaid interest, and wrote off $6 million of previously deferred financing costs to net financing charges. As of June 30, 2022, the remaining balance of this debt was $92 million.

Adient plc | Form 10-Q | 17

Net Financing Charges

Adient's net financing charges in the consolidated statements of income (loss) contained the following components:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Interest expense, net of capitalized interest costs	$	36	$	46	$	121	$	162
Banking fees and debt issuance cost amortization	6		14		20		27
Interest income	(2)		(2)		(5)		(6)
Premium paid on repurchase of debt	—		4		34		49
Derivative loss on Yanfeng transaction	—		24		3		24
Net foreign exchange	(1)		1		(1)		—
Net financing charges	$	39	$	87	$	172	$	256

Total interest paid on both short and long-term debt for the nine months ended June 30, 2022 and 2021 was $126 million and $183 million, respectively.

Adient enters into supply chain financing programs in certain domestic and foreign jurisdictions to either sell or discount accounts receivable without recourse to third-party institutions. Sales or discounts of accounts receivable are reflected as a reduction of accounts receivable on the consolidated statements of financial position and the proceeds are included in cash flows from operating activities in the consolidated statements of cash flows. As of June 30, 2022, $262 million has been funded under these programs compared to $126 million as of September 30, 2021.

9. Derivative Instruments and Hedging Activities

Adient selectively uses derivative instruments to reduce Adient's market risk associated with changes in foreign currency. Under Adient's policy, the use of derivatives is restricted to those intended for hedging purposes; the use of any derivative instrument for speculative purposes is strictly prohibited. A description of each type of derivative utilized to manage Adient's risk is included in the following paragraphs. In addition, refer to Note 10, "Fair Value Measurements," of the notes to consolidated financial statements for information related to the fair value measurements and valuation methods utilized by Adient for each derivative type.

Adient has global operations and participates in the foreign exchange markets to minimize its risk of loss from fluctuations in foreign currency exchange rates. Adient primarily uses foreign currency exchange contracts to hedge certain foreign exchange rate exposures. Adient hedges 70% to 90% of the nominal amount of each of its known foreign exchange transactional exposures. Gains and losses on derivative contracts offset gains and losses on underlying foreign currency exposures. These contracts have been designated as cash flow hedges under ASC 815, "Derivatives and Hedging," and the hedge gains or losses due to changes in fair value are initially recorded as a component of accumulated other comprehensive income (AOCI) and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. All contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at June 30, 2022 and September 30, 2021, respectively.

As of June 30, 2022, the €823 million ($860 million) aggregate principal amount of 3.50% euro-denominated unsecured notes due 2024 was designated as a net investment hedge to selectively hedge portions of Adient's net investment in Europe. The currency effects of Adient's euro-denominated bonds are reflected in the AOCI account within shareholders' equity attributable to Adient where they offset gains and losses recorded on Adient's net investment in Europe.

Adient entered into a cross-currency interest rate swap during fiscal 2019 to selectively hedge portions of its net investment in Japan. The currency effects of the cross-currency interest rate swap is reflected in the AOCI account within shareholders' equity attributable to Adient, where they offset gains and losses recorded on Adient's net investment in Japan. The contract matured during the fourth quarter of fiscal 2021. As of June 30, 2022, there was no outstanding Japanese yen denominated cross-currency interest rate swap.

Adient plc | Form 10-Q | 18

Adient purchased interest rate caps during fiscal 2019 to selectively limit the impact of USD LIBOR increases on its interest payments related to Adient's Term Loan B Agreement. The interest rate caps were designated as cash flow hedges under ASC 815. As of June 30, 2022, Adient had two outstanding interest rate caps with total notional amount of approximately $200 million. During the third quarter of fiscal 2021, in conjunction with the Term Loan B Amendment as discussed in Note 8, "Debt and Financing Arrangements," Adient de-designated these two contracts, the impact of which was not material.

Adient entered into a ¥150 million ($23 million) foreign exchange forward contract during the second quarter of fiscal 2022 to selectively hedge portions of its net investment in China. The currency effects of the forward contract are reflected in the AOCI account within shareholder’s equity attributable to Adient, where they offset gains and losses recorded on Adient’s net investment in China. The forward contract is set to mature in October 2022.

The following table presents the location and fair values of derivative instruments and other amounts used in hedging activities included in Adient's consolidated statements of financial position:

	Derivatives and Hedging Activities Designated as Hedging Instruments under ASC 815				Derivatives and Hedging Activities Not Designated as Hedging Instruments under ASC 815
(in millions)	June 30, 2022		September 30, 2021		June 30, 2022		September 30, 2021
Other current assets
Foreign currency exchange derivatives	$	9	$	8	$	1	$	—
Other noncurrent assets
Foreign currency exchange derivatives	—		—		—		1
Total assets	$	9	$	8	$	1	$	1
Other current liabilities
Foreign currency exchange derivatives	$	17	$	11	$	—	$	13
Other noncurrent liabilities
Foreign currency exchange derivatives	3		4		—		—
Long-term debt
Foreign currency denominated debt	860		1,161		—		—
Total liabilities	$	880	$	1,176	$	—	$	13

Adient enters into International Swaps and Derivatives Associations (ISDA) master netting agreements with counterparties that permit the net settlement of amounts owed under the derivative contracts. The master netting agreements generally provide for net settlement of all outstanding contracts with a counterparty in the case of an event of default or a termination event. Adient has not elected to offset the fair value positions of the derivative contracts recorded in the consolidated statements of financial position. Collateral is generally not required of Adient or the counterparties under the master netting agreements. As of June 30, 2022 and September 30, 2021, no cash collateral was received or pledged under the master netting agreements.

The gross and net amounts of derivative instruments and other amounts used in hedging activities are as follows:

	Assets				Liabilities
(in millions)	June 30, 2022		September 30, 2021		June 30, 2022		September 30, 2021
Gross amount recognized	$	10	$	9	$	880	$	1,189
Gross amount eligible for offsetting	(10)		(9)		(10)		(9)
Net amount	$	—	$	—	$	870	$	1,180

The following table presents the effective portion of pretax gains (losses) recorded in other comprehensive income related to cash flow hedges:

Adient plc | Form 10-Q | 19

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Foreign currency exchange derivatives	$	(6)	$	21	$	—	$	40

The following table presents the location and amount of the effective portion of pretax gains (losses) on cash flow hedges reclassified from AOCI into Adient's consolidated statements of income:

(in millions)		Three Months Ended June 30,				Nine Months Ended June 30,
		2022		2021		2022		2021
Foreign currency exchange derivatives	Cost of sales	$	2	$	1	$	5	$	(2)

The following table presents the location and amount of pretax gains (losses) on derivatives not designated as hedging instruments recognized in Adient's consolidated statements of income (loss):

(in millions)		Three Months Ended June 30,				Nine Months Ended June 30,
		2022		2021		2022		2021
Foreign currency exchange derivatives	Cost of sales	$	(2)	$	—	$	(1)	$	(2)
Foreign currency exchange derivatives	Net financing charges	(5)		(24)		(24)		(22)
Total		$	(7)	$	(24)	$	(25)	$	(24)

The effective portion of pretax gains (losses) recorded in currency translation adjustment (CTA) within other comprehensive income (loss) related to net investment hedges was $59 million and $(17) million for the three months ended June 30, 2022 and 2021, respectively. For the three months ended June 30, 2022 and 2021, no gains or losses were reclassified from CTA into income for Adient's outstanding net investment hedges. For the three months ended June 30, 2022 and 2021, no ineffectiveness was recognized in the consolidated statements of income (loss) resulting from cash flow hedges.

10. Fair Value Measurements

ASC 820, "Fair Value Measurement," defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a three-level fair value hierarchy that prioritizes information used in developing assumptions when pricing an asset or liability as follows:

Level 1: Observable inputs such as quoted prices in active markets;

Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and

Level 3: Unobservable inputs where there is little or no market data, which requires the reporting entity to develop its own assumptions.

ASC 820 requires the use of observable market data, when available, in making fair value measurements. When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement.

Adient plc | Form 10-Q | 20

Recurring Fair Value Measurements

The following tables present Adient's fair value hierarchy for those assets and liabilities measured at fair value:

	Fair Value Measurements Using:
(in millions)	Total as of June 30, 2022		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Other current assets
Foreign currency exchange derivatives	$	10	$	—	$	10	$	—
Total assets	$	10	$	—	$	10	$	—
Other current liabilities
Foreign currency exchange derivatives	$	17	$	—	$	17	$	—
Other noncurrent liabilities
Foreign currency exchange derivatives	3		—		3		—
Total liabilities	$	20	$	—	$	20	$	—

	Fair Value Measurements Using:
(in millions)	Total as of September 30, 2021		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Other current assets
Foreign currency exchange derivatives	$	8	$	—	$	8	$	—
Other noncurrent assets
Interest rate cap	1		—		1		—
Total assets	$	9	$	—	$	9	$	—
Other current liabilities
Foreign currency exchange derivatives	$	24	$	—	$	24	$	—
Other noncurrent liabilities
Foreign currency exchange derivatives	4		—		4		—
Total liabilities	$	28	$	—	$	28	$	—

Valuation Methods

Foreign currency exchange derivatives Adient selectively hedges anticipated transactions and net investments that are subject to foreign exchange rate risk primarily using foreign currency exchange hedge contracts. The foreign currency exchange derivatives are valued under a market approach using publicized spot and forward prices. Changes in fair value on foreign exchange derivatives accounted for as hedging instruments under ASC 815 are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. These contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at June 30, 2022 and September 30, 2021, respectively. The changes in fair value of foreign currency exchange derivatives not designated as hedging instruments under ASC 815 are recorded in the consolidated statements of income.

Cross-currency interest rate swaps Adient determines the fair value of a cross-currency interest rate swap contract using a market approach which is based on quoted market price for similar instruments in markets. All significant inputs are corroborated by observable market data for the term of such a contract. Adient selectively uses cross-currency interest rate swaps to hedge portions of its net investments. As of June 30, 2022, Adient had one ¥150 million ($23 million) cross-currency interest rate swap outstanding which was designated as a net investment hedge in Adient's net investment in China.

Adient plc | Form 10-Q | 21

Interest rate caps Adient determines the fair value of an interest rate cap contract using a market approach which is based on quoted market price for identical or similar instruments in markets. All significant inputs are corroborated by observable market data for the term of such a contract. Adient selectively uses interest rate caps to limit the impact of floating rate interest payment increases on its Term Loan B Agreement. As of June 30, 2022, Adient had two interest rate caps outstanding totaling approximately $200 million which are going to mature in August 2022.

The fair value of cash and cash equivalents, accounts receivable, short-term debt and accounts payable approximate their carrying values. The fair value of long-term debt, which was $2.5 billion and $3.8 billion at June 30, 2022 and September 30, 2021, respectively, was determined primarily using market quotes classified as Level 1 inputs within the ASC 820 fair value hierarchy.

11. Equity and Noncontrolling Interests

For the nine months ended June 30, 2022:

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at September 30, 2021	$	—	$	3,991	$	(988)	$	(627)	$	2,376	$	342	$	2,718
Net income (loss)	—		—		(165)		—		(165)		29		(136)
Foreign currency translation adjustments	—		—		—		(110)		(110)		(10)		(120)
Realized and unrealized gains (losses) on derivatives	—		—		—		(5)		(5)		—		(5)
Dividends attributable to noncontrolling interests	—		—		—		—		—		(19)		(19)
Purchase of subsidiary shares from noncontrolling interest	—		12		—		—		12		(12)		—
Share based compensation and other	—		15		—		—		15		—		15
Balance at June 30, 2022	$	—	$	4,018	$	(1,153)	$	(742)	$	2,123	$	330	$	2,453

For the three months ended June 30, 2022:

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at March 31, 2022	$	—	$	4,008	$	(1,123)	$	(600)	$	2,285	$	340	$	2,625
Net income (loss)	—		—		(30)		—		(30)		6		(24)
Foreign currency translation adjustments	—		—		—		(135)		(135)		(13)		(148)
Realized and unrealized gains (losses) on derivatives	—		—		—		(7)		(7)		—		(7)
Dividends attributable to noncontrolling interests	—		—		—		—		—		(3)		(3)
Share based compensation and other	—		10		—		—		10		—		10
Balance at June 30, 2022	$	—	$	4,018	$	(1,153)	$	(742)	$	2,123	$	330	$	2,453

For the nine months ended June 30, 2021:

Adient plc | Form 10-Q | 22

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at September 30, 2020	$	—	$	3,974	$	(2,096)	$	(665)	$	1,213	$	322	$	1,535
Net income (loss)	—		—		148		—		148		51		199
Foreign currency translation adjustments	—		—		—		53		53		9		62
Realized and unrealized gains (losses) on derivatives	—		—		—		34		34		—		34
Dividends attributable to noncontrolling interests	—		—		—		—		—		(40)		(40)
Change in noncontrolling interest share	—		—		—		—		—		(3)		(3)
Share based compensation and other	—		19		—		—		19		1		20
Balance at June 30, 2021	$	—	$	3,993	$	(1,948)	$	(578)	$	1,467	$	340	$	1,807

For the three months ended June 30, 2021:

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at March 31, 2021	$	—	$	3,985	$	(1,877)	$	(619)	$	1,489	$	353	$	1,842
Net income (loss)	—		—		(71)		—		(71)		16		(55)
Foreign currency translation adjustments	—		—		—		24		24		3		27
Realized and unrealized gains (losses) on derivatives	—		—		—		17		17		—		17
Dividends attributable to noncontrolling interests	—		—		—		—		—		(29)		(29)
Change in noncontrolling interest share	—		—		—		—		—		(3)		(3)
Share based compensation and other	—		8		—		—		8		—		8
Balance at June 30, 2021	$	—	$	3,993	$	(1,948)	$	(578)	$	1,467	$	340	$	1,807

The following table presents changes in AOCI attributable to Adient:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Foreign currency translation adjustments
Balance at beginning of period	$	(592)	$	(605)	$	(617)	$	(634)
Aggregate adjustment for the period, net of tax	(135)		24		(110)		53
Balance at end of period	$	(727)	$	(581)	$	(727)	$	(581)
Realized and unrealized gains (losses) on derivatives
Balance at beginning of period	$	(6)	$	(11)	$	(8)	$	(28)
Current period changes in fair value, net of tax	(5)		18		—		33
Reclassification to income, net of tax	(2)		(1)		(5)		1
Balance at end of period	$	(13)	$	6	$	(13)	$	6
Pension and postretirement plans
Balance at beginning of period	$	(2)	$	(3)	$	(2)	$	(3)
Balance at end of period	$	(2)	$	(3)	$	(2)	$	(3)
Accumulated other comprehensive income (loss), end of period	$	(742)	$	(578)	$	(742)	$	(578)

Adient plc | Form 10-Q | 23

Adient consolidates certain subsidiaries in which the noncontrolling interest party has within their control the right to require Adient to redeem all or a portion of its interest in the subsidiary. These redeemable noncontrolling interests are reported at their estimated redemption value. Any adjustment to the redemption value impacts retained earnings but does not impact net income. Redeemable noncontrolling interests which are redeemable only upon future events, the occurrence of which is not currently probable, are recorded at carrying value. The following table presents changes in the redeemable noncontrolling interests:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Beginning balance	$	48	$	44	$	240	$	43
Net income	4		6		26		19
Dividends	—		—		(33)		(14)
Change in redeemable noncontrolling interest	—		—		(186)		—
Foreign currency translation adjustments	(7)		(2)		(2)		—
Ending balance	$	45	$	48	$	45	$	48

Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information on the change in redeemable noncontrolling interest during the nine months ended June 30, 2022.

12. Retirement Plans

Adient maintains non-contributory defined benefit pension plans covering primarily non-U.S. employees and a limited number of U.S. employees. The following table contains the components of net periodic benefit cost:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Service cost	$	1	$	2	$	5	$	6
Interest cost	2		3		8		7
Expected return on plan assets	(3)		(6)		(11)		(14)
Net actuarial and settlement/curtailment (gain) loss	(3)		(1)		(3)		(1)
Net periodic benefit cost	$	(3)	$	(2)	$	(1)	$	(2)

The interest cost and expected return on plan assets components of net periodic benefit cost are included in other pension expense (income) in the consolidated statements of income (loss).

During the three months ended June 30, 2022, Adient remeasured pension plans in the Americas and recorded a mark-to-market gain of $4 million and a curtailment loss of $1 million. During the three months ended June 30, 2021, Adient remeasured a pension plan in the Americas and recorded a mark-to-market gain of $1 million.

13. Restructuring and Impairment Costs

To better align its resources with its overall strategies and reduce the cost structure of its global operations to address the softness in certain underlying markets, Adient commits to restructuring plans as necessary.

During fiscal 2022, Adient committed to a restructuring plan ("2022 Plan") of $20 million that was offset by $8 million of prior year underspend. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in EMEA and Americas. The restructuring actions are expected to be substantially completed by fiscal 2023.

Adient plc | Form 10-Q | 24

(in millions)	Employee Severance and Termination Benefits		Total
Original reserve	$	20	$	20
Utilized—cash	(5)		(5)
Noncash adjustment—other	(1)		(1)
Balance at June 30, 2022	$	14	$	14

During fiscal 2021, Adient committed to a restructuring plan ("2021 Plan") of $27 million that was offset by $16 million of prior year underspend. Of the restructuring costs recorded, $23 million related to the EMEA segment, $3 million related to the Americas segment, and $1 million related to the Asia segment. The restructuring actions related to cost reduction initiatives and consisted primarily of workforce reductions and lease contract terminations. The restructuring actions are expected to be substantially completed by fiscal 2023.

(in millions)	Employee Severance and Termination Benefits		Currency Translation		Total
Balance at September 30, 2021	$	22	$	—	$	22
Utilized—cash	(15)		—		(15)
Noncash adjustment—other	(1)		(1)		(2)
Balance at June 30, 2022	$	6	$	(1)	$	5

During fiscal 2020, Adient committed to a restructuring plan ("2020 Plan") of $205 million. Of the restructuring costs recorded, $20 million related to the Americas segment, $175 million related to the EMEA segment and $10 million related to the Asia segment. The restructuring actions related to cost reduction initiatives and consist primarily of workforce reductions. Also recorded in fiscal 2020 was $20 million of underspend related to prior year plan reserves. The restructuring actions are expected to be substantially completed by fiscal 2023.

The following table summarizes the changes in Adient's 2020 Plan reserve:

(in millions)	Employee Severance and Termination Benefits		Currency Translation		Total
Balance at September 30, 2021	$	75	$	2	$	77
Utilized—cash	(23)		—		(23)
Noncash adjustment—underspend/other	(6)		(6)		(12)
Balance at June 30, 2022	$	46	$	(4)	$	42

The following table summarizes the changes in Adient's 2019 Plan reserve:

(in millions)	Employee Severance and Termination Benefits		Currency Translation		Total
Balance at September 30, 2021	$	8	$	1	$	9
Utilized—cash	(4)		—		(4)
Noncash adjustment—underspend/other	(1)		—		(1)
Balance at June 30, 2022	$	3	$	1	$	4

Adient plc | Form 10-Q | 25

During the first nine months of fiscal 2022, there was $2 million of cash utilized against the 2018, 2017 and 2016 Plan's reserve balances. The majority of the cash utilized during the period was related to the 2016 Plan's reserve balance. The 2018, 2017, and 2016 Plan's reserve balances at June 30, 2022 were $2 million, $2 million, and $1 million, respectively.

Adient's restructuring plans include workforce reductions of approximately 15,000 employees. Restructuring charges associated with employee severance and termination benefits are paid over the severance period granted to each employee or on a lump sum basis in accordance with individual severance agreements. As of June 30, 2022, approximately 14,000 of the employees have been separated from Adient pursuant to the restructuring plans. In addition, the restructuring plans included twenty-nine plant closures. As of June 30, 2022, twenty-one of the twenty-nine plants have been closed.

Adient's management closely monitors its overall cost structure and continually analyzes each of its businesses for opportunities to consolidate current operations, improve operating efficiencies and locate facilities in low cost countries in close proximity to customers. This ongoing analysis includes a review of its manufacturing, engineering, purchasing and administrative functions, as well as the overall global footprint for all its businesses. Because of the importance of new vehicle sales by major automotive manufacturers to operations, Adient is affected by the general business conditions in the automotive industry. Future adverse developments in the automotive industry, particularly related to the COVID-19 pandemic and supply chain disruptions, could impact Adient's liquidity position, lead to impairment charges and/or require additional restructuring of its operations.

14. Income Taxes

In calculating the provision for income taxes, Adient uses an estimate of the annual effective tax rate based upon the facts and circumstances known at each interim period. On a quarterly basis, the actual effective tax rate is adjusted, as appropriate, based on changes in facts and circumstances, if any, as compared to those forecasted at the beginning of the fiscal year and each interim period thereafter. For the three months ended June 30, 2022, Adient’s income tax expense was $20 million on income before income taxes of $0 million. For the nine months ended June 30, 2022, Adient's income tax expense was $65 million equating to an effective tax rate of (144)%. The three and nine month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, foreign tax rate differentials, and the recognition of valuation allowances in Canada. For the three and nine months ended June 30, 2021, Adient’s income tax expense was $10 million equating to an effective tax rate of (26)%, and $90 million equating to an effective tax rate of 29%, respectively. The three and nine month income tax expense was higher than the statutory rate impact of 12.5% primarily due to foreign tax rate differentials and the inability to record a tax benefit for losses in jurisdictions with valuation allowances, partially offset by a tax benefit from the write-off of a deferred tax liability related to withholding taxes.

Valuation Allowances

As a result of the Company's third quarter fiscal 2022 analysis of the realizability of its worldwide deferred tax assets, and after considering tax planning initiatives and other positive and negative evidence, Adient determined it was more likely than not that deferred tax assets in Canada would not be realized and recorded income tax expense of $12 million to establish a valuation allowance.

As a result of the Company's second quarter fiscal 2022 analysis of the realizability of its worldwide deferred tax assets, and after considering tax planning initiatives and other positive and negative evidence, Adient determined it was more likely than not that certain deferred tax assets in Slovakia would not be realized and established a valuation allowance, which did not have a material impact on Adient’s consolidated financial statements.

Adient reviews the realizability of its deferred tax assets on a quarterly basis, or whenever events or changes in circumstances indicate that a review is required. In determining the requirement for a valuation allowance, the historical and projected financial results of the legal entity or combined group recording the net deferred tax asset are considered, along with any other positive or negative evidence. All of the factors that Adient considers in evaluating whether and when to establish or release all or a portion of the deferred tax asset valuation allowance involve significant judgment. Since future financial results may differ from previous estimates, periodic adjustments to Adient's valuation allowances may be necessary.

Uncertain Tax Positions

At June 30, 2022, Adient had gross tax effected unrecognized tax benefits of $463 million. If recognized, $124 million of Adient's unrecognized tax benefits would impact the effective tax rate. Total net accrued interest at June 30, 2022 was approximately $22 million (net of tax benefit). The interest and penalties accrued for the three and nine months ended June 30,

Adient plc | Form 10-Q | 26

2022 was $2 million and $7 million, respectively. Adient recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.

Impacts of Tax Legislation and Change in Statutory Tax Rates

Tax legislation was adopted during the nine months ended June 30, 2022 in various jurisdictions, which did not have a material impact on Adient’s consolidated financial statements.

Other Tax Matters

During the second quarter of fiscal 2022, Adient recognized a $4 million tax benefit related to the adjustment of deferred tax liabilities of a Chinese subsidiary which obtained government approval for a temporary income tax rate reduction.

During the first quarter of fiscal 2022, Adient recognized a $3 million tax benefit related to the write-off of deferred tax liabilities on Brazil indirect tax credits as a result of a favorable court ruling.

During the third quarter of fiscal 2021, Adient recognized an additional $30 million pre-tax gain related to Brazil indirect tax credits as a result of a favorable supreme court ruling. The tax expense associated with this gain was $10 million.

During the third quarter of fiscal 2021, Adient recognized a tax benefit of $11 million related to the write-off of a deferred tax liability associated with a Chinese joint venture’s distribution of unremitted earnings. The distribution was reinvested in a wholly-owned Chinese subsidiary, thereby exempting the distribution from withholding tax. The investment in the wholly-owned subsidiary is intended to be indefinitely reinvested, warranting the derecognition of the pre-existing deferred tax liability.

During the second quarter of fiscal 2021, Adient recognized a $33 million pre-tax gain related to the sale of its equity interest in Shenyang Jinbei Adient Automotive Components Co., Ltd. The tax expense associated with this gain was $5 million.

During the first quarter of fiscal 2021, Adient recognized an $8 million pre-tax gain related to Brazil indirect tax recoveries. The tax expense associated with this gain was $3 million.

15. Segment Information

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Net Sales
Americas	$	1,673	$	1,440	$	4,767	$	4,821
EMEA	1,215		1,328		3,663		4,568
Asia	627		516		2,134		1,658
Eliminations	(30)		(42)		(93)		(138)
Total net sales	$	3,485	$	3,242	$	10,471	$	10,909

Adient plc | Form 10-Q | 27

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Adjusted EBITDA
Americas	$	70	$	23	$	125	$	219
EMEA	31		22		104		277
Asia	64		92		283		364
Corporate-related costs (1)	(22)		(19)		(64)		(61)
Restructuring and impairment costs (2)	(12)		(8)		(20)		(20)
Purchase accounting amortization (3)	(14)		(11)		(41)		(32)
Restructuring related charges (4)	(1)		—		(5)		(6)
Gain on sale / (impairment) of nonconsolidated partially-owned affiliates (5)	—		—		(9)		33
Depreciation	(72)		(71)		(223)		(210)
Stock based compensation	(7)		(10)		(21)		(36)
Other items (6)	(2)		26		(8)		28
Earnings (loss) before interest and income taxes	35		44		121		556
Net financing charges	(39)		(87)		(172)		(256)
Other pension income (expense)	4		4		6		8
Income (loss) before income taxes	$	—	$	(39)	$	(45)	$	308

Notes:

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects qualified restructuring charges for costs that are directly attributable to restructuring activities and meet the definition of restructuring under ASC 420 and non-recurring impairment charges. During the nine months ended June 30, 2022, an impairment charge of $2 million related to net assets in Russia, and a held-for-sale impairment charge of $6 million were recorded in EMEA. During the nine months ended June 30, 2021, a held-for-sale impairment charge of $8 million was recorded in EMEA.

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects restructuring related charges for costs that are directly attributable to restructuring activities, but do not meet the definition of restructuring under ASC 420.

(5) The nine months ended June 30, 2022 reflects $3 million and $6 million of non-cash impairments of certain of Adient's investments in nonconsolidated partially-owned affiliates in China and South Africa, respectively. The nine months ended June 30, 2021 reflects a pre-tax gain of $33 million on the sale of Adient's interest in SJA. Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for additional information.

(6) The three months ended June 30, 2022 primarily reflects $2 million of transaction costs. The nine months ended June 30, 2022 reflects $7 million of transaction costs and $2 million of loss on finalization of asset sale in Turkey. The three months ended June 30, 2021 reflects $2 million of transaction costs and a one-time gain of $30 million associated with retrospective recoveries of Brazil indirect tax credits resulting from a favorable court ruling (of which $28 million relates to recoveries covering the past 20 years and is adjusted out of Americas' segment results). The nine months ended June 30, 2021 reflects a one-time gain of $38 million associated with the retrospective recoveries of Brazil indirect tax credits resulting from a favorable court ruling (of which $36 million relates to recoveries covering the past 20 years and is adjusted out of Americas' segment results), a $5 million gain on previously held interest at YFAS in an affiliate, and $13 million of transaction costs.

Adient plc | Form 10-Q | 28

Geographic Information

Revenue by geographic area is as follows:

Net Sales
	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Americas
United States	$	1,501	$	1,298	$	4,276	$	4,332
Mexico	628		558		1,756		1,783
Other Americas	106		64		284		238
Regional elimination	(562)		(480)		(1,549)		(1,532)
	1,673		1,440		4,767		4,821
EMEA
Germany	258		261		737		891
Czech Republic	257		276		757		964
Other EMEA	1,030		1,144		3,170		3,918
Regional elimination	(330)		(353)		(1,001)		(1,205)
	1,215		1,328		3,663		4,568
Asia
Thailand	101		113		370		357
China	274		171		1,004		525
Japan	59		60		183		253
Other Asia	200		177		597		539
Regional elimination	(7)		(5)		(20)		(16)
	627		516		2,134		1,658
Inter-segment elimination	(30)		(42)		(93)		(138)
Total	$	3,485	$	3,242	$	10,471	$	10,909

The increase in net sales in China is attributable to the consolidation of CQADNT beginning October 1, 2021. Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for additional information.

16. Nonconsolidated Partially-Owned Affiliates

Investments in the net assets of nonconsolidated partially-owned affiliates are reported in the "Investments in partially-owned affiliates" line in the consolidated statements of financial position as of June 30, 2022 and September 30, 2021. Equity in the net income of nonconsolidated partially-owned affiliates are reported in the "Equity income (loss)" line in the consolidated statements of income (loss) for the three and nine months ended June 30, 2022 and 2021, respectively.

Adient plc | Form 10-Q | 29

Adient maintains total investments in partially-owned affiliates of $348 million and $335 million at June 30, 2022 and September 30, 2021, respectively. Operating information for nonconsolidated partially-owned affiliates is as follows:

	Nine Months Ended June 30,
(in millions)	2022		2021
Income statement data:
Net sales	$	2,993	$	6,795
Gross profit	$	291	$	717
Net income	$	132	$	418
Net income attributable to the entity	$	131	$	413

The decrease in net sales and profitability at Adient's nonconsolidated partially-owned affiliates are primarily attributable to the 2021 Yanfeng Transaction. Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for transactions involving Adient's investments in nonconsolidated partially-owned affiliates. Further, Adient is pursing a sale of a portion of a partially-owned affiliate in South Africa for $2 million. As a result, Adient concluded that indicators of other-than-temporary impairment were present related to this joint venture and recorded a non-cash impairment charge of $6 million during the second quarter of fiscal 2022.

An affiliate of Yanfeng has asserted that, in its capacity as a customer of KEIPER, it is entitled to a payment in the amount of approximately $46 million. Adient believes there is no basis for such payment by KEIPER and is disputing that such Yanfeng affiliate is entitled to any payment by KEIPER. Payment of such claim by KEIPER could have an approximate $17 million impact on Adient’s equity income after taxes from the KEIPER joint venture. KEIPER is also currently disputing the payment obligation.

17. Commitments and Contingencies

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product liability, casualty environmental, safety and health, intellectual property, employment, commercial and contractual matters, and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Costs related to such matters were not material to the periods presented.

Adient accrues for potential environmental liabilities when it is probable a liability has been incurred and the amount of the liability is reasonably estimable. Reserves for environmental liabilities totaled $6 million and $8 million at June 30, 2022 and September 30, 2021, respectively. Adient reviews the status of its environmental sites on a quarterly basis and adjusts its reserves accordingly. Such potential liabilities accrued by Adient do not take into consideration possible recoveries of future insurance proceeds. They do, however, take into account the likely share other parties will bear at remediation sites. It is difficult to estimate Adient's ultimate level of liability at many remediation sites due to the large number of other parties that may be involved, the complexity of determining the relative liability among those parties, the uncertainty as to the nature and scope of the investigations and remediation to be conducted, the uncertainty in the application of law and risk assessment, the various choices and costs associated with diverse technologies that may be used in corrective actions at the sites, and the often quite lengthy periods over which eventual remediation may occur. Nevertheless, Adient does not currently believe that any claims, penalties or costs in connection with known environmental matters will have a material adverse effect on Adient's financial position, results of operations or cash flows.

Adient plc | Form 10-Q | 30

18. Related Party Transactions

In the ordinary course of business, Adient enters into transactions with related parties, such as equity affiliates. Such transactions consist of the sale or purchase of goods and other arrangements.

The following table sets forth the net sales to and purchases from related parties included in the consolidated statements of income:

		Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)		2022		2021		2022		2021
Net sales to related parties	Net sales	$	53	$	70	$	175	$	209
Purchases from related parties	Cost of sales	95		139		298		433

The following table sets forth the amount of accounts receivable due from and payable to related parties in the consolidated statements of financial position:

(in millions)		June 30, 2022		September 30, 2021
Accounts receivable due from related parties	Accounts receivable	$	34	$	30
Accounts payable due to related parties	Accounts payable	69		41

Average receivable and payable balances with related parties remained consistent with the period end balances shown above.

Adient plc | Form 10-Q | 31

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This section and other parts of this Quarterly Report on Form 10-Q contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as "future," "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "will," "would," "could," "can," "may," or similar terms. Forward-looking statements are not guarantees of future performance and Adient's actual results may differ significantly from the results discussed in the forward-looking statements. Adient cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Adient’s control, that could cause Adient’s actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, risks related to: the Ukraine conflict and widespread COVID lockdowns in China and their impact on regional, global economies and additional pressure on supply chains and vehicle production, the effects of local and national economic, credit and capital market conditions on the economy in general, and other risks and uncertainties, the continued financial and operational impacts of and uncertainties relating to the COVID-19 pandemic on Adient and its customers, suppliers, joint venture partners and other parties, work stoppages, including due to supply chain disruptions and similar events, energy and commodity (particularly steel) prices, the availability of raw materials and component products (including components required by our customers for the manufacture of vehicles (i.e., semiconductors)), whether deleveraging activities may yield additional value for shareholders at all or on the same or different terms as those described herein, the ability of Adient to execute its turnaround plan, automotive vehicle production levels, mix and schedules, as well as our concentration of exposure to certain automotive manufacturers, the ability of Adient to effectively launch new business at forecast and profitable levels, the ability of Adient to meet debt service requirements, the terms of future financing, the impact of tax reform legislation, uncertainties in U.S. administrative policy regarding trade agreements, tariffs and other international trade relations, general economic and business conditions, the strength of the U.S. or other economies, shifts in market shares among vehicles, vehicle segments or away from vehicles on which Adient has significant content, changes in consumer demand, global climate change and related emphasis on ESG matters by various stakeholders, currency exchange rates and cancellation of or changes to commercial arrangements, and the ability of Adient to identify, recruit, and retain key leadership. Additional information regarding these and other risks related to Adient’s business that could cause actual results to differ materially from what is contained in the forward-looking statements is included in the section entitled "Risk Factors," contained in Item Part II, Other Information - Item 1A of this report, as well as in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021. The following discussion should be read in conjunction with the consolidated financial statements and notes thereto included within this report as well as within Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended September 30, 2021. All information presented herein is based on Adient's fiscal calendar. Unless otherwise stated, references to particular years, quarters, months or periods refer to Adient's fiscal years ended in September and the associated quarters, months and periods of those fiscal years. Adient assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.

Overview

Adient is a global leader in the automotive seating supply industry with leading market positions in the Americas, Europe and China and maintains longstanding relationships with the largest global automotive original equipment manufacturers (OEMs). Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests and trim covers. Adient is a global seat supplier with the capability to design, develop, engineer, manufacture, and deliver complete seat systems and components in every major automotive producing region in the world.

Adient designs, manufactures and markets a full range of seating systems and components for passenger cars, commercial vehicles and light trucks, including vans, pick-up trucks and sport/crossover utility vehicles. Adient operates in 208 wholly- and majority-owned manufacturing or assembly facilities, with operations in 33 countries. Additionally, Adient has partially-owned affiliates in China, Asia, Europe and North America. Through its global footprint, vertical integration and partnerships in China, Adient leverages its capabilities to drive growth in the automotive seating industry.

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient plc | Form 10-Q | 32

Supply Chain Disruptions, Inflationary Pressures and Russia/Ukraine Conflict

The global automotive industry continues to experience widespread supply chain disruptions related to semiconductor chip shortages, hostilities in Ukraine and COVID-19 lockdowns in China. Although Adient’s seating products are not highly dependent on semiconductor chips, Adient is directly impacted by the lower production levels at the OEMs as a result of these supply disruptions. These disruptions have led to unplanned downtime at Adient’s production facilities, often with very little warning, which results in operating inefficiencies and limits Adient’s ability to adequately mitigate such inefficiencies. Additionally, the Russia/Ukraine conflict has resulted in further disruptions in the global automotive industry. Although Adient does not have significant presence in Russia and no presence in Ukraine, some of Adient's customers' operations have been adversely impacted by unstable supplies of other components. Adient is also experiencing higher utility costs in EMEA as a result of the Russia/Ukraine conflict. The automotive industry has also experienced a period of sustained price increases for commodities, primarily related to steel, and to a lesser extent petrochemicals, as well as for freight and utilities. These utility, commodity and shipping cost increases may continue into the future as demand increases and supply may remain constrained, which has resulted in, and may continue to result in, increased costs for Adient that may not be, or may only be partially, offset. Adient has also experienced wage inflationary pressures as a result of constrained labor availability. Although Adient has developed and implemented strategies to mitigate the impact of higher utility, commodity, labor and shipping costs, these strategies (which include targeted SG&A savings through hiring freezes, delayed merit increases, suspended 401(k) matches in the U.S. and RSU replacement awards in lieu of salary for certain executives of Adient), together with commercial negotiations with Adient's customers and suppliers, are only expected to offset a portion of the adverse impact. Refer to the consolidated results of operations and segment analysis discussion below for additional information on the impacts of these items on Adient's results.

On-Going Impact of COVID-19

The impact of COVID-19, and related mutations including the Omicron variant, continues to be present throughout the world, including in all global and regional markets served by Adient. The elevated COVID-19 rates in China have led to new or continuing widespread lockdowns during the second and third quarters of fiscal 2022, negatively impacting automotive production levels in that region, along with creating further supply chain disruptions. Although vaccines have been introduced that are expected to have the result of reducing the effect of COVID-19 and COVID-19 has waned in certain geographic areas, governmental authorities continue to implement numerous measures attempting to contain and mitigate the effects of COVID-19, including travel bans and restrictions, quarantines, social distancing orders, shelter in place orders and shutdowns of non-essential activities. Adient's manufacturing facilities are located in areas that continue to be affected by the pandemic.

Although the global automotive industry experienced increased demand for new vehicles as the industry emerged from the global shutdowns in late fiscal year 2020 and early fiscal year 2021, it is possible that, in the event of the resurgence of COVID-19, the global automotive industry will experience significantly lower demand for new vehicle sales over the long-term as a result of the global economic slowdown caused by the COVID-19 pandemic because new vehicle sales are highly dependent on strong consumer confidence and low unemployment. As a result, new vehicle sales could be significantly lower than historical and previously projected pre-pandemic sales levels.

Throughout fiscal years 2020 and 2021 and continuing in fiscal year 2022, Adient actively monitors the threat and impacts of COVID-19. Adient has taken, and continues to take, steps to mitigate the potential risks to the Company posed by COVID-19 and its impacts. In addition, Adient continues to assess and update its business continuity plans in the context of this pandemic, including analyzing constraints at its customers and suppliers, particularly components and labor-related shortages, respectively. Adient has taken precautions to help keep its workforce healthy and safe, including establishing a Global Response Team, implementing strict travel restrictions, enforcing rigorous hygiene protocols, increasing sanitization efforts at all facilities, enacting visitor restrictions, social distancing, face covering expectations, and temperature and health screenings and implementing remote working arrangements for the vast majority of Adient's employees who work outside the plants.

The spread of COVID-19 and the measures taken to restrain the spread of the virus have had, and may continue to have, a material negative impact on Adient's financial results and liquidity, and such negative impact may continue well beyond the containment of COVID-19 through the results of widespread use of the vaccine or otherwise. Adient cannot assure that the assumptions used to estimate its liquidity requirements will be correct because it had never previously experienced such a widespread cessation of its operations as it experienced during fiscal year 2020, and it is unclear what the lasting impacts of the slowdown in the automotive industry will be. In addition, the magnitude, duration, speed and potential resurgence or surges of the global pandemic are all uncertain. Consequently, the impact of the pandemic and its myriad of effects on Adient's business, financial condition or longer-term financial or operational results remain uncertain. Based on the actions it has taken and its

Adient plc | Form 10-Q | 33

current assumptions regarding the impact of COVID-19, Adient believes that its current financial resources will be sufficient to fund the company's liquidity requirements for at least the next twelve months.

Global Automotive Industry

Adient conducts its business globally in the automotive industry, which is highly competitive and sensitive to economic, political and social factors in the various regions. During fiscal 2021, automotive production across the globe declined due to the economic slow down resulting from the COVID-19 pandemic and the widespread supply chain disruptions primarily due to semiconductor chip shortages. During the first nine months of fiscal 2022, global light vehicle production decreased 4.9% year over year as a result of on-going supply chain disruptions. Unplanned production stoppages by customers resulted in lower sales as well as higher operational costs and other surcharges at Adient. The challenging operational environment is expected to continue for the remainder of fiscal 2022 and into fiscal 2023.

Light vehicle production levels by geographic region are provided below:

	Light Vehicle Production
	Three Months Ended June 30,			Nine Months Ended June 30,
(units in millions)	2022	Change	2021	2022	Change	2021
Global	18.8	—%	18.8	59.9	(4.9)%	63.0
North America	3.6	11.7%	3.2	10.4	(2.8)%	10.7
South America	0.7	12.8%	0.6	2.0	(4.8)%	2.1
EMEA	3.9	(6.1)%	4.2	11.9	(16.8)%	14.3
China	5.5	(5.9)%	5.8	19.4	—%	19.4
Asia, excluding China, and Other	5.1	3.0%	4.9	16.2	(1.8)%	16.5
Source: IHS Automotive, July 2022

Financial Results Summary

Significant aspects of Adient's financial results for the third quarter of fiscal 2022 include the following:

•Adient recorded net sales of $3,485 million for the third quarter of fiscal 2022, representing an increase of $243 million or 7.5% when compared to the third quarter of fiscal 2021. The increase in net sales is attributable to higher overall production volumes in the Americas, operational footprint changes primarily related to the consolidation of CQADNT in China, favorable material economics recoveries, and higher levels of commercial settlements, partially offset by unplanned operational interruptions and production stoppages primarily resulting from semiconductor chip shortages and other supply chain issues intensified by the Russia/Ukraine conflict in EMEA and the COVID-19 lockdowns in China, and the unfavorable impact of foreign currencies.

•Gross profit was $173 million, or 5.0% of net sales, for the third quarter of fiscal 2022 compared to $150 million, or 4.6% of net sales for the third quarter of fiscal 2021. Profitability, including gross profit as a percentage of net sales, was higher due to favorable impacts of material economics, higher levels of commercial settlements, higher production volume in the Americas, and operational footprint changes primarily related to the consolidation of CQADNT in China, partially offset by operational inefficiencies including higher premium freight primarily resulting from semiconductor chip shortages and other supply chain issues intensified by the Russia/Ukraine conflict in EMEA and the COVID-19 lockdowns in China.

•Equity income was $16 million for the third quarter of fiscal 2022, compared to $38 million for the third quarter of fiscal 2021. The decrease is primarily attributable to prior year divestitures of Adient's interests in certain China joint ventures (YFAS, SJA and GZDFAS) as well as the acquisition of controlling interest in CQADNT, and operational interruptions and production stoppages resulting from semiconductor chip shortages and COVID-19 lockdowns in China.

•Net loss attributable to Adient was $30 million for the third quarter of fiscal 2022, compared to net loss attributable to Adient of $71 million for the third quarter of fiscal 2021. The lower net loss in the third quarter of fiscal 2022 is primarily attributable to the favorable impact of operational footprint changes primarily related to the consolidation of CQADNT in China, favorable material economics recoveries, higher commercial settlements, and lower net financing charges, partially offset by operational inefficiencies including higher premium freight resulting from semiconductor chip shortages and

Adient plc | Form 10-Q | 34

other supply chain issues as described above, lower equity income resulting from prior year divestitures of certain affiliates in China, and higher restructuring charges.

Consolidated Results of Operations

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Net sales	$	3,485	7%	$	3,242	$	10,471	(4)%	$	10,909
Cost of sales	3,312		7%	3,092		9,947		(2)%	10,120
Gross profit	173		15%	150		524		(34)%	789
Selling, general and administrative expenses	142		4%	136		439		1%	433
Restructuring and impairment costs	12		50%	8		20		—%	20
Equity income (loss)	16		(58)%	38		56		(75)%	220
Earnings (loss) before interest and income taxes	35		(20)%	44		121		(78)%	556
Net financing charges	39		(55)%	87		172		(33)%	256
Other pension expense (income)	(4)		—%	(4)		(6)		25%	(8)
Income (loss) before income taxes	—		n/a	(39)		(45)		>(100%)	308
Income tax provision (benefit)	20		100%	10		65		(28)%	90
Net income (loss)	(20)		59%	(49)		(110)		>(100%)	218
Income (loss) attributable to noncontrolling interests	10		(55)%	22		55		(21)%	70
Net income (loss) attributable to Adient	$	(30)	58%	$	(71)	$	(165)	>(100%)	$	148

Net Sales

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Net sales	$	3,485	7%	$	3,242	$	10,471	(4)%	$	10,909

Net sales increased by $243 million, or 7%, in the third quarter of fiscal 2022 as compared to the third quarter of fiscal 2021 due to higher production volumes ($112 million), operational footprint changes primarily related to the consolidation of CQADNT in China ($183 million), favorable material economics recoveries ($96 million), and higher levels of commercial settlements ($24 million), partially offset by the unfavorable impact of foreign currencies ($172 million). Production volumes, particularly in EMEA and Asia, continue to be adversely impacted by unplanned production stoppages resulting from semiconductor chip shortages and other supply chain issues which were intensified by the impact of the Russia/Ukraine conflict and COVID-19 lockdowns in China.

Net sales decreased by $438 million, or 4%, in the first nine months of fiscal 2022 as compared to the first nine months of fiscal 2021 due to unplanned production stoppages primarily resulting from semiconductor chip shortages and other supply chain issues which were intensified by the impact of the Russia/Ukraine conflict, and COVID-19 lockdowns in China ($705 million), the unfavorable impact of foreign currencies ($371 million), and lower levels of commercial settlements ($43 million), partially offset by favorable material economics recoveries ($240 million) and operational footprint changes primarily related to the consolidation of CQADNT in China ($441 million).

Adient plc | Form 10-Q | 35

Cost of Sales / Gross Profit

	Three Months Ended June 30,							Nine Months Ended June 30,
(in millions)	2022			Change	2021			2022			Change	2021
Cost of sales	$	3,312		7%	$	3,092		$	9,947		(2)%	$	10,120
Gross profit	$	173		15%	$	150		$	524		(34)%	$	789
% of sales	5.0		%		4.6		%	5.0		%		7.2		%

Cost of sales increased by $220 million, or 7%, and gross profit increased by $23 million in the third quarter of fiscal 2022 as compared to the third quarter of fiscal 2021. The year over year increase in cost of sales was due to higher production volumes ($116 million), operational footprint changes primarily related to the consolidation of CQADNT in China ($153 million), higher commodity costs ($80 million), operational inefficiencies including higher premium freight resulting from unplanned production stoppages ($20 million), prior year non-recurring favorable items ($28 million), and higher depreciation and amortization expense ($2 million), partially offset by the favorable impact of foreign currencies ($172 million) and favorable supplier pricing ($8 million). Gross profit was impacted by favorable material economics recoveries, and operational footprint changes primarily related to the consolidation of CQADNT in China, partially offset by inefficiencies caused by unplanned production stoppages, less favorable product mix, and prior year non-recurring favorable items. Refer to the segment analysis below for a discussion of segment profitability.

Cost of sales decreased by $173 million, or 2%, and gross profit decreased by $265 million in the first nine months of fiscal 2022 as compared to the first nine months of fiscal 2021. The year over year decrease in cost of sales was due to lower volumes primarily resulting from the semiconductor chip shortages and other supply chain issues which were intensified by the impact of the Russia/Ukraine conflict and COVID-19 lockdowns in China ($542 million), the favorable impact of foreign currencies ($352 million), and favorable supplier pricing ($39 million), partially offset by operational footprint changes primarily related to the consolidation of CQADNT in China ($373 million), higher commodity costs ($246 million), operational inefficiencies including higher premium freight resulting from unplanned production stoppages ($98 million), prior year non-recurring favorable items ($33 million), and higher depreciation and amortization expense ($9 million). Gross profit was unfavorably impacted by lower overall volumes, the unfavorable impact of foreign currencies, higher commodity costs, inefficiencies caused by unplanned production stoppages, and prior year non-recurring favorable items, partially offset by operational footprint changes primarily related to the consolidation of CQADNT in China. Refer to the segment analysis below for a discussion of segment profitability.

Selling, General and Administrative Expenses

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Selling, general and administrative expenses	$	142	4%	$	136	$	439	1%	$	433
% of sales	4.1%			4.2%		4.2%			4.0%

Selling, general and administrative expenses (SG&A) increased by $6 million, or 4% in the third quarter of fiscal 2022 as compared to the third quarter of fiscal 2021. The year over year increase in SG&A is attributable to the prior year acquisitions and consolidations of CQADNT and LFADNT ($7 million), higher amortization expense attributable to the acquired intangible assets ($3 million), and higher overall engineering and other administrative spending ($8 million), partially offset by lower compensation expense including stock-based and performance-based incentive compensation costs ($6 million), and the favorable impact of foreign currencies ($6 million).

Selling, general and administrative expenses (SG&A) for the first nine months of fiscal 2022 increased by $6 million as compared to the first nine months of fiscal 2021. The year over year increase in SG&A is attributable to higher overall engineering and other administrative spending in the current year (primarily the Malaysia flooding event and certain legal settlements) and certain one-time non-recurring benefits in the prior year ($27 million), higher depreciation expense ($5 million), higher amortization expense attributable to the acquired intangible assets ($10 million), and the prior year acquisitions and consolidations of CQADNT and LFADNT ($24 million). These were offset by lower compensation expense including stock-based and performance-based incentive compensation costs ($43 million), the favorable impact of foreign currencies ($11 million), and lower transaction costs ($6 million).

Adient plc | Form 10-Q | 36

Restructuring and Impairment Costs

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Restructuring and impairment costs	$	12	50%	$	8	$	20	—%	$	20

Restructuring and impairment costs were higher by $4 million during the third quarter of fiscal 2022 as compared to the third quarter of fiscal 2021 and consistent for the nine months ended June 30, 2022 as compared to the nine months ended June 30, 2021. Refer to Note 3, "Acquisitions and Divestitures," and Note 13, "Restructuring and Impairment Costs," of the notes to the consolidated financial statements for information related to Adient's restructuring plans.

Equity Income (Loss)

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Equity income (loss)	$	16	(58)%	$	38	$	56	(75)%	$	220

Equity income was $16 million for the third quarter of fiscal 2022, compared to $38 million in the third quarter of fiscal 2021. The decrease is primarily attributable to prior year divestitures of Adient's interests in certain China joint ventures (YFAS, GZDFAS and SJA) as well as acquisition of controlling interest in CQADNT ($17 million), along with operational interruptions and production stoppages resulting from semiconductor chip shortages and COVID-19 lockdowns in China ($5 million).

Equity income was $56 million for the first nine months of fiscal 2022, compared to $220 million for the first nine months of fiscal 2021. The decrease is primarily attributable to prior year divestitures of Adient's interests in certain China joint ventures (YFAS, GZDFAS and SJA) as well as the acquisition of controlling interest in CQADNT ($135 million, including a $33 million gain on sale of SJA), operational interruptions and production stoppages resulting from semiconductor chip shortages and COVID-19 lockdowns primarily in China ($19 million), higher restructuring charges primarily at Adient's affiliates in China ($5 million), and current year non-cash impairment charges recorded on certain of Adient's investments in non-consolidated affiliates in South Africa and China ($9 million), partially offset by lower purchase accounting amortization ($2 million) and the favorable impact of foreign currencies ($2 million).

Net Financing Charges

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Net financing charges	$	39	(55)%	$	87	$	172	(33)%	$	256

Net financing charges decreased in the third quarter of fiscal 2022 as compared to the third quarter of fiscal 2021 as a result of lower levels of outstanding debt, premiums paid to tender outstanding debt in the prior year, and the prior year write offs of deferred financing costs. Refer to Note 8, "Debt and Financing Arrangements," of the notes to the consolidated financial statements for further information related to Adient's debt transactions during the current quarter and components of the net financing charges.

Net financing charges decreased for the first nine months of fiscal 2022 as compared to the first nine months of fiscal 2021 as a result of lower levels of outstanding debt, lower amounts of premiums paid to tender outstanding debt, and higher levels of write offs of deferred financing costs in the prior year. Refer to Note 8, "Debt and Financing Arrangements," of the notes to the consolidated financial statements for further information related to Adient's debt transactions during fiscal 2022 and components of the net financing charges.

Adient plc | Form 10-Q | 37

Other Pension Expense (Income)

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Other pension expense (income)	$	(4)	—%	$	(4)	$	(6)	25%	$	(8)

Other pension income remained consistent year over year. Refer to Note 12, "Retirement Plans," of the notes to the consolidated financial statements for information related to the non-service components of Adient's net periodic pension costs.

Income Tax Provision

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Income tax provision (benefit)	$	20	100%	$	10	$	65	(28)%	$	90

The third quarter of fiscal 2022 income tax expense of $20 million was higher than the statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, foreign tax rate differentials, and the recognition of valuation allowances in Canada. The third quarter of fiscal 2021 income tax expense of $10 million was higher than the statutory rate of 12.5% primarily due to foreign tax rate differentials and the inability to record a tax benefit for losses in jurisdictions with valuation allowances, partially offset by a tax benefit from the write-off of a deferred tax liability related to withholding taxes.

The first nine months of fiscal 2022 income tax expense of $65 million was higher than the statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, foreign tax rate differentials, and the recognition of valuation allowances in Canada. The first nine months of fiscal 2021 income tax expense of $90 million was higher than the statutory rate of 12.5% primarily due to foreign tax rate differentials and the inability to record a tax benefit for losses in jurisdictions with valuation allowances, partially offset by a tax benefit from the write-off of a deferred tax liability related to withholding taxes.

Income Attributable to Noncontrolling Interests

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Income (loss) attributable to noncontrolling interests	$	10	(55)%	$	22	$	55	(21)%	$	70

The decreases in income attributable to noncontrolling interests in the third quarter ($12 million) and the first nine months of fiscal 2022 ($15 million) as compared to the third quarter and first nine months of fiscal 2021 are primarily attributable to lower production volumes due to production stoppages and supply chain issues at certain Seating affiliates in various jurisdictions.

Net Income (Loss) Attributable to Adient

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Net income (loss) attributable to Adient	$	(30)	58%	$	(71)	$	(165)	>(100%)	$	148

Net loss attributable to Adient was $30 million for the third quarter of fiscal 2022, compared to $71 million of net loss attributable to Adient for the third quarter of fiscal 2021. The lower net loss in the third quarter of fiscal 2022 is primarily attributable to the favorable impact of operational footprint changes primarily related to the consolidation of CQADNT in China, favorable material economics recoveries, higher commercial settlements, and lower net financing charges, partially offset by operational inefficiencies including higher premium freight resulting from semiconductor chip shortages and other

Adient plc | Form 10-Q | 38

supply chain issues as described above, higher utilities and freight costs, lower equity income resulting from prior year divestitures of certain affiliates in China, and higher restructuring charges.

Net loss attributable to Adient was $165 million for the first nine months of fiscal 2022, compared to $148 million of net income attributable to Adient for the first nine months of fiscal 2021. The loss in the first nine months of fiscal 2022 is primarily attributable to unplanned production stoppages resulting from semiconductor chip shortages and other supply chain issues, which were intensified by the Russia/Ukraine conflict and COVID-19 lockdowns in China, higher utilities and freight costs, and lower equity income attributable to prior year divestitures of Adient's interests in YFAS and SJA, partially offset by lower net financing charges and income tax expense.

Comprehensive Income (Loss) Attributable to Adient

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Comprehensive income (loss) attributable to Adient	$	(172)	>(100%)	$	(30)	$	(280)	>(100%)	$	235

Comprehensive loss attributable to Adient was $172 million for the third quarter of fiscal 2022 compared to $30 million of comprehensive income for the third quarter of fiscal 2021. The decrease of $142 million is due primarily to the unfavorable impact of foreign currency translation adjustments ($180 million), and the impact of realized and unrealized losses on derivatives ($24 million), partially offset by a smaller net loss ($29 million) and lower comprehensive income attributable to noncontrolling interests ($33 million).

Comprehensive loss attributable to Adient was $280 million for the first nine months of fiscal 2022 compared to $235 million of comprehensive income for the first nine months of fiscal 2021. The decrease of $515 million is due primarily to a larger net loss ($328 million), the unfavorable impact of foreign currency translation adjustments ($184 million) and the impact of realized and unrealized losses on derivatives ($39 million), partially offset by lower comprehensive income attributable to noncontrolling interests ($36 million).

Segment Analysis

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, qualified restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

The results presented below are not necessarily indicative of full-year results, particularly due to the on-going impacts of higher commodity costs, inefficiencies caused by unplanned production stoppages, the COVID-19 pandemic, and the Russia/Ukraine conflict, all of which are significantly impacting Adient's results. Refer to the Supply Chain Disruptions, Inflationary Pressures and Russia/Ukraine Conflict, and On-Going Impact of COVID-19 sections earlier in Item 2. of this Report and our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, for additional information related to the impacts on Adient.

Financial information relating to Adient's reportable segments is as follows:

Adient plc | Form 10-Q | 39

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Net Sales
Americas	$	1,673	$	1,440	$	4,767	$	4,821
EMEA	1,215		1,328		3,663		4,568
Asia	627		516		2,134		1,658
Eliminations	(30)		(42)		(93)		(138)
Total net sales	$	3,485	$	3,242	$	10,471	$	10,909

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Adjusted EBITDA
Americas	$	70	$	23	$	125	$	219
EMEA	31		22		104		277
Asia	64		92		283		364
Corporate-related costs (1)	(22)		(19)		(64)		(61)
Restructuring and impairment costs (2)	(12)		(8)		(20)		(20)
Purchase accounting amortization (3)	(14)		(11)		(41)		(32)
Restructuring related charges (4)	(1)		—		(5)		(6)
Gain on sale / (impairment) of nonconsolidated partially-owned affiliates (5)	—		—		(9)		33
Depreciation	(72)		(71)		(223)		(210)
Stock based compensation	(7)		(10)		(21)		(36)
Other items (6)	(2)		26		(8)		28
Earnings (loss) before interest and income taxes	35		44		121		556
Net financing charges	(39)		(87)		(172)		(256)
Other pension income (expense)	4		4		6		8
Income (loss) before income taxes	$	—	$	(39)	$	(45)	$	308

Notes:

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects qualified restructuring charges for costs that are directly attributable to restructuring activities and meet the definition of restructuring under ASC 420 and non-recurring impairment charges. During the nine months ended June 30, 2022, an impairment charge of $2 million related to net assets in Russia, and a held-for-sale impairment charge of $6 million were recorded in EMEA. During the nine months ended June 30, 2021, a held-for-sale impairment charge of $8 million was recorded in EMEA.

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects restructuring related charges for costs that are directly attributable to restructuring activities, but do not meet the definition of restructuring under ASC 420.

(5) The nine months ended June 30, 2022 reflects $3 million and $6 million of non-cash impairments of certain of Adient's investments in nonconsolidated partially-owned affiliates in China and South Africa, respectively. The nine months ended June 30, 2021 reflects a pre-tax gain of $33 million on the sale of Adient's interest in SJA. Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for additional information.

Adient plc | Form 10-Q | 40

(6) The three months ended June 30, 2022 primarily reflects $2 million of transaction costs. The nine months ended June 30, 2022 reflects $7 million of transaction costs and $2 million of loss on finalization of asset sale in Turkey. The three months ended June 30, 2021 reflects $2 million of transaction costs and a one-time gain of $30 million associated with retrospective recoveries of Brazil indirect tax credits resulting from a favorable court ruling (of which $28 million relates to recoveries covering the past 20 years and is adjusted out of Americas' segment results). The nine months ended June 30, 2021 reflects a one-time gain of $38 million associated with the retrospective recoveries of Brazil indirect tax credits resulting from a favorable court ruling (of which $36 million relates to recoveries covering the past 20 years and is adjusted out of Americas' segment results), a $5 million gain on previously held interest at YFAS in an affiliate, and $13 million of transaction costs.

Americas

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Net sales	$	1,673	16%	$	1,440	$	4,767	(1)%	$	4,821
Adjusted EBITDA	$	70	>100%	$	23	$	125	(43)%	$	219

Net sales increased during the third quarter of fiscal 2022 by $233 million primarily as a result of higher current quarter production volumes despite operational interruptions due to certain unplanned production stoppages resulting from semiconductor chip shortages and other supply chain issues ($174 million), the favorable impact of material economics recoveries ($47 million), the impact of favorable commercial settlements and net pricing adjustments ($9 million), and favorable impact of foreign currencies ($3 million).

Net sales decreased during the first nine months of fiscal 2022 by $54 million primarily as a result of operational interruptions due to certain unplanned production stoppages resulting from semiconductor chip shortages and supply chain issues ($132 million), the impact of operational footprint changes ($20 million), and the impact of unfavorable commercial settlements and net pricing adjustments ($46 million), partially offset by the favorable impact of material economics recoveries ($142 million) and the favorable impact of foreign currencies ($2 million).

Adjusted EBITDA increased during the third quarter of fiscal 2022 by $47 million due to higher current quarter production volumes as explained above ($14 million), higher levels of commercial settlements and net pricing adjustments ($11 million), lower administrative and engineering expense ($11 million), favorable material economics, net of recoveries ($5 million), the favorable impact of foreign currencies ($4 million), and operational performance and other labor and overhead efficiency improvements, net of higher freight costs ($2 million).

Adjusted EBITDA decreased during the first nine months of fiscal 2022 by $94 million due to lower current year production volumes as explained above ($49 million), increased labor and freight costs along with other operating inefficiencies associated with lower volumes ($18 million), lower levels of commercial settlements and net pricing adjustments ($40 million), unfavorable material economics, net of recoveries ($15 million), and the impact of operational footprint changes ($4 million), partially offset by lower administrative and engineering expense ($26 million), the favorable impact of foreign currencies ($5 million), and higher equity income ($1 million). The higher level of costs associated with labor and freight are expected to persist during the remainder of fiscal 2022.

EMEA

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Net sales	$	1,215	(9)%	$	1,328	$	3,663	(20)%	$	4,568
Adjusted EBITDA	$	31	41%	$	22	$	104	(62)%	$	277

Net sales decreased during the third quarter of fiscal 2022 by $113 million primarily as a result of the unfavorable impact of foreign currency ($145 million), operational interruptions due to certain unplanned production stoppages resulting from semiconductor chip shortages and other supply chain disruptions which have been intensified by the Russia/Ukraine conflict ($12 million), and the impact of operational footprint changes ($17 million), partially offset by the favorable impact of material economics recoveries ($45 million) and favorable impact of commercial settlements and net pricing adjustments ($16 million).

Adient plc | Form 10-Q | 41

Net sales decreased during the first nine months of fiscal 2022 by $905 million primarily as a result of operational interruptions due to certain unplanned production stoppages resulting from semiconductor chip shortages and other supply chain disruptions which have been intensified by the Russia/Ukraine conflict ($592 million), the unfavorable impact of foreign currency ($312 million), and the impact of operational footprint changes ($95 million), partially offset by the favorable impact of material economics recoveries ($86 million) and favorable impact of commercial settlements and net pricing adjustments ($8 million).

Adjusted EBITDA increased during the third quarter of fiscal 2022 by $9 million due primarily to favorable commercial settlements and net pricing adjustments ($21 million), favorable material economics, net of recoveries ($10 million), lower administrative and engineering expense ($7 million), and higher equity income ($3 million), partially offset by lower current quarter production volumes as explained above ($7 million), increased utilities, labor and freight costs along with other operating inefficiencies associated with lower volumes ($21 million), the unfavorable impact of foreign currencies ($3 million), and the impact of operational footprint changes ($1 million). The higher level of costs associated with freight, labor and utilities are expected to persist for the remainder of fiscal 2022.

Adjusted EBITDA decreased during the first nine months of fiscal 2022 by $173 million due primarily to lower current year production volumes as explained above ($112 million), increased utilities, labor and freight costs along with other operating inefficiencies associated with lower volumes ($71 million), the impact of operational footprint changes ($18 million), the unfavorable impact of foreign currencies ($16 million), and lower equity income ($4 million), partially offset by favorable commercial settlements and net pricing adjustments ($22 million), lower administrative and engineering expense ($14 million), and favorable material economics, net of recoveries ($12 million). The higher level of costs associated with freight, labor and utilities are expected to persist for the remainder of fiscal 2022.

Asia

	Three Months Ended June 30,					Nine Months Ended June 30,
(in millions)	2022		Change	2021		2022		Change	2021
Net sales	$	627	22%	$	516	$	2,134	29%	$	1,658
Adjusted EBITDA	$	64	(30)%	$	92	$	283	(22)%	$	364

Net sales increased during the third quarter of fiscal 2022 by $111 million due to the impact of operational footprint changes in China primarily related to the consolidation of CQADNT and LFADNT ($200 million), and the favorable impact of material economics recoveries ($4 million), partially offset by the unfavorable impact of foreign currencies ($36 million), unfavorable volume and mix ($56 million), and unfavorable impact of commercial settlements and net pricing adjustments ($1 million).

Net sales increased during the first nine months of fiscal 2022 by $476 million due to the impact of operational footprint changes in China primarily related to the consolidation of CQADNT and LFADNT ($556 million), and the favorable impact of material economics recoveries ($12 million), partially offset by the unfavorable impact of foreign currencies ($79 million), unfavorable volume and mix ($8 million), and unfavorable impact of commercial settlements and net pricing adjustments ($5 million).

Adjusted EBITDA decreased during the third quarter of fiscal 2022 by $28 million due to unfavorable volume and mix including the impact of COVID-19 lockdowns in China ($12 million) and related operating inefficiencies ($10 million), lower equity income due to lower volumes primarily at Adient's affiliates in China attributable to the COVID-19 lockdowns ($8 million), the unfavorable impact of foreign currencies ($4 million), and higher administrative and engineering expense ($3 million), partially offset by operational footprint changes including the impact of the 2021 Yanfeng Transaction ($8 million), and favorable impact of material economics, net of recoveries ($1 million).

Adjusted EBITDA decreased during the first nine months of fiscal 2022 by $81 million due primarily to operational footprint changes including the impact of the 2021 Yanfeng Transaction ($37 million), the unfavorable impact of material economics, net of recoveries ($3 million), operating inefficiencies including freight and labor economics, and launch timing ($25 million), the unfavorable impact of foreign currencies ($7 million), lower equity income due to lower volumes primarily at Adient's affiliates in China attributable to the COVID-19 lockdowns ($16 million), unfavorable volume and mix including the impact of COVID-19 lockdowns in China ($3 million), and higher administrative and engineering expense primarily related to the impact of the Malaysia flooding ($5 million), partially off set by favorable commercial settlements and net pricing adjustments which includes $9 million of a non-recurring settlement in China ($15 million).

Adient plc | Form 10-Q | 42

Liquidity and Capital Resources

Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintains an asset-based revolving credit facility (the “ABL Credit Facility”), which provides for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity and certain other restrictions, including a minimum fixed charge coverage ratio. The ABL Credit Facility will mature on May 6, 2024, subject to a springing maturity date 91 days earlier if certain amounts remain outstanding at that time under the Term Loan B Agreement (defined below). Adient will pay a commitment fee of 0.25% to 0.375% on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the ABL Credit Facility then in effect. Subject to certain conditions, the ABL Credit Facility may be expanded by up to $250 million in additional commitments. Loans under the ABL Credit Facility may be denominated, at the option of Adient, in U.S. dollars, Euros, Pounds Sterling or Swedish Kroner. The ABL Credit Agreement is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. On November 24, 2021, Adient entered into an amendment to its ABL Credit Facility (the “ABL Amendment”) to amend certain terms and provisions, including to (i) change the interest rate benchmark rates applicable under the ABL Credit Facility for borrowings denominated in euro, Swedish krona and pounds sterling to EURIBOR, STIBOR, and SONIA, in each case subject to certain adjustments, and (ii) update the provisions in our ABL Credit Facility by which U.S. dollar LIBOR will eventually be replaced with SOFR or another interest rate benchmark, in each case, to reflect the most recent standards and practices used in the industry. Interest is payable on the ABL Credit Facility at a fluctuating rate of interest determined by reference to LIBOR, in the case of amounts outstanding in dollars, EURIBOR, in the case of amounts outstanding in euros, STIBOR, in the case of amounts outstanding in Swedish krona and SONIA, in the case of amounts outstanding in pounds sterling, in each case, plus an applicable margin of 1.50% to 2.00%. As of June 30, 2022, Adient had not drawn down on the ABL Credit Facility and had availability under this facility of $780 million (net of $42 million of letters of credit).

In addition, Adient US and Adient Global Holdings S.à r.l., a wholly-owned subsidiary of Adient, maintain a term loan credit agreement (the “Term Loan B Agreement”) that initially provided for a 5-year $800 million senior secured term loan facility that was fully drawn on closing. The Term Loan B Agreement amortizes in equal quarterly installments at a rate of 1.00% per annum of the original principal amount thereof, with the remaining balance originally due at final maturity on May 6, 2024. Interest on the Term Loan B Agreement accrues at the Eurodollar rate plus an applicable margin originally equal to 4.25% (with one 0.25% step down based on achievement of a specific secured net leverage level starting with the fiscal quarter ending December 31, 2019). The Term Loan B Agreement also permits Adient to incur incremental term loans in an aggregate amount not to exceed the greater of $750 million and an unlimited amount subject to a pro forma first lien secured net leverage ratio of not greater than 1.75 to 1.00 and certain other conditions. In April 2021, Adient amended the Term Loan B Agreement ("Amended Agreement") which, among other changes (i) extended the maturity date for loans outstanding to April 8, 2028, (ii) reduced the interest rate margin applicable thereunder by 0.75% to 3.50%, in the case of Eurodollar Rate loans, and 2.50% (in the case of Base Rate loans) (in each case, with one 0.25% step down based on achievement of a specified first lien secured net leverage level starting with the fiscal quarter ending December 31, 2021) and (iii) made certain other negative covenant and mandatory prepayment changes in connection therewith. The amendment also established incremental term loans in an aggregate principal amount of $214 million resulting in total loans outstanding under the Amended Agreement of $1.0 billion. Adient paid $7 million related to the Amended Agreement and wrote off $8 million of previously deferred financing costs as a result of the debt extinguishment during the third quarter of fiscal 2021.

Adient US was also a party to an indenture relating to the issuance of $800 million aggregate principal amount of Senior First Lien Notes. The notes originally mature on May 15, 2026 and bore interest at a rate of 7.00% per annum. Interest on these notes was payable semi-annually in arrears on November 15 and May 15 of each year, commencing on November 15, 2019. During the second quarter of fiscal 2021, Adient repurchased $640 million of the outstanding balance of the Senior First Lien Notes at a price of 107% of the principal plus $17 million of accrued and unpaid interest. As a result, $9 million of previously deferred financing costs was written off to net financing charges. During the third quarter of fiscal 2021, Adient redeemed the $160 million of remaining balance of the Senior First Lien Notes at a price of 103% of the principal plus $4 million of accrued and unpaid interest, and wrote off $3 million of previously deferred financing costs as a result of the debt extinguishment.

The ABL Credit Facility, Term Loan B Agreement and the Senior First Lien Notes due 2026 contain covenants that are usual and customary for facilities and debt instruments of this type and that, among other things, restrict the ability of Adient and its restricted subsidiaries to: create certain liens and enter into sale and lease-back transactions; create, assume, incur or guarantee certain indebtedness; pay dividends or make other distributions on, or repurchase or redeem, Adient’s capital stock or certain other debt; make other restricted payments; and consolidate or merge with, or convey, transfer or lease all or substantially all of

Adient plc | Form 10-Q | 43

Adient’s and its restricted subsidiaries’ assets, to another person. These covenants are subject to a number of other limitations and exceptions set forth in the agreements. The agreements also provide for customary events of default, including, but not limited to, cross-default clauses with other debt arrangements, failure to pay principal and interest, failure to comply with covenants, agreements or conditions, and certain events of bankruptcy or insolvency involving Adient and its significant subsidiaries.

Adient Global Holdings Ltd. ("AGH"), a wholly-owned subsidiary of Adient, previously maintained $900 million aggregate principal amount of 4.875% USD-denominated unsecured notes due 2026. During the fourth quarter of fiscal 2020, Adient redeemed $103 million of face value of these notes, resulting in a remaining balance of $797 million as of September 30, 2020. Adient further redeemed $2 million of the notes during fiscal 2021, resulting in a remaining balance of $795 million as of June 30, 2022 and September 30, 2021. AGH also previously maintained €1.0 billion aggregate principal amount of 3.50% unsecured notes due 2024. In February 2022, Adient repurchased €177 million ($198 million) of the 3.50% unsecured notes due 2024 at a price of 102% of the principal plus €17 million ($19 million) of accrued and unpaid interest, and wrote off €1 million ($1 million) of previously deferred financing costs to net financing charges. As of June 30, 2022, the remaining balance of this debt was €823 million ($860 million).

Adient Germany Ltd. & Co. KG, a wholly owned subsidiary of Adient, previously maintained €135 million ($150 million) in an unsecured term loan from the European Investment Bank ("EIB") due in 2022. The loan bore interest at the 6-month EURIBOR rate plus 158 basis points. During the first quarter of fiscal 2021, Adient repaid $16 million of the EIB loan, triggered in part by the redemption of debt in the prior year. Adient repaid $20 million of the EIB loan in May 2021, triggered by the prior year sale of the fabrics business. Adient fully repaid the remaining balance of the EIB loan in May 2022 upon its maturity.

On April 20, 2020, Adient US issued $600 million (net proceeds of $591 million) aggregate principal amount of 9.00% Senior First Lien Notes due 2025. These notes will mature on April 15, 2025, provided that if AGH has not refinanced (or otherwise redeemed) in whole its outstanding 3.50% unsecured notes due 2024 or any refinancing indebtedness thereof that matures earlier than 91 days prior to the maturity date of the Senior First Lien Notes due 2025 on or prior to May 15, 2024, these notes will mature on May 15, 2024. Interest on these notes is due on April 15 and October 15 each year, beginning on October 15, 2020. These notes contain covenants that are usual and customary, similar to the covenants on the Senior First Lien Notes due 2026 as described above. Adient incurred $10 million of debt issuance cost associated with this new debt in fiscal 2020. In February 2022, Adient repurchased $508 million of 9.00% Senior First Lien Notes due 2025 at a price of 105.875% of the principal plus $15 million of accrued and unpaid interest, and wrote off $6 million of previously deferred financing costs to net financing charges. As of June 30, 2022, the remaining balance of this debt was $92 million.

As discussed in the Supply Chain Disruptions, Inflationary Pressures and Russia/Ukraine Conflict and On-Going Impact of COVID-19 sections, the widespread supply chain disruptions related to semiconductor chip shortages, hostilities in Ukraine and COVID-19 lockdowns in China have had, and may continue to have, a material negative impact on Adient's financial results and liquidity, and such negative impact may continue well into the future. The impact of these issues on Adient's business, financial condition or longer-term financial or operational results is uncertain. Based on the actions it has taken and its assumptions regarding the impacts of widespread supply chain disruptions, hostilities in Ukraine, and COVID-19 lockdowns, Adient believes that its current financial resources will be sufficient to fund its liquidity requirements for at least the next twelve months.

As previously noted, in connection with the YFAS Sale, as part of the 2021 Yanfeng Transaction, Adient received CNY ¥8,064 million ($1,210 million) for all of the issued and outstanding equity interest in YFAS held by Adient. A portion of these proceeds (¥3,446 million ($519 million)) was paid to Adient upon the YFAS Sale Closing on September 30, 2021 and the remainder (¥4,618 million ($691 million)) was paid to Adient during the first quarter of fiscal 2022. Further, in conjunction with the closing of the Boxun Equity Purchase as part of the 2021 Yanfeng Transaction, Adient paid Boxun approximately $200 million, of which $15 million of historical dividends were paid in December 2021, and $185 million, including $32 million of historical dividends, was paid in the second quarter of fiscal 2022. Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for additional information.

Adient plc | Form 10-Q | 44

Sources of Cash Flows

	Nine Months Ended June 30,
(in millions)	2022		2021
Cash provided (used) by operating activities	$	38	$	362
Cash provided (used) by investing activities	539		(347)
Cash provided (used) by financing activities	(1,164)		(718)
Capital expenditures	(170)		(186)

Operating Cash Flows: The decrease in cash flows from operating activities is primarily due to the net loss attributable to Adient for the first nine months of fiscal 2022, lower cash dividends received from nonconsolidated partially-owned affiliates, and overall unfavorable changes to working capital year-over-year resulting in part from higher accounts receivable (net of $227 million favorable impact from accounts receivable factoring programs) and inventory levels.

Investing Cash Flows: The increase in cash provided by investing activities is primarily attributable to the following cash flow activities during the first nine months of fiscal 2022: the $651 million of proceeds received related to the 2021 Yanfeng Transaction, $46 million in proceeds received from the sale of the assets in Turkey, the collection of $41 million of deferred proceeds from the sale of Adient's interest in YFAI as part of the 2020 Yanfeng Transaction and lower capital expenditures, partially offset by the $30 million settlement of the derivative contracts related to the cash proceeds of the 2021 Yanfeng Transaction. Refer to Note 3, “Acquisitions and Divestitures,” and Note 9, “Derivative Instruments and Hedging Activities,” of the notes to the consolidated financial statements for additional information.

Financing Cash Flows: The increase in cash used by financing activities is attributable to the repayment of long-term debt, including premiums paid, of $888 million, amounts paid to acquire the noncontrolling interest of CQADNT ($153 million), along with higher dividend payments to noncontrolling interest primarily in connection with the acquisition of CQANDT, all of which occurred in the first nine months of fiscal 2022. Refer to Note 8, “Debt and Financing Arrangements,” and Note 3, “Acquisitions and Divestitures,” of the notes to the consolidated financial statements for additional information.

Capital expenditures: Capital expenditures decreased year over year based on timing of program spend on product launches and continued tightening of controls around overall spending.

Working capital

(in millions)	June 30, 2022		September 30, 2021
Current assets	$	4,062	$	5,086
Current liabilities	3,387		3,511
Working capital	$	675	$	1,575

The decrease in working capital of $900 million is primarily attributable to lower cash and cash equivalents as a result of the repayment of long-term debt during the current year, and lower other current assets balances due to the settlement of all outstanding balances related to the 2021 Yanfeng Transaction.

Restructuring Costs

During fiscal 2022, Adient committed to a restructuring plan ("2022 Plan") of $20 million that was offset by $8 million of prior year underspend. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in EMEA and Americas. Adient currently estimates that upon completion of the restructuring actions, the fiscal 2022 restructuring plan will reduce annual operating costs by approximately $20 million, which is primarily the result of lower costs of sales and selling, general and administrative expenses due to reduced employee-related costs, of which approximately 20% will result in net savings. The restructuring actions are expected to be substantially completed within fiscal 2023.

During fiscal 2021, Adient committed to a restructuring plan ("2021 Plan") of $27 million that was offset by $16 million of prior year underspend. Of the restructuring costs recorded, $23 million related to the EMEA segment, $3 million related to the Americas segment, and $1 million related to the Asia segment. Adient currently estimates that upon completion of the restructuring actions, the fiscal 2021 restructuring plan will reduce annual operating costs by approximately $23 million, which

Adient plc | Form 10-Q | 45

is primarily the result of lower costs of sales and selling, general and administrative expenses due to reduced employee-related costs, of which approximately 20%-30% will result in net savings. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions and lease contract terminations. The restructuring actions are expected to be substantially completed by fiscal 2023.

Adient's restructuring plans include workforce reductions of approximately 15,000 employees. Restructuring charges associated with employee severance and termination benefits are paid over the severance period granted to each employee or on a lump sum basis in accordance with individual severance agreements. As of June 30, 2022, approximately 14,000 of the employees have been separated from Adient pursuant to the restructuring plans. In addition, the restructuring plans included twenty-nine plant closures. As of June 30, 2022, twenty-one of the twenty-nine plants have been closed.

Adient's management closely monitors its overall cost structure and continually analyzes each of its businesses for opportunities to consolidate current operations, improve operating efficiencies and locate facilities in low cost countries in close proximity to customers. This ongoing analysis includes a review of its manufacturing, engineering, purchasing and administrative functions, as well as the overall global footprint for all its businesses. Because of the importance of new vehicle sales by major automotive manufacturers to operations, Adient is affected by the general business conditions in the automotive industry. Future adverse developments in the automotive industry, particularly related to the COVID-19 pandemic and supply chain disruptions, could impact Adient's liquidity position, lead to impairment charges and/or require additional restructuring of its operations.

Off-Balance Sheet Arrangements and Contractual Obligations

Adient enters into supply chain financing programs in certain domestic and foreign jurisdictions to either sell or discount accounts receivable without recourse to third-party institutions. Sales or discounts of accounts receivable are reflected as a reduction of accounts receivable on the consolidated statements of financial position and the proceeds are included in cash flows from operating activities in the consolidated statements of cash flows. As of June 30, 2022, $262 million has been funded under these programs compared to $126 million as of September 30, 2021.

Effects of Inflation and Changing Prices

The effects of inflation have historically not been significant to Adient's results of operations. Generally, Adient has been able to implement operating efficiencies to sufficiently offset cost increases, which have been moderate. The automotive industry has recently experienced a period of sustained price increases for commodities such as steel and to a lesser extent petrochemicals, as well as higher freight, labor and utility costs, that may continue in the future as demand increases and supply may remain constrained which has resulted in, and may continue to result in, increased costs for Adient that may not be, or may only be partially, offset.

Critical Accounting Estimates and Policies

See "Critical Accounting Estimates and Policies" under the heading "Item 7" of Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2021, for a discussion of critical accounting estimates and policies. There have been no material changes to Adient's critical accounting estimates and policies during the three months ended June 30, 2022.

New Accounting Pronouncements

See Note 1, "Basis of Presentation and Summary of Significant Accounting Policies," of the notes to consolidated financial statements for a discussion of new accounting pronouncements.

Adient plc | Form 10-Q | 46

Other Information

Not applicable

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As of June 30, 2022, Adient had not experienced any adverse changes in market risk exposures that materially affected the quantitative and qualitative disclosures presented in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2021.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report, Adient's principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934 (the "Exchange Act")), which are designed to provide reasonable assurance that we are able to record, process, summarize and report the information required to be disclosed in our reports under the Exchange Act within the time periods specified in SEC rules and forms. Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed in reports that we file or submit under the Exchange Act is accumulated and communicated to management, and made known to our principal executive officer and principal financial officer, on a timely basis to ensure that it is recorded, processed, summarized and reported within the time period specified in the SEC's rules and forms.

Changes in Internal Control over Financial Reporting

There were no changes in internal control over financial reporting during the three months ended June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Adient plc | Form 10-Q | 47

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product liability, product safety, environmental, safety and health, intellectual property, employment, commercial and contractual matters and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Adient accrues for potential liabilities in a manner consistent with accounting principles generally accepted in the United States, that is, when it is probable a liability has been incurred and the amount of the liability is reasonably estimable.

Information with respect to this item may be found in Note 17, "Commitments and Contingencies," of the notes to consolidated financial statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.

Additional information on Adient's commitments and contingencies can be found in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2021.

Item 1A. Risk Factors

Adient has updated or supplemented the below risk factors to reflect recent developments and these should be read in combination with those previously reported in Adient’s Annual Report on Form 10-K for the fiscal year ended September 30, 2021. To the extent applicable, the following risk factor updates supersede the corresponding risk factor previously reported in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2021.

COVID-19 vaccination mandates adopted by federal, state and local governments could have a material adverse impact on our business and results of operations.

While OSHA’s Emergency Temporary Standard has been withdrawn, state and local governments in which our business operates may implement or announce COVID-19 vaccination requirements applicable to certain of our employees. It is currently not possible to predict with certainty the impact these vaccination mandates, if implemented, will have on our business, especially on our workforce. Our implementation of these requirements may result in costs to us in the form of vaccinations or testing of employees. These requirements may also result in attrition in our workforce, including attrition of critically skilled labor, and difficulty securing future labor needs, which could have a material adverse effect on our business, financial condition, and results of operations.

Risks associated with Adient's non-U.S. operations could adversely affect Adient's business, financial condition and results of operations.

Adient has significant operations in a number of countries outside the U.S., some of which are located in emerging markets. Long-term economic uncertainty in some of the regions of the world in which Adient operates, such as Asia, South America and Europe and other emerging markets, could result in the disruption of markets and negatively affect cash flows from Adient's operations to cover its capital needs and debt service requirements.

In addition, as a result of Adient's global presence, a significant portion of its revenues and expenses is denominated in currencies other than the U.S. dollar. Adient is therefore subject to foreign currency risks and foreign exchange exposure. While Adient employs financial instruments to hedge some of its transactional foreign exchange exposure, these activities do not insulate Adient completely from those exposures. Exchange rates can be volatile and could adversely impact Adient's financial results and the comparability of results from period to period. Our use of financial instruments to limit this risk is guided by strict policies and processes and the success of our hedging programs depends primarily on the performance of the business in comparison with our forecasted sales proceeds and costs. If we incorrectly forecast these and other related factors, the transactions we have entered into may have an adverse impact on our financial results. No assurance can be given that our judgment in this respect will be correct.

There are other risks that are inherent in Adient's non-U.S. operations, including the potential for changes in socioeconomic conditions, laws and regulations, including import, export, direct and indirect taxes, value-added taxes, labor and environmental

Adient plc | Form 10-Q | 48

laws, and monetary and fiscal policies; protectionist measures that may prohibit acquisitions or joint ventures, or impact trade volumes; unsettled political conditions; government-imposed plant or other operational shutdowns; backlash from foreign labor organizations related to Adient's restructuring actions; corruption; natural and man-made disasters; global health epidemics (such as COVID-19); hazards and losses; violence, civil and labor unrest; and possible terrorist attacks.

On June 23, 2016, the U.K. voted in a national referendum to withdraw from the European Union and in March 2017 the U.K. invoked Article 50 of the Treaty on European Union, which began the U.K.’s withdrawal from the European Union. The U.K. formally left the European Union on January 31, 2020 and entered into a transition period which ended on December 31, 2020.

On December 30, 2020, the U.K. and the European Union entered into an agreement regarding their future relationship, the Trade and Cooperation Agreement, which was ratified by the parties and entered into full force on May 1, 2021. However, significant political and economic uncertainties remain in connection with the future of the U.K. and its relationship with the European Union. These uncertainties have caused and may continue to cause disruptions to capital and currency markets worldwide. The consequences of the withdrawal by the U.K. from the European Union and the impact on markets, as well as the impact on Adient’s operations, remain highly uncertain.

Russia’s invasion in Ukraine in February 2022 has resulted in significant uncertainty and instability in global supply chains and availability of certain commodities and raw materials. Although Adient has no operations in Ukraine and its operation in Russia has since been disposed, certain of its suppliers as well as customers depend on commodities and other material supplies that originate in Ukraine or Russia. In response to Russia’s invasion in Ukraine, a number of countries, including the United States, the United Kingdom and members of the European Union, have implemented economic sanctions on Russia and certain Russian enterprises including several large banks. If the conflict continues, it may trigger a series of additional economic and other sanctions which in turn could further disrupt the global automotive supply chains by limiting supplies of key components and increasing inflationary pressures. The continued conflict could have broader adverse impacts on Adient's business, cash flows, financial condition and results of operations. Additionally, it could intensify many of the other risk factors noted in Part I, Item 1A, Risk Factors in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(a) Unregistered Sale of Equity Securities

None.

(b) Use of Proceeds

Not applicable.

(c) Repurchase of Equity Securities

There has been no share repurchase activity during the three months ended June 30, 2022.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Adient plc | Form 10-Q | 49

Item 6. Exhibit Index

EXHIBIT INDEX

Exhibit No.	Exhibit Title
31.1	Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Periodic Financial Report by the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

Adient plc | Form 10-Q | 50

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Adient plc
By:	/s/ Douglas G. Del Grosso
	Douglas G. Del Grosso
	President and Chief Executive Officer and a Director
Date:	August 5, 2022
By:	/s/ Jeffrey M. Stafeil
	Jeffrey M. Stafeil
	Executive Vice President and Chief Financial Officer
Date:	August 5, 2022

Adient plc | Form 10-Q | 51

EX-31.1

Exhibit 31.1

Certification

I, Douglas G. Del Grosso, certify that:

1 I have reviewed this quarterly report on Form 10-Q of Adient plc;

2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3 Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4 The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5 The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date:	August 5, 2022
		By:	/s/ Douglas G. Del Grosso
			Douglas G. Del Grosso
			President and Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification

I, Jeffrey M. Stafeil, certify that:

1 I have reviewed this quarterly report on Form 10-Q of Adient plc;

2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3 Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4 The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5 The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize, and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date:	August 5, 2022
		By:	/s/ Jeffrey M. Stafeil
			Jeffrey M. Stafeil
			Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Douglas G. Del Grosso, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Adient plc on Form 10-Q for the period ended June 30, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Adient plc.

Date:	August 5, 2022
		By:	/s/ Douglas G. Del Grosso
			Douglas G. Del Grosso
			President and Chief Executive Officer

I, Jeffrey M. Stafeil, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Adient plc on Form 10-Q for the period ended June 30, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Adient plc.

Date:	August 5, 2022
		By:	/s/ Jeffrey M. Stafeil
			Jeffrey M. Stafeil
			Executive Vice President and Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to Adient plc and will be retained by Adient plc and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover	9 Months Ended
	Jun. 30, 2022 shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	001-37757
Entity Registrant Name	Adient plc
Entity Incorporation, State or Country Code	L2
Entity Tax Identification Number	98-1328821
Entity Address, Address Line One	25-28 North Wall Quay
Entity Address, Address Line Two	IFSC
Entity Address, City or Town	Dublin 1
Entity Address, Country	IE
Entity Address, Postal Zip Code	D01 H104
City Area Code	734
Local Phone Number	254-5000
Title of 12(b) Security	Ordinary Shares, par value $0.001
Trading Symbol	ADNT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	94,813,661
Entity Central Index Key	0001670541
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Current Fiscal Year End Date	--09-30

XML

Consolidated Statements of Income (Loss) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Net sales	$ 3,485	$ 3,242	$ 10,471	$ 10,909
Cost of sales	3,312	3,092	9,947	10,120
Gross profit	173	150	524	789
Selling, general and administrative expenses	142	136	439	433
Restructuring and impairment costs	12	8	20	20
Equity income (loss)	16	38	56	220
Earnings (loss) before interest and income taxes	35	44	121	556
Net financing charges	39	87	172	256
Other pension expense (income)	(4)	(4)	(6)	(8)
Income (loss) before income taxes	0	(39)	(45)	308
Income tax provision (benefit)	20	10	65	90
Net income (loss)	(20)	(49)	(110)	218
Income (loss) attributable to noncontrolling interests	10	22	55	70
Net income (loss) attributable to Adient	$ (30)	$ (71)	$ (165)	$ 148
Earnings (loss) per share:
Basic (in usd per share)	$ (0.32)	$ (0.75)	$ (1.74)	$ 1.57
Diluted (in usd per share)	$ (0.32)	$ (0.75)	$ (1.74)	$ 1.55
Shares used in computing earnings per share:
Basic (in shares)	94.8	94.2	94.7	94.1
Diluted (in shares)	94.8	94.2	94.7	95.6

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (20)	$ (49)	$ (110)	$ 218
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(155)	25	(122)	62
Realized and unrealized gains (losses) on derivatives	(7)	17	(5)	34
Other comprehensive income (loss)	(162)	42	(127)	96
Total comprehensive income (loss)	(182)	(7)	(237)	314
Comprehensive income (loss) attributable to noncontrolling interests	(10)	23	43	79
Comprehensive income (loss) attributable to Adient	$ (172)	$ (30)	$ (280)	$ 235

XML

Consolidated Statements of Financial Position - USD ($) $ in Millions	Jun. 30, 2022	Sep. 30, 2021
Assets
Cash and cash equivalents	$ 892	$ 1,521
Accounts receivable - net	1,761	1,426
Inventories	953	976
Assets held for sale	0	49
Other current assets	456	1,114
Current assets	4,062	5,086
Property, plant and equipment - net	1,443	1,607
Goodwill	2,122	2,212
Other intangible assets - net	504	555
Investments in partially-owned affiliates	348	335
Assets held for sale	7	25
Other noncurrent assets	829	958
Total assets	9,315	10,778
Liabilities and Shareholders' Equity
Short-term debt	9	17
Current portion of long-term debt	11	167
Accounts payable	2,361	2,130
Accrued compensation and benefits	336	389
Liabilities held for sale	0	16
Restructuring reserve	70	115
Other current liabilities	600	677
Current liabilities	3,387	3,511
Long-term debt	2,707	3,512
Liabilities held for sale	0	0
Pension and postretirement benefits	110	128
Other noncurrent liabilities	613	669
Long-term liabilities	3,430	4,309
Commitments and Contingencies (Note 17)
Redeemable noncontrolling interests	45	240
Preferred shares issued, par value $0.001; 100,000,000 shares authorized, Zero shares issued and outstanding at June 30, 2022	0	0
Ordinary shares issued, par value $0.001; 500,000,000 shares authorized, 94,813,661 shares issued and outstanding at June 30, 2022	0	0
Additional paid-in capital	4,018	3,991
Accumulated deficit	(1,153)	(988)
Accumulated other comprehensive income (loss)	(742)	(627)
Shareholders' equity attributable to Adient	2,123	2,376
Noncontrolling interests	330	342
Total shareholders' equity	2,453	2,718
Total liabilities and shareholders' equity	$ 9,315	$ 10,778

XML

Consolidated Statements of Financial Position (Parenthetical)	Jun. 30, 2022 $ / shares shares
Statement of Financial Position [Abstract]
Preferred stock, par value (in usd per share) | $ / shares	$ 0.001
Preferred stock, shares authorized (in shares)	100,000,000
Preferred stock, shares issued (in shares)	0
Preferred stock, shares outstanding (in shares)	0
Common stock, par value (in usd per share) | $ / shares	$ 0.001
Common stock, shares authorized (in shares)	500,000,000
Common stock, shares issued (in shares)	94,813,661
Common stock, shares outstanding (in shares)	94,813,661

XML

Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating Activities
Net income (loss) attributable to Adient	$ (165)	$ 148
Income attributable to noncontrolling interests	55	70
Net income (loss)	(110)	218
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities:
Depreciation	223	210
Amortization of intangibles	40	29
Pension and postretirement expense (benefit)	(1)	(1)
Pension and postretirement contributions, net	(17)	(18)
Equity in earnings of partially-owned affiliates, net of dividends received (includes purchase accounting amortization of $1 and $3, respectively)	(38)	106
Impairment/(gain) on sale of nonconsolidated partially-owned affiliates	8	(33)
Premium and transaction costs paid on repurchase of debt	34	50
Retrospective recoveries of Brazil indirect tax credits	0	(38)
Derivative loss on the 2021 Yanfeng Transaction	3	24
Deferred income taxes	5	(5)
Non-cash impairment charges	12	11
Equity-based compensation	21	36
Other	14	16
Changes in assets and liabilities:
Receivables	(415)	195
Inventories	(26)	(158)
Other assets	62	(63)
Restructuring reserves	(49)	(118)
Accounts payable and accrued liabilities	283	(142)
Accrued income taxes	(11)	43
Cash provided (used) by operating activities	38	362
Investing Activities
Capital expenditures	(170)	(186)
Sale of property, plant and equipment	18	23
Settlement of derivatives	(30)	0
Advance payment for business acquisitions	(19)	(271)
Proceeds from business divestitures	740	72
Loans to affiliates	0	15
Cash provided (used) by investing activities	539	(347)
Financing Activities
Increase (decrease) in short-term debt	(8)	36
Increase (decrease) in long-term debt	0	214
Repayment of long-term debt	(888)	(890)
Debt financing costs	(1)	(8)
Cash paid to acquire a noncontrolling interest	(153)	0
Dividends paid to noncontrolling interests	(102)	(66)
Other	(12)	(4)
Cash provided (used) by financing activities	(1,164)	(718)
Effect of exchange rate changes on cash and cash equivalents	(42)	12
Increase (decrease) in cash and cash equivalents, including cash classified within current assets held for sale	(629)	(691)
Change in cash classified within current assets held for sale	0	(1)
Increase (decrease) in cash and cash equivalents	(629)	(692)
Cash and cash equivalents at beginning of period	1,521	1,692
Cash and cash equivalents at end of period	$ 892	$ 1,000

XML

Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Statement of Cash Flows [Abstract]
Purchase accounting amortization	$ 1	$ 3

XML

Basis of Presentation and Summary of Significant Accounting Policies

9 Months Ended

Jun. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Summary of Significant Accounting Policies

1. Basis of Presentation and Summary of Significant Accounting Policies

Adient is a global leader in the automotive seating supplier industry. Adient has a leading market position in the Americas, Europe and China, and has longstanding relationships with the largest global original equipment manufacturers, or OEMs, in the automotive space. Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests and trim covers. Adient is an independent seat supplier with global scale and the capability to design, develop, engineer, manufacture, and deliver complete seat systems and components in every major automotive producing region in the world.

Basis of Presentation

The consolidated financial statements of Adient have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"). During the second half of fiscal 2021 and continuing into the first nine months of fiscal 2022, Adient faced, along with the entire global automotive industry, widespread supply chain disruptions primarily related to semiconductor chip shortages. Although Adient’s seating products are not highly dependent directly on semiconductor chips, Adient is directly impacted by the lower production levels at OEM’s as a direct result of these supply chain disruptions. These disruptions have led to unplanned down time at Adient’s production facilities, often with very little warning, which creates operating inefficiencies and limits Adient’s ability to adequately mitigate such inefficiencies. Further, the Russia/Ukraine conflict has created additional risks to the macroeconomic environment of the global automotive industry by restricting availabilities of certain key raw material components. Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information on the impacts from the Russia/Ukraine conflict.

The automotive industry has also experienced price increases for commodities, utilities and shipping costs throughout fiscal 2022 which have negatively impacted Adient's results. These cost increases may continue into the future as demand increases and supply may remain constrained, which has resulted in, and may continue to result in, increased costs for Adient that may not be, or may only be partially, offset. Adient has also experienced wage inflationary pressures as a result of constrained labor availability in fiscal 2022.

Additionally, the impact of COVID-19, and related variants and sub-variants, continues to be present throughout the world, including in all global and regional markets served by Adient. The elevated COVID-19 rates in China led to widespread lockdowns during the second and third quarters of fiscal 2022, negatively impacting the automotive production levels in that region, along with creating further supply chain disruptions. Although vaccines have been introduced that are expected to have the result of reducing the effect of COVID-19 and COVID-19 has waned in certain geographic areas, governmental authorities continue to implement numerous measures attempting to contain and mitigate the effects of COVID-19, including travel bans and restrictions, quarantines, social distancing orders, shelter in place orders and shutdowns of non-essential activities. Adient's manufacturing facilities are located in areas that continue to be affected by the pandemic.

Principles of Consolidation

Adient consolidates its wholly-owned subsidiaries and those entities in which it has a controlling interest. Investments in partially-owned affiliates are accounted for by the equity method when Adient's interest exceeds 20% and does not have a controlling interest.

Consolidated VIEs

Based upon the criteria set forth in the Financial Accounting Standards Board (the FASB) Accounting Standards Codification (ASC) 810, "Consolidation," Adient has determined that it was the primary beneficiary in two variable interest entities (VIEs) for the reporting periods ended June 30, 2022, and September 30, 2021, respectively, as Adient absorbs significant economics of the entities and has the power to direct the activities that are considered most significant to the entities.

The two VIEs manufacture seating products in North America for the automotive industry. Adient funds the entities' short-term liquidity needs through revolving credit facilities and has the power to direct the activities that are considered most significant to the entities through its key customer supply relationships.

The carrying amounts and classification of assets (none of which is restricted) and liabilities included in Adient's consolidated statements of financial position for the consolidated VIEs are as follows:

(in millions)	June 30, 2022		September 30, 2021
Current assets	$	223	$	158
Noncurrent assets	105		88
Total assets	$	328	$	246
Current liabilities	$	193	$	143
Noncurrent liabilities	13		8
Total liabilities	$	206	$	151

Earnings Per Share

The following table shows the computation of basic and diluted earnings (loss) per share:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions, except per share data)	2022		2021		2022		2021
Numerator:
Net income (loss) attributable to Adient	$	(30)	$	(71)	$	(165)	$	148
Denominator:
Shares outstanding	94.8		94.2		94.7		94.1
Effect of dilutive securities	—		—		—		1.5
Diluted shares	94.8		94.2		94.7		95.6
Earnings (loss) per share:
Basic	$	(0.32)	$	(0.75)	$	(1.74)	$	1.57
Diluted	$	(0.32)	$	(0.75)	$	(1.74)	$	1.55

The effect of common stock equivalents which would have been anti-dilutive was excluded from the calculation of diluted earnings per share for the nine months ended June 30, 2021. Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings per share which for the three and nine months ended June 30, 2022 and for the three months ended June 30, 2021 is a result of being in a loss position.

New Accounting Pronouncements

Standards Adopted During Fiscal 2022

On October 1, 2021, Adient adopted Accounting Standards Codification (ASU) 2018-14 Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20). ASU 20218-14 eliminates, adds, and modifies certain disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The guidance is to be applied on a retrospective basis. The adoption of this guidance on October 1, 2021 did not significantly impact Adient's consolidated financial statements for the nine months ended June 30, 2022.

On October 1, 2021, Adient adopted ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 modifies ASC 740, Income Taxes, by simplifying accounting for income taxes. As part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements, the FASB’s amendments may impact both interim and annual reporting periods. The adoption of this guidance on October 1, 2021 did not significantly impact Adient's consolidated financial statements for the nine months ended June 30, 2022.

Standards Effective After Fiscal 2022

Adient has considered the ASUs summarized below, effective after fiscal 2022, none of which are expected to significantly impact the consolidated financial statements:

Standard Adopted	Description	Date Effective
ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40)	ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity by reducing the number of accounting models for convertible debt and convertible preferred stock.	October 1, 2022
ASU 2021-10, Government Assistance (Topic 832) - Disclosures by Business Entities about Government Assistance	The ASU requires annual disclosures of: i) information about the nature of government assistance transactions and the related accounting policy used to account for the transactions, ii) the balance sheet and income statement line items affected by the transactions, and the amounts for each financial statement line item, and iii) significant transaction terms and conditions.	October 1, 2022

XML

Revenue Recognition

9 Months Ended

Jun. 30, 2022

Revenue from Contract with Customer [Abstract]

Revenue Recognition

2. Revenue Recognition

Adient generates revenue through the sale of automotive seating solutions, including complete seating systems and the components of complete seating systems. Adient provides production and service parts to its customers under awarded multi-year programs. The duration of a program is generally consistent with the life cycle of a vehicle, however, the program can be canceled at any time without cause by the customer. Programs awarded to Adient to supply parts to its customers do not contain a firm commitment by the customer for volume or price and do not reach the level of a performance obligation until Adient receives either a purchase order and/or a materials release from the customer for a specific number of parts at a specified price, at which point an enforceable contract exists. Sales revenue is generally recognized at the point in time when parts are shipped and control has transferred to the customer, at which point an enforceable right to payment exists. Contracts may provide for annual price reductions over the production life of the awarded program, and prices are adjusted on an ongoing basis to reflect changes in product content/cost and other commercial factors. The amount of revenue recognized reflects the consideration that Adient expects to be entitled to in exchange for such products based on purchase orders, annual price reductions and ongoing price adjustments (some of which are accounted for as variable consideration and subject to being constrained), net of the impact, if any, of consideration paid to the customer.

In a typical arrangement with the customer, purchase orders are issued for pre-production activities which consist of engineering, design and development, tooling and prototypes for the manufacture and delivery of component parts. Adient has concluded that these activities are not in the scope of ASC 606.

Adient has elected to include shipping and handling fees billed to customers in revenue, while including costs of shipping and handling in cost of sales. Taxes collected from customers are excluded from revenue and credited directly to obligations to the appropriate government agencies. Payment terms with customers are established based on customary industry and regional practices. Adient has evaluated the terms of its arrangements and determined that they do not contain significant financing components.

Contract assets primarily relate to the right to consideration for work completed, but not billed at the reporting date on contracts with customers. The contracts assets are transferred to receivables when the rights become unconditional. Contract liabilities primarily relate to contracts where advance payments or deposits have been received, but performance obligations have not yet been satisfied and revenue has not been recognized. No significant contract assets or liabilities were identified at September 30, 2021 or at June 30, 2022. As described above, the issuance of a purchase order and/or a materials release by the customer represents the point at which an enforceable contract with the customer exists. Therefore, Adient has elected to apply the practical expedient in ASC 606, paragraph 606-10-50-14 and does not disclose information about the remaining performance obligations that have an original expected duration of one year or less. Refer to Note 15, "Segment Information," of the notes to consolidated financial statements for disaggregated revenue by geographical market.

XML

Acquisitions and Divestitures

9 Months Ended

Jun. 30, 2022

Business Combination and Asset Acquisition [Abstract]

Acquisitions and Divestitures

3. Acquisitions and Divestitures

2021 Yanfeng Transaction

On March 12, 2021, Adient, Yanfeng Automotive Trim Systems Company Ltd. (“Yanfeng”), Yanfeng Adient Seating Co., Ltd. (“YFAS”), a joint venture owned, directly or indirectly, by Yanfeng (50.01%) and Adient (49.99%), and KEIPER Seating Mechanisms Co., Ltd. (f/k/a Adient Yanfeng Seating Mechanisms Co., Ltd. (“AYM” or "KEIPER"), a joint venture owned, directly or indirectly, by Yanfeng (50%) and Adient (50%), entered into a Master Agreement (the “2021 Agreement”), pursuant to which the parties agreed to, among other things, the following transactions (collectively, the “2021 Yanfeng Transaction”). The 2021 Yanfeng Transaction closed on September 30, 2021 (“Closing Date”).

a.Adient transferred all of the issued and outstanding equity interest in YFAS held by Adient, which represents 49.99% of YFAS’s total issued and outstanding equity interest, to Yanfeng pursuant to the Equity Transfer Agreement, dated as of March 12, 2021, by and between Yanfeng and Adient, for CNY ¥8,064 million ($1,210 million), of which ¥3,446 million ($519 million) was paid by Yanfeng to Adient on the Closing Date, and ¥4,618 million ($691 million) was paid by Yanfeng to Adient in December 2021, and;

b.YFAS transferred all of the issued and outstanding equity interests in Yanfeng Adient Automotive Components Co., Ltd. ("CQADNT") and Adient (Langfang) Seating Co., Ltd. ("LFADNT") held directly or indirectly by YFAS to Adient for a price of ¥1,754 million ($271 million) (the “YFAS JVs Acquisition”). The YFAS JVs Acquisition was funded, in part, by annual cash dividends from YFAS and KEIPER, paid to shareholders of YFAS and KEIPER;

c.YFAS transferred all of the issued and outstanding equity interest in Yanfeng Adient Founder Motor Co., Ltd. (“YFM”) held, directly or indirectly, by YFAS, which represented 70% of YFM’s total issued and outstanding equity interest, to KEIPER for ¥71 million ($11 million) (the “YFM Sale”);

d.YFAS transferred all of the issued and outstanding equity interest in Nantong Yanfeng Adient Seating Trim Co., Ltd. (“YFAT”) held, directly or indirectly, by YFAS, which represented 75% of YFAT’s total issued and outstanding equity interest, to KEIPER for ¥113 million ($17 million) (the “YFAT Sale”);

e.Adient granted to Yanfeng a license of intellectual property for use on a non-exclusive and perpetual basis for a payment of ¥385 million ($59 million), and Yanfeng/YFAS granted to Adient a royalty-free, non-exclusive and perpetual intellectual property license of the Yanfeng/YFAS intellectual property; and

f.YFAS declared and distributed dividends in the amounts and at the times as set forth in the 2021 Agreement to its shareholders (proportionately to their ownership interest, namely 50.01% to Yanfeng and 49.99% to Adient) of approximately ¥4,168 million ($635 million) in the aggregate. YFAS paid an aggregate dividend of ¥2,809 million ($436 million) during the third quarter of fiscal 2021, and ¥1,359 million ($199 million) was distributed on the Closing Date.

In addition, on March 12, 2021, Adient, YFAS, Yanfeng and KEIPER, entered into an Ancillary Master Agreement (the “Ancillary Master Agreement”), pursuant to which the parties have agreed to, among other things, the following transactions (collectively, the “Ancillary Transactions”). The Ancillary Transactions were also completed on the Closing Date.

a.Adient and Yanfeng amended the KEIPER Equity Joint Venture Contract, dated as of January 31, 2020, as amended, and the Articles of Association of KEIPER, dated as of September 9, 2013, as amended, to, among other things, (i) provide that KEIPER would declare and pay certain annual dividends to KEIPER’s shareholders with respect to each of its 2021 to 2023 fiscal years and (ii) upon closing of the earlier of the YFAT Sales (as defined below) or YFM Sale, because of KEIPER’s ownership of YFAT and YFM, certain amendments relating thereto, including modifying the scope of KEIPER’s business to include the manufacture and sale of automotive seat trim products and micro-motors; and

b.KEIPER and Yanfeng and KEIPER and Adient each entered into a long-term supply agreement.

In conjunction with the 2021 Yanfeng Transaction, Adient entered into an agreement (the “Boxun Agreement”) with Chongqing Boxun Industrial Co., Ltd. (“Boxun”). Pursuant to such agreement, upon consummation of the YFAS JVs Acquisition, Adient provided Boxun with the right to sell and, if exercised, Adient agreed to purchase, all of the issued and outstanding equity interest in CQADNT held by Boxun, which represents 25% of CQADNT’s total issued and outstanding equity interest (the “Boxun Equity Purchase”). On October 29, 2021, Boxun exercised its right to sell its equity interest to

Adient. In January 2022, Boxun and Adient closed the transaction. The total payment to Boxun from Adient was approximately $200 million, of which $15 million of historical dividends were paid in December 2021, and $185 million, including $32 million of historical dividends, was paid in the second quarter of fiscal 2022. At September 30, 2021, $194 million had been reflected as redeemable noncontrolling interest. With the acquisitions of Boxun’s 25% and YFAS’s 50% interest of CQADNT, Adient owns 100% of CQADNT effective January 2022.

In addition, in conjunction with the 2021 Yanfeng Transaction, Adient entered into agreements, whereby, Adient would: (i) transfer all of the issued and outstanding equity interest in YFAT held, directly or indirectly, by Adient, which represents 25% of YFAT’s total issued and outstanding equity interest, to KEIPER for ¥38 million ($6 million) (the “Adient YFAT Sale” and together with the YFAT Sale, the “YFAT Sales”); (ii) transfer all of the issued and outstanding equity interest in Guangzhou Dongfeng Adient Seating Co., Ltd. (“GZDFAS”) held by Adient, which represents 25% of GZDFAS’s total issued and outstanding equity interest, to YFAS for ¥371 million ($56 million) (the “GZDFAS Sale”) and (iii) transfer all of the issued and outstanding equity interest in Hefei Adient Yunhe Automotive Seating Co., Ltd. (“YHAS”) held by Adient, which represents 10% of YHAS’s total issued and outstanding equity interest, to YFAS for ¥13 million ($2 million) (the “YHAS Sale,” together with the Adient YFAT Sale and GZDFAS Sale, each an “Additional Equity Sale” and collectively, the “Additional Equity Sales”). The Additional Equity Sales were completed on the Closing Date.

As a result of the 2021 Agreement, Adient received $41 million in November 2021 representing the remaining balance of proceeds from the sale of its interest in Yanfeng Global Automotive Interior Systems Co. ("YFAI"), a joint venture previously owned, directly or indirectly, by Yanfeng (70%) and Adient (30%), which was part of the 2020 Yanfeng Transaction (as defined and described in Form 10-K for the fiscal year ended September 30, 2021).

Upon completion of the 2021 Yanfeng Transaction on September 30, 2021, Adient started consolidating CQADNT and LFADNT. The net purchase consideration of $271 million consisted of net cash consideration of $211 million, net of $60 million acquired. The acquisition was accounted for using the acquisition method, and the operating results and cash flows of CQADNT and LFADNT will be included in Adient's consolidated financial statements starting from October 1, 2021. The acquisitions are expected to provide substantial synergies through vertical integration, purchasing and logistics improvements. The acquisitions also provide for an immediate manufacturing presence in strategic locations in China.

Adient recorded a purchase price allocation for the assets acquired and liabilities assumed based on their estimated fair values as of the September 30, 2021 acquisition date. The preliminary purchase price adjustments and allocation is as follows:

	Fair value allocation
(in millions)	CQADNT		LFADNT
Cash	$	55	$	5
Accounts receivable	296		2
Inventory	37		5
Property, plant and equipment	86		8
Other assets	46		2
Goodwill	180		8
Intangible assets	234		6
Accounts payable	(252)		(19)
Other liabilities	(127)		(4)
Subtotal	555		13
Less: Interest already owned	103		—
Less: Redeemable noncontrolling interest	194		—
Total purchase consideration	258		13
Less: cash acquired	55		5
Net cash paid	$	203	$	8

The values allocated to CQADNT and LFADNT’s intangible assets of $234 million and $6 million, respectively, primarily consisted of customer relationships and patented technologies which are being amortized on a straight line basis over estimated useful lives of 3 to 12 years. The assets were valued using a combination of an income approach and a relief from royalty

approach. These values were considered level 3 measurements under the U.S. GAAP fair value hierarchy. Key assumptions used in the valuation of customer relationships included a rate of return of 13.5% and the life of the relationship of approximately 12 years. Key assumptions used in the valuation of patented technologies included a rate of return of 13.5% and the life of the technologies of approximately 10 years.

The allocation of the purchase price was based on the valuations performed to determine the fair value of the net assets as of the acquisition date. The amounts allocated to goodwill and intangible assets along with fair value adjustments on property, plant and equipment and inventory reflected preliminary valuations.

In April 2022, Adient entered into an agreement whereby Adient would purchase all of the issued and outstanding equity interest in YFAT held by KEIPER for ¥150 million ($24 million). Adient made an initial deposit of ¥37 million ($6 million) (reflected within other current assets as of June 30, 2022), and a second deposit of ¥37 million ($6 million) in April 2022, which represents 50% of the estimated purchase price. The transaction is subject to a public bidding process and other customary regulatory approvals, and is expected to be completed in the second half of calendar year 2022. The remaining 50% of the estimated purchase price will be paid at the time of completion of the transaction.

Also, Adient has entered into agreements whereby Adient would transfer all of the issued and outstanding equity interests in two joint ventures in China held directly by Adient, each of which represents 25% of their total issued and outstanding equity interests, to Yanfeng for $3 million. As a result, Adient concluded that indicators of other-than-temporary impairment were present related to the investments in these joint ventures, and recorded a non-cash impairment charge of $3 million during the second quarter of fiscal 2022. The transactions are expected to be completed during the second half of fiscal 2022.

SJA

On March 31, 2021, Adient sold its 50% equity interest in Shenyang Jinbei Adient Automotive Components Co., Ltd. ("SJA") to the joint venture partner for $58 million, which resulted in a $33 million one-time gain recognized during the second quarter of fiscal 2021. The receivable was recorded as part of other current assets on March 31, 2021, and the net proceeds of $53 million were received on April 1, 2021.

Russia/Ukraine conflict

Following Russia's invasion of Ukraine in February 2022, Adient has determined to withdraw from the Russian market. Adient recorded a charge of $3 million during the second quarter of fiscal 2022, which included a $2 million impairment of Adient's Russian entity and $1 million of allowance for doubtful accounts in EMEA. Adient's Russian operation, which primarily produces automotive seating trim products for the domestic market, recorded $7 million of net sales and de minimis amount of net income in fiscal 2021. In July 2022, Adient entered into a sale agreement and finalized the sale transaction of its Russian operation for one ruble. In conjunction with the sale transaction, Adient will record an additional charge of $3 million related to accumulated foreign currency translation losses that are reflected in accumulated other comprehensive income (loss) under shareholders' equity on Adient's consolidated statements of financial position as of June 30, 2022.

Assets held for sale

During the first quarter of fiscal 2022, Adient committed to sell certain assets in EMEA. As a result, these assets were classified as assets held for sale and were required to be adjusted to the lower of fair value less cost to sell or carrying value. This resulted in an impairment charge of $7 million. The impairment was measured using third party sales pricing to determine fair values of the assets. The inputs utilized in the analyses are classified as Level 3 inputs within the fair value hierarchy as defined in ASC 820, "Fair Value Measurement." During the third quarter of fiscal 2022, the impairment charge was reduced by $1 million as the finalized sale agreement indicated a higher sale price than the originally estimated fair value.

During the second quarter of fiscal 2022, Adient collected the final portion of proceeds from the sale of certain assets in Turkey, which had been classified as assets held for sale during fiscal 2021. The finalization of the transaction resulted in a loss on sale of $2 million, recorded within selling, general and administrative costs on the consolidated statement of income (loss) in the second quarter of fiscal 2022.

During fiscal 2021, Adient committed to sell certain assets in France and Turkey. As a result, these assets were classified as assets held for sale (including an allocation of $11 million of goodwill) and were required to be adjusted to the lower of fair value less cost to sell or carrying value. This resulted in Adient recording an impairment charge of $9 million within restructuring and impairment costs on the consolidated statement of income (loss) related to the assets in France. The impairment was measured using third party sales pricing to determine fair values of the assets. The inputs utilized in the analyses are classified as Level 3 inputs within the fair value hierarchy as defined in ASC 820, "Fair Value Measurement." The

sale of the assets in France was completed during the third quarter of fiscal 2021 for minimal proceeds while the sale of the assets in Turkey was completed in October 2021 for total proceeds of $46 million, of which $36 million was collected at closing, and $10 million was collected in the second quarter of fiscal 2022.

XML

Inventories

9 Months Ended

Jun. 30, 2022

Inventory Disclosure [Abstract]

Inventories

4. Inventories

Inventories consisted of the following:

(in millions)	June 30, 2022		September 30, 2021
Raw materials and supplies	$	765	$	750
Work-in-process	24		29
Finished goods	164		197
Inventories	$	953	$	976

XML

Goodwill and Other Intangible Assets

9 Months Ended

Jun. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

5. Goodwill and Other Intangible Assets

The changes in the carrying amount of goodwill are as follows:

(in millions)	Americas		EMEA		Asia		Total
Balance at September 30, 2021	$	607	$	354	$	1,251	$	2,212
Currency translation and other	1		(38)		(53)		(90)
Balance at June 30, 2022	$	608	$	316	$	1,198	$	2,122

Refer to Note 15, "Segment Information," of the notes to consolidated financial statements for more information on Adient's reportable segments.

Adient's other intangible assets, primarily from business acquisitions valued based on independent appraisals, consisted of:

	June 30, 2022						September 30, 2021
(in millions)	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Intangible assets
Patented technology	$	86	$	(24)	$	62	$	86	$	(19)	$	67
Customer relationships	627		(201)		426		649		(178)		471
Trademarks	18		(16)		2		26		(21)		5
Miscellaneous	26		(12)		14		24		(12)		12
Total intangible assets	$	757	$	(253)	$	504	$	785	$	(230)	$	555

Amortization of other intangible assets for the nine months ended June 30, 2022 and 2021 was $40 million and $29 million, respectively.

Refer to Note 15, "Segment Information," of the notes to consolidated financial statements for more information on Adient's reportable segments.

XML

Product Warranties

9 Months Ended

Jun. 30, 2022

Product Warranties Disclosures [Abstract]

Product Warranties

6. Product Warranties

Adient offers warranties to its customers depending upon the specific product and terms of the customer purchase agreement. A typical warranty program requires that Adient replace defective products within a specified time period from the date of sale. Adient records an estimate for future warranty-related costs based on actual historical return rates and other known factors. Based on analysis of return rates and other factors, Adient's warranty provisions are adjusted as necessary. Adient monitors its warranty activity and adjusts its reserve estimates when it is probable that future warranty costs will be different than those estimates. Adient's product warranty liability is recorded in the consolidated statements of financial position in other current liabilities.

The changes in Adient's total product warranty liability are as follows:

	Nine Months Ended June 30,
(in millions)	2022		2021
Balance at beginning of period	$	23	$	24
Accruals for warranties issued during the period	7		7
Changes in accruals related to pre-existing warranties (including changes in estimates)	—		(1)
Settlements made (in cash or in kind) during the period	(7)		(6)
Currency translation	(1)		—
Balance at end of period	$	22	$	24

XML

Leases

9 Months Ended

Jun. 30, 2022

Leases [Abstract]

Leases

7. Leases

Adient's lease portfolio consists of operating leases for real estate including production facilities, warehouses and administrative offices, equipment such as forklifts and computer servers and laptops, and fleet vehicles.

The components of lease costs included in the consolidated statement of income (loss) for the three and nine months ended June 30, 2022 and 2021 were as follows:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Operating lease cost	$	32	$	32	$	90	$	94
Short-term lease cost	2		4		14		16
Total lease cost	$	34	$	36	$	104	$	110

Operating lease right-of-use assets and lease liabilities included in the consolidated statement of financial position were as follows:

(in millions)		June 30, 2022			September 30, 2021
Operating leases:
Operating lease right-of-use assets	Other noncurrent assets	$	293		$	335
Operating lease liabilities - current	Other current liabilities	$	85		$	89
Operating lease liabilities - noncurrent	Other noncurrent liabilities	209			246
		$	294		$	335
Weighted average remaining lease term:
Operating leases		6 years			6 years
Weighted average discount rate:
Operating leases		5.4		%	5.2		%

Maturities of operating lease liabilities and minimum payments for operating leases having initial or remaining non-cancelable terms in excess of one year as of June 30, 2022 are as follows:

	Operating leases
Fiscal years (in millions)	June 30, 2022
2022 (excluding the nine months ended June 30, 2022)	$	26
2023	89
2024	66
2025	47
2026	31
Thereafter	81
Total lease payments	340
Less: imputed interest	(46)
Present value of lease liabilities	$	294

Supplemental cash flow information related to leases is as follows:

	Nine Months Ended June 30,
(in millions)	2022		2021
Right-of-use assets obtained in exchange for lease obligations:
Operating leases (non-cash activity)	$	38	$	102
Operating cash flows:
Cash paid for amounts included in the measurement of lease liabilities	$	89	$	96

XML

Debt and Financing Arrangements

9 Months Ended

Jun. 30, 2022

Debt Disclosure [Abstract]

Debt and Financing Arrangements

8. Debt and Financing Arrangements

Debt consisted of the following:

(in millions)	June 30, 2022		September 30, 2021
Long-term debt:
Term Loan B - LIBOR plus 3.25% due in 2028	$	990	$	998
4.875% Notes due in 2026	795		795
3.50% Notes due in 2024	860		1,161
9.00% Notes due in 2025	92		600
European Investment Bank Loan - EURIBOR plus 1.58% due in 2022	—		156
Finance lease obligations	1		1
Less: debt issuance costs	(20)		(32)
Gross long-term debt	2,718		3,679
Less: current portion	11		167
Net long-term debt	$	2,707	$	3,512
Short-term debt:
Other bank borrowings	$	9	$	17
Total short-term debt	$	9	$	17

Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintains an asset-based revolving credit facility (the “ABL Credit Facility”), which provides for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity and certain other restrictions, including a minimum fixed charge coverage ratio. The ABL Credit Facility will mature on May 6, 2024, subject to a springing maturity date 91 days earlier if certain amounts remain outstanding at that time under the Term Loan B Agreement (defined below). Adient will pay a commitment fee of 0.25% to 0.375% on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the ABL Credit Facility then in effect. Subject to certain conditions, the ABL Credit Facility may be expanded by up to $250 million in additional commitments. Loans under the ABL Credit Facility may be denominated, at the option of Adient, in U.S. dollars, Euros, Pounds Sterling or Swedish Kroner. The ABL Credit Agreement is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. On November 24, 2021, Adient entered into an amendment to its ABL Credit Facility (the “ABL Amendment”) to amend certain terms and provisions, including to (i) change the interest rate benchmark rates applicable under the ABL Credit Facility for borrowings denominated in euro, Swedish krona and pounds sterling to EURIBOR, STIBOR, and SONIA, in each case subject to certain adjustments, and (ii) update the provisions in our ABL Credit Facility by which U.S. dollar LIBOR will eventually be replaced with SOFR or another interest rate benchmark, in each case, to reflect the most recent standards and practices used in the industry. Interest is payable on the ABL Credit Facility at a fluctuating rate of interest determined by reference to LIBOR, in the case of amounts outstanding in dollars, EURIBOR, in the case of amounts outstanding in euros, STIBOR, in the case of amounts outstanding in Swedish krona and SONIA, in the case of amounts outstanding in pounds sterling, in each case, plus an applicable margin of 1.50% to 2.00%. As of June 30, 2022, Adient had not drawn down on the ABL Credit Facility and had availability under this facility of $780 million (net of $42 million of letters of credit).

In addition, Adient US and Adient Global Holdings S.à r.l., a wholly-owned subsidiary of Adient, maintain a term loan credit agreement (the “Term Loan B Agreement”) that initially provided for a 5-year $800 million senior secured term loan facility that was fully drawn on closing. The Term Loan B Agreement amortizes in equal quarterly installments at a rate of 1.00% per annum of the original principal amount thereof, with the remaining balance originally due at final maturity on May 6, 2024. Interest on the Term Loan B Agreement accrues at the Eurodollar rate plus an applicable margin originally equal to 4.25% (with one 0.25% step down based on achievement of a specific secured net leverage level starting with the fiscal quarter ending December 31, 2019). The Term Loan B Agreement also permits Adient to incur incremental term loans in an aggregate amount not to exceed the greater of $750 million and an unlimited amount subject to a pro forma first lien secured net leverage ratio of

not greater than 1.75 to 1.00 and certain other conditions. In April 2021, Adient amended the Term Loan B Agreement ("Amended Agreement") which, among other changes (i) extended the maturity date for loans outstanding to April 8, 2028, (ii) reduced the interest rate margin applicable thereunder by 0.75% to 3.50%, in the case of Eurodollar Rate loans, and 2.50% (in the case of Base Rate loans) (in each case, with one 0.25% step down based on achievement of a specified first lien secured net leverage level starting with the fiscal quarter ending December 31, 2021) and (iii) made certain other negative covenant and mandatory prepayment changes in connection therewith. The amendment also established incremental term loans in an aggregate principal amount of $214 million resulting in total loans outstanding under the Amended Agreement of $1.0 billion. Adient paid $7 million related to the Amended Agreement and wrote off $8 million of previously deferred financing costs as a result of the debt extinguishment during the third quarter of fiscal 2021.

Adient US was also a party to an indenture relating to the issuance of $800 million aggregate principal amount of Senior First Lien Notes. The notes originally mature on May 15, 2026 and bore interest at a rate of 7.00% per annum. Interest on these notes was payable semi-annually in arrears on November 15 and May 15 of each year, commencing on November 15, 2019. During the second quarter of fiscal 2021, Adient repurchased $640 million of the outstanding balance of the Senior First Lien Notes at a price of 107% of the principal plus $17 million of accrued and unpaid interest. As a result, $9 million of previously deferred financing costs was written off to net financing charges. During the third quarter of fiscal 2021, Adient redeemed the $160 million of remaining balance of the Senior First Lien Notes at a price of 103% of the principal plus $4 million of accrued and unpaid interest, and wrote off $3 million of previously deferred financing costs as a result of the debt extinguishment.

The ABL Credit Facility, Term Loan B Agreement and the Senior First Lien Notes due 2026 contain covenants that are usual and customary for facilities and debt instruments of this type and that, among other things, restrict the ability of Adient and its restricted subsidiaries to: create certain liens and enter into sale and lease-back transactions; create, assume, incur or guarantee certain indebtedness; pay dividends or make other distributions on, or repurchase or redeem, Adient’s capital stock or certain other debt; make other restricted payments; and consolidate or merge with, or convey, transfer or lease all or substantially all of Adient’s and its restricted subsidiaries’ assets, to another person. These covenants are subject to a number of other limitations and exceptions set forth in the agreements. The agreements also provide for customary events of default, including, but not limited to, cross-default clauses with other debt arrangements, failure to pay principal and interest, failure to comply with covenants, agreements or conditions, and certain events of bankruptcy or insolvency involving Adient and its significant subsidiaries.

Adient Global Holdings Ltd. ("AGH"), a wholly-owned subsidiary of Adient, previously maintained $900 million aggregate principal amount of 4.875% USD-denominated unsecured notes due 2026. During the fourth quarter of fiscal 2020, Adient redeemed $103 million of face value of these notes, resulting in a remaining balance of $797 million as of September 30, 2020. Adient further redeemed $2 million of the notes during fiscal 2021, resulting in a remaining balance of $795 million as of June 30, 2022 and September 30, 2021. AGH also previously maintained €1.0 billion aggregate principal amount of 3.50% unsecured notes due 2024. In February 2022, Adient repurchased €177 million ($198 million) of the 3.50% unsecured notes due 2024 at a price of 102% of the principal plus €17 million ($19 million) of accrued and unpaid interest, and wrote off €1 million ($1 million) of previously deferred financing costs to net financing charges. As of June 30, 2022, the remaining balance of this debt was €823 million ($860 million).

Adient Germany Ltd. & Co. KG, a wholly owned subsidiary of Adient, previously maintained €135 million ($150 million) in an unsecured term loan from the European Investment Bank ("EIB") due in 2022. The loan bore interest at the 6-month EURIBOR rate plus 158 basis points. During the first quarter of fiscal 2021, Adient repaid $16 million of the EIB loan, triggered in part by the redemption of debt in the prior year. Adient repaid $20 million of the EIB loan in May 2021, triggered by the prior year sale of the fabrics business. Adient fully repaid the remaining balance of the EIB loan in May 2022 upon its maturity.

On April 20, 2020, Adient US issued $600 million (net proceeds of $591 million) aggregate principal amount of 9.00% Senior First Lien Notes due 2025. These notes will mature on April 15, 2025, provided that if AGH has not refinanced (or otherwise redeemed) in whole its outstanding 3.50% unsecured notes due 2024 or any refinancing indebtedness thereof that matures earlier than 91 days prior to the maturity date of the Senior First Lien Notes due 2025 on or prior to May 15, 2024, these notes will mature on May 15, 2024. Interest on these notes is due on April 15 and October 15 each year, beginning on October 15, 2020. These notes contain covenants that are usual and customary, similar to the covenants on the Senior First Lien Notes due 2026 as described above. Adient incurred $10 million of debt issuance cost associated with this new debt in fiscal 2020. In February 2022, Adient repurchased $508 million of 9.00% Senior First Lien Notes due 2025 at a price of 105.875% of the principal plus $15 million of accrued and unpaid interest, and wrote off $6 million of previously deferred financing costs to net financing charges. As of June 30, 2022, the remaining balance of this debt was $92 million.

Net Financing Charges

Adient's net financing charges in the consolidated statements of income (loss) contained the following components:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Interest expense, net of capitalized interest costs	$	36	$	46	$	121	$	162
Banking fees and debt issuance cost amortization	6		14		20		27
Interest income	(2)		(2)		(5)		(6)
Premium paid on repurchase of debt	—		4		34		49
Derivative loss on Yanfeng transaction	—		24		3		24
Net foreign exchange	(1)		1		(1)		—
Net financing charges	$	39	$	87	$	172	$	256

Total interest paid on both short and long-term debt for the nine months ended June 30, 2022 and 2021 was $126 million and $183 million, respectively.

Adient enters into supply chain financing programs in certain domestic and foreign jurisdictions to either sell or discount accounts receivable without recourse to third-party institutions. Sales or discounts of accounts receivable are reflected as a reduction of accounts receivable on the consolidated statements of financial position and the proceeds are included in cash flows from operating activities in the consolidated statements of cash flows. As of June 30, 2022, $262 million has been funded under these programs compared to $126 million as of September 30, 2021.

XML

Derivative Instruments and Hedging Activities

9 Months Ended

Jun. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities

9. Derivative Instruments and Hedging Activities

Adient selectively uses derivative instruments to reduce Adient's market risk associated with changes in foreign currency. Under Adient's policy, the use of derivatives is restricted to those intended for hedging purposes; the use of any derivative instrument for speculative purposes is strictly prohibited. A description of each type of derivative utilized to manage Adient's risk is included in the following paragraphs. In addition, refer to Note 10, "Fair Value Measurements," of the notes to consolidated financial statements for information related to the fair value measurements and valuation methods utilized by Adient for each derivative type.

Adient has global operations and participates in the foreign exchange markets to minimize its risk of loss from fluctuations in foreign currency exchange rates. Adient primarily uses foreign currency exchange contracts to hedge certain foreign exchange rate exposures. Adient hedges 70% to 90% of the nominal amount of each of its known foreign exchange transactional exposures. Gains and losses on derivative contracts offset gains and losses on underlying foreign currency exposures. These contracts have been designated as cash flow hedges under ASC 815, "Derivatives and Hedging," and the hedge gains or losses due to changes in fair value are initially recorded as a component of accumulated other comprehensive income (AOCI) and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. All contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at June 30, 2022 and September 30, 2021, respectively.

As of June 30, 2022, the €823 million ($860 million) aggregate principal amount of 3.50% euro-denominated unsecured notes due 2024 was designated as a net investment hedge to selectively hedge portions of Adient's net investment in Europe. The currency effects of Adient's euro-denominated bonds are reflected in the AOCI account within shareholders' equity attributable to Adient where they offset gains and losses recorded on Adient's net investment in Europe.

Adient entered into a cross-currency interest rate swap during fiscal 2019 to selectively hedge portions of its net investment in Japan. The currency effects of the cross-currency interest rate swap is reflected in the AOCI account within shareholders' equity attributable to Adient, where they offset gains and losses recorded on Adient's net investment in Japan. The contract matured during the fourth quarter of fiscal 2021. As of June 30, 2022, there was no outstanding Japanese yen denominated cross-currency interest rate swap.

Adient purchased interest rate caps during fiscal 2019 to selectively limit the impact of USD LIBOR increases on its interest payments related to Adient's Term Loan B Agreement. The interest rate caps were designated as cash flow hedges under ASC 815. As of June 30, 2022, Adient had two outstanding interest rate caps with total notional amount of approximately $200 million. During the third quarter of fiscal 2021, in conjunction with the Term Loan B Amendment as discussed in Note 8, "Debt and Financing Arrangements," Adient de-designated these two contracts, the impact of which was not material.

Adient entered into a ¥150 million ($23 million) foreign exchange forward contract during the second quarter of fiscal 2022 to selectively hedge portions of its net investment in China. The currency effects of the forward contract are reflected in the AOCI account within shareholder’s equity attributable to Adient, where they offset gains and losses recorded on Adient’s net investment in China. The forward contract is set to mature in October 2022.

The following table presents the location and fair values of derivative instruments and other amounts used in hedging activities included in Adient's consolidated statements of financial position:

	Derivatives and Hedging Activities Designated as Hedging Instruments under ASC 815				Derivatives and Hedging Activities Not Designated as Hedging Instruments under ASC 815
(in millions)	June 30, 2022		September 30, 2021		June 30, 2022		September 30, 2021
Other current assets
Foreign currency exchange derivatives	$	9	$	8	$	1	$	—
Other noncurrent assets
Foreign currency exchange derivatives	—		—		—		1
Total assets	$	9	$	8	$	1	$	1
Other current liabilities
Foreign currency exchange derivatives	$	17	$	11	$	—	$	13
Other noncurrent liabilities
Foreign currency exchange derivatives	3		4		—		—
Long-term debt
Foreign currency denominated debt	860		1,161		—		—
Total liabilities	$	880	$	1,176	$	—	$	13

Adient enters into International Swaps and Derivatives Associations (ISDA) master netting agreements with counterparties that permit the net settlement of amounts owed under the derivative contracts. The master netting agreements generally provide for net settlement of all outstanding contracts with a counterparty in the case of an event of default or a termination event. Adient has not elected to offset the fair value positions of the derivative contracts recorded in the consolidated statements of financial position. Collateral is generally not required of Adient or the counterparties under the master netting agreements. As of June 30, 2022 and September 30, 2021, no cash collateral was received or pledged under the master netting agreements.

The gross and net amounts of derivative instruments and other amounts used in hedging activities are as follows:

	Assets				Liabilities
(in millions)	June 30, 2022		September 30, 2021		June 30, 2022		September 30, 2021
Gross amount recognized	$	10	$	9	$	880	$	1,189
Gross amount eligible for offsetting	(10)		(9)		(10)		(9)
Net amount	$	—	$	—	$	870	$	1,180

The following table presents the effective portion of pretax gains (losses) recorded in other comprehensive income related to cash flow hedges:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Foreign currency exchange derivatives	$	(6)	$	21	$	—	$	40

The following table presents the location and amount of the effective portion of pretax gains (losses) on cash flow hedges reclassified from AOCI into Adient's consolidated statements of income:

(in millions)		Three Months Ended June 30,				Nine Months Ended June 30,
		2022		2021		2022		2021
Foreign currency exchange derivatives	Cost of sales	$	2	$	1	$	5	$	(2)

The following table presents the location and amount of pretax gains (losses) on derivatives not designated as hedging instruments recognized in Adient's consolidated statements of income (loss):

(in millions)		Three Months Ended June 30,				Nine Months Ended June 30,
		2022		2021		2022		2021
Foreign currency exchange derivatives	Cost of sales	$	(2)	$	—	$	(1)	$	(2)
Foreign currency exchange derivatives	Net financing charges	(5)		(24)		(24)		(22)
Total		$	(7)	$	(24)	$	(25)	$	(24)

The effective portion of pretax gains (losses) recorded in currency translation adjustment (CTA) within other comprehensive income (loss) related to net investment hedges was $59 million and $(17) million for the three months ended June 30, 2022 and 2021, respectively. For the three months ended June 30, 2022 and 2021, no gains or losses were reclassified from CTA into income for Adient's outstanding net investment hedges. For the three months ended June 30, 2022 and 2021, no ineffectiveness was recognized in the consolidated statements of income (loss) resulting from cash flow hedges

XML

Fair Value Measurements

9 Months Ended

Jun. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

10. Fair Value Measurements

ASC 820, "Fair Value Measurement," defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a three-level fair value hierarchy that prioritizes information used in developing assumptions when pricing an asset or liability as follows:

Level 1: Observable inputs such as quoted prices in active markets;

Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and

Level 3: Unobservable inputs where there is little or no market data, which requires the reporting entity to develop its own assumptions.

ASC 820 requires the use of observable market data, when available, in making fair value measurements. When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement.

Recurring Fair Value Measurements

The following tables present Adient's fair value hierarchy for those assets and liabilities measured at fair value:

	Fair Value Measurements Using:
(in millions)	Total as of June 30, 2022		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Other current assets
Foreign currency exchange derivatives	$	10	$	—	$	10	$	—
Total assets	$	10	$	—	$	10	$	—
Other current liabilities
Foreign currency exchange derivatives	$	17	$	—	$	17	$	—
Other noncurrent liabilities
Foreign currency exchange derivatives	3		—		3		—
Total liabilities	$	20	$	—	$	20	$	—

	Fair Value Measurements Using:
(in millions)	Total as of September 30, 2021		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Other current assets
Foreign currency exchange derivatives	$	8	$	—	$	8	$	—
Other noncurrent assets
Interest rate cap	1		—		1		—
Total assets	$	9	$	—	$	9	$	—
Other current liabilities
Foreign currency exchange derivatives	$	24	$	—	$	24	$	—
Other noncurrent liabilities
Foreign currency exchange derivatives	4		—		4		—
Total liabilities	$	28	$	—	$	28	$	—

Valuation Methods

Foreign currency exchange derivatives Adient selectively hedges anticipated transactions and net investments that are subject to foreign exchange rate risk primarily using foreign currency exchange hedge contracts. The foreign currency exchange derivatives are valued under a market approach using publicized spot and forward prices. Changes in fair value on foreign exchange derivatives accounted for as hedging instruments under ASC 815 are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. These contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at June 30, 2022 and September 30, 2021, respectively. The changes in fair value of foreign currency exchange derivatives not designated as hedging instruments under ASC 815 are recorded in the consolidated statements of income.

Cross-currency interest rate swaps Adient determines the fair value of a cross-currency interest rate swap contract using a market approach which is based on quoted market price for similar instruments in markets. All significant inputs are corroborated by observable market data for the term of such a contract. Adient selectively uses cross-currency interest rate swaps to hedge portions of its net investments. As of June 30, 2022, Adient had one ¥150 million ($23 million) cross-currency interest rate swap outstanding which was designated as a net investment hedge in Adient's net investment in China.

Interest rate caps Adient determines the fair value of an interest rate cap contract using a market approach which is based on quoted market price for identical or similar instruments in markets. All significant inputs are corroborated by observable market data for the term of such a contract. Adient selectively uses interest rate caps to limit the impact of floating rate interest payment increases on its Term Loan B Agreement. As of June 30, 2022, Adient had two interest rate caps outstanding totaling approximately $200 million which are going to mature in August 2022.

The fair value of cash and cash equivalents, accounts receivable, short-term debt and accounts payable approximate their carrying values. The fair value of long-term debt, which was $2.5 billion and $3.8 billion at June 30, 2022 and September 30, 2021, respectively, was determined primarily using market quotes classified as Level 1 inputs within the ASC 820 fair value hierarchy.

XML

Equity and Noncontrolling Interests

9 Months Ended

Jun. 30, 2022

Equity [Abstract]

Equity and Noncontrolling Interests

11. Equity and Noncontrolling Interests

For the nine months ended June 30, 2022:

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at September 30, 2021	$	—	$	3,991	$	(988)	$	(627)	$	2,376	$	342	$	2,718
Net income (loss)	—		—		(165)		—		(165)		29		(136)
Foreign currency translation adjustments	—		—		—		(110)		(110)		(10)		(120)
Realized and unrealized gains (losses) on derivatives	—		—		—		(5)		(5)		—		(5)
Dividends attributable to noncontrolling interests	—		—		—		—		—		(19)		(19)
Purchase of subsidiary shares from noncontrolling interest	—		12		—		—		12		(12)		—
Share based compensation and other	—		15		—		—		15		—		15
Balance at June 30, 2022	$	—	$	4,018	$	(1,153)	$	(742)	$	2,123	$	330	$	2,453

For the three months ended June 30, 2022:

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at March 31, 2022	$	—	$	4,008	$	(1,123)	$	(600)	$	2,285	$	340	$	2,625
Net income (loss)	—		—		(30)		—		(30)		6		(24)
Foreign currency translation adjustments	—		—		—		(135)		(135)		(13)		(148)
Realized and unrealized gains (losses) on derivatives	—		—		—		(7)		(7)		—		(7)
Dividends attributable to noncontrolling interests	—		—		—		—		—		(3)		(3)
Share based compensation and other	—		10		—		—		10		—		10
Balance at June 30, 2022	$	—	$	4,018	$	(1,153)	$	(742)	$	2,123	$	330	$	2,453

For the nine months ended June 30, 2021:

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at September 30, 2020	$	—	$	3,974	$	(2,096)	$	(665)	$	1,213	$	322	$	1,535
Net income (loss)	—		—		148		—		148		51		199
Foreign currency translation adjustments	—		—		—		53		53		9		62
Realized and unrealized gains (losses) on derivatives	—		—		—		34		34		—		34
Dividends attributable to noncontrolling interests	—		—		—		—		—		(40)		(40)
Change in noncontrolling interest share	—		—		—		—		—		(3)		(3)
Share based compensation and other	—		19		—		—		19		1		20
Balance at June 30, 2021	$	—	$	3,993	$	(1,948)	$	(578)	$	1,467	$	340	$	1,807

For the three months ended June 30, 2021:

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at March 31, 2021	$	—	$	3,985	$	(1,877)	$	(619)	$	1,489	$	353	$	1,842
Net income (loss)	—		—		(71)		—		(71)		16		(55)
Foreign currency translation adjustments	—		—		—		24		24		3		27
Realized and unrealized gains (losses) on derivatives	—		—		—		17		17		—		17
Dividends attributable to noncontrolling interests	—		—		—		—		—		(29)		(29)
Change in noncontrolling interest share	—		—		—		—		—		(3)		(3)
Share based compensation and other	—		8		—		—		8		—		8
Balance at June 30, 2021	$	—	$	3,993	$	(1,948)	$	(578)	$	1,467	$	340	$	1,807

The following table presents changes in AOCI attributable to Adient:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Foreign currency translation adjustments
Balance at beginning of period	$	(592)	$	(605)	$	(617)	$	(634)
Aggregate adjustment for the period, net of tax	(135)		24		(110)		53
Balance at end of period	$	(727)	$	(581)	$	(727)	$	(581)
Realized and unrealized gains (losses) on derivatives
Balance at beginning of period	$	(6)	$	(11)	$	(8)	$	(28)
Current period changes in fair value, net of tax	(5)		18		—		33
Reclassification to income, net of tax	(2)		(1)		(5)		1
Balance at end of period	$	(13)	$	6	$	(13)	$	6
Pension and postretirement plans
Balance at beginning of period	$	(2)	$	(3)	$	(2)	$	(3)
Balance at end of period	$	(2)	$	(3)	$	(2)	$	(3)
Accumulated other comprehensive income (loss), end of period	$	(742)	$	(578)	$	(742)	$	(578)

Adient consolidates certain subsidiaries in which the noncontrolling interest party has within their control the right to require Adient to redeem all or a portion of its interest in the subsidiary. These redeemable noncontrolling interests are reported at their estimated redemption value. Any adjustment to the redemption value impacts retained earnings but does not impact net income. Redeemable noncontrolling interests which are redeemable only upon future events, the occurrence of which is not currently probable, are recorded at carrying value. The following table presents changes in the redeemable noncontrolling interests:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Beginning balance	$	48	$	44	$	240	$	43
Net income	4		6		26		19
Dividends	—		—		(33)		(14)
Change in redeemable noncontrolling interest	—		—		(186)		—
Foreign currency translation adjustments	(7)		(2)		(2)		—
Ending balance	$	45	$	48	$	45	$	48

Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information on the change in redeemable noncontrolling interest during the nine months ended June 30, 2022.

XML

Retirement Plans

9 Months Ended

Jun. 30, 2022

Retirement Benefits [Abstract]

Retirement Plans

12. Retirement Plans

Adient maintains non-contributory defined benefit pension plans covering primarily non-U.S. employees and a limited number of U.S. employees. The following table contains the components of net periodic benefit cost:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Service cost	$	1	$	2	$	5	$	6
Interest cost	2		3		8		7
Expected return on plan assets	(3)		(6)		(11)		(14)
Net actuarial and settlement/curtailment (gain) loss	(3)		(1)		(3)		(1)
Net periodic benefit cost	$	(3)	$	(2)	$	(1)	$	(2)

The interest cost and expected return on plan assets components of net periodic benefit cost are included in other pension expense (income) in the consolidated statements of income (loss).

During the three months ended June 30, 2022, Adient remeasured pension plans in the Americas and recorded a mark-to-market gain of $4 million and a curtailment loss of $1 million. During the three months ended June 30, 2021, Adient remeasured a pension plan in the Americas and recorded a mark-to-market gain of $1 million.

XML

Restructuring and Impairment Costs

9 Months Ended

Jun. 30, 2022

Restructuring and Related Activities [Abstract]

Restructuring and Impairment Costs

13. Restructuring and Impairment Costs

To better align its resources with its overall strategies and reduce the cost structure of its global operations to address the softness in certain underlying markets, Adient commits to restructuring plans as necessary.

During fiscal 2022, Adient committed to a restructuring plan ("2022 Plan") of $20 million that was offset by $8 million of prior year underspend. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in EMEA and Americas. The restructuring actions are expected to be substantially completed by fiscal 2023.

(in millions)	Employee Severance and Termination Benefits		Total
Original reserve	$	20	$	20
Utilized—cash	(5)		(5)
Noncash adjustment—other	(1)		(1)
Balance at June 30, 2022	$	14	$	14

During fiscal 2021, Adient committed to a restructuring plan ("2021 Plan") of $27 million that was offset by $16 million of prior year underspend. Of the restructuring costs recorded, $23 million related to the EMEA segment, $3 million related to the Americas segment, and $1 million related to the Asia segment. The restructuring actions related to cost reduction initiatives and consisted primarily of workforce reductions and lease contract terminations. The restructuring actions are expected to be substantially completed by fiscal 2023.

(in millions)	Employee Severance and Termination Benefits		Currency Translation		Total
Balance at September 30, 2021	$	22	$	—	$	22
Utilized—cash	(15)		—		(15)
Noncash adjustment—other	(1)		(1)		(2)
Balance at June 30, 2022	$	6	$	(1)	$	5

During fiscal 2020, Adient committed to a restructuring plan ("2020 Plan") of $205 million. Of the restructuring costs recorded, $20 million related to the Americas segment, $175 million related to the EMEA segment and $10 million related to the Asia segment. The restructuring actions related to cost reduction initiatives and consist primarily of workforce reductions. Also recorded in fiscal 2020 was $20 million of underspend related to prior year plan reserves. The restructuring actions are expected to be substantially completed by fiscal 2023.

The following table summarizes the changes in Adient's 2020 Plan reserve:

(in millions)	Employee Severance and Termination Benefits		Currency Translation		Total
Balance at September 30, 2021	$	75	$	2	$	77
Utilized—cash	(23)		—		(23)
Noncash adjustment—underspend/other	(6)		(6)		(12)
Balance at June 30, 2022	$	46	$	(4)	$	42

The following table summarizes the changes in Adient's 2019 Plan reserve:

(in millions)	Employee Severance and Termination Benefits		Currency Translation		Total
Balance at September 30, 2021	$	8	$	1	$	9
Utilized—cash	(4)		—		(4)
Noncash adjustment—underspend/other	(1)		—		(1)
Balance at June 30, 2022	$	3	$	1	$	4

During the first nine months of fiscal 2022, there was $2 million of cash utilized against the 2018, 2017 and 2016 Plan's reserve balances. The majority of the cash utilized during the period was related to the 2016 Plan's reserve balance. The 2018, 2017, and 2016 Plan's reserve balances at June 30, 2022 were $2 million, $2 million, and $1 million, respectively.

Adient's restructuring plans include workforce reductions of approximately 15,000 employees. Restructuring charges associated with employee severance and termination benefits are paid over the severance period granted to each employee or on a lump sum basis in accordance with individual severance agreements. As of June 30, 2022, approximately 14,000 of the employees have been separated from Adient pursuant to the restructuring plans. In addition, the restructuring plans included twenty-nine plant closures. As of June 30, 2022, twenty-one of the twenty-nine plants have been closed.

Adient's management closely monitors its overall cost structure and continually analyzes each of its businesses for opportunities to consolidate current operations, improve operating efficiencies and locate facilities in low cost countries in close proximity to customers. This ongoing analysis includes a review of its manufacturing, engineering, purchasing and administrative functions, as well as the overall global footprint for all its businesses. Because of the importance of new vehicle sales by major automotive manufacturers to operations, Adient is affected by the general business conditions in the automotive industry. Future adverse developments in the automotive industry, particularly related to the COVID-19 pandemic and supply chain disruptions, could impact Adient's liquidity position, lead to impairment charges and/or require additional restructuring of its operations.

XML

Income Taxes

9 Months Ended

Jun. 30, 2022

Income Tax Disclosure [Abstract]

Income Taxes

14. Income Taxes

In calculating the provision for income taxes, Adient uses an estimate of the annual effective tax rate based upon the facts and circumstances known at each interim period. On a quarterly basis, the actual effective tax rate is adjusted, as appropriate, based on changes in facts and circumstances, if any, as compared to those forecasted at the beginning of the fiscal year and each interim period thereafter. For the three months ended June 30, 2022, Adient’s income tax expense was $20 million on income before income taxes of $0 million. For the nine months ended June 30, 2022, Adient's income tax expense was $65 million equating to an effective tax rate of (144)%. The three and nine month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, foreign tax rate differentials, and the recognition of valuation allowances in Canada. For the three and nine months ended June 30, 2021, Adient’s income tax expense was $10 million equating to an effective tax rate of (26)%, and $90 million equating to an effective tax rate of 29%, respectively. The three and nine month income tax expense was higher than the statutory rate impact of 12.5% primarily due to foreign tax rate differentials and the inability to record a tax benefit for losses in jurisdictions with valuation allowances, partially offset by a tax benefit from the write-off of a deferred tax liability related to withholding taxes.

Valuation Allowances

As a result of the Company's third quarter fiscal 2022 analysis of the realizability of its worldwide deferred tax assets, and after considering tax planning initiatives and other positive and negative evidence, Adient determined it was more likely than not that deferred tax assets in Canada would not be realized and recorded income tax expense of $12 million to establish a valuation allowance.

As a result of the Company's second quarter fiscal 2022 analysis of the realizability of its worldwide deferred tax assets, and after considering tax planning initiatives and other positive and negative evidence, Adient determined it was more likely than not that certain deferred tax assets in Slovakia would not be realized and established a valuation allowance, which did not have a material impact on Adient’s consolidated financial statements.

Adient reviews the realizability of its deferred tax assets on a quarterly basis, or whenever events or changes in circumstances indicate that a review is required. In determining the requirement for a valuation allowance, the historical and projected financial results of the legal entity or combined group recording the net deferred tax asset are considered, along with any other positive or negative evidence. All of the factors that Adient considers in evaluating whether and when to establish or release all or a portion of the deferred tax asset valuation allowance involve significant judgment. Since future financial results may differ from previous estimates, periodic adjustments to Adient's valuation allowances may be necessary.

Uncertain Tax Positions

At June 30, 2022, Adient had gross tax effected unrecognized tax benefits of $463 million. If recognized, $124 million of Adient's unrecognized tax benefits would impact the effective tax rate. Total net accrued interest at June 30, 2022 was approximately $22 million (net of tax benefit). The interest and penalties accrued for the three and nine months ended June 30,

2022 was $2 million and $7 million, respectively. Adient recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.

Impacts of Tax Legislation and Change in Statutory Tax Rates

Tax legislation was adopted during the nine months ended June 30, 2022 in various jurisdictions, which did not have a material impact on Adient’s consolidated financial statements.

Other Tax Matters

During the second quarter of fiscal 2022, Adient recognized a $4 million tax benefit related to the adjustment of deferred tax liabilities of a Chinese subsidiary which obtained government approval for a temporary income tax rate reduction.

During the first quarter of fiscal 2022, Adient recognized a $3 million tax benefit related to the write-off of deferred tax liabilities on Brazil indirect tax credits as a result of a favorable court ruling.

During the third quarter of fiscal 2021, Adient recognized an additional $30 million pre-tax gain related to Brazil indirect tax credits as a result of a favorable supreme court ruling. The tax expense associated with this gain was $10 million.

During the third quarter of fiscal 2021, Adient recognized a tax benefit of $11 million related to the write-off of a deferred tax liability associated with a Chinese joint venture’s distribution of unremitted earnings. The distribution was reinvested in a wholly-owned Chinese subsidiary, thereby exempting the distribution from withholding tax. The investment in the wholly-owned subsidiary is intended to be indefinitely reinvested, warranting the derecognition of the pre-existing deferred tax liability.

During the second quarter of fiscal 2021, Adient recognized a $33 million pre-tax gain related to the sale of its equity interest in Shenyang Jinbei Adient Automotive Components Co., Ltd. The tax expense associated with this gain was $5 million.

During the first quarter of fiscal 2021, Adient recognized an $8 million pre-tax gain related to Brazil indirect tax recoveries. The tax expense associated with this gain was $3 million.

XML

Segment Information

9 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Segment Information

15. Segment Information

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Net Sales
Americas	$	1,673	$	1,440	$	4,767	$	4,821
EMEA	1,215		1,328		3,663		4,568
Asia	627		516		2,134		1,658
Eliminations	(30)		(42)		(93)		(138)
Total net sales	$	3,485	$	3,242	$	10,471	$	10,909

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Adjusted EBITDA
Americas	$	70	$	23	$	125	$	219
EMEA	31		22		104		277
Asia	64		92		283		364
Corporate-related costs (1)	(22)		(19)		(64)		(61)
Restructuring and impairment costs (2)	(12)		(8)		(20)		(20)
Purchase accounting amortization (3)	(14)		(11)		(41)		(32)
Restructuring related charges (4)	(1)		—		(5)		(6)
Gain on sale / (impairment) of nonconsolidated partially-owned affiliates (5)	—		—		(9)		33
Depreciation	(72)		(71)		(223)		(210)
Stock based compensation	(7)		(10)		(21)		(36)
Other items (6)	(2)		26		(8)		28
Earnings (loss) before interest and income taxes	35		44		121		556
Net financing charges	(39)		(87)		(172)		(256)
Other pension income (expense)	4		4		6		8
Income (loss) before income taxes	$	—	$	(39)	$	(45)	$	308

Notes:

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects qualified restructuring charges for costs that are directly attributable to restructuring activities and meet the definition of restructuring under ASC 420 and non-recurring impairment charges. During the nine months ended June 30, 2022, an impairment charge of $2 million related to net assets in Russia, and a held-for-sale impairment charge of $6 million were recorded in EMEA. During the nine months ended June 30, 2021, a held-for-sale impairment charge of $8 million was recorded in EMEA.

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects restructuring related charges for costs that are directly attributable to restructuring activities, but do not meet the definition of restructuring under ASC 420.

(5) The nine months ended June 30, 2022 reflects $3 million and $6 million of non-cash impairments of certain of Adient's investments in nonconsolidated partially-owned affiliates in China and South Africa, respectively. The nine months ended June 30, 2021 reflects a pre-tax gain of $33 million on the sale of Adient's interest in SJA. Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for additional information.

(6) The three months ended June 30, 2022 primarily reflects $2 million of transaction costs. The nine months ended June 30, 2022 reflects $7 million of transaction costs and $2 million of loss on finalization of asset sale in Turkey. The three months ended June 30, 2021 reflects $2 million of transaction costs and a one-time gain of $30 million associated with retrospective recoveries of Brazil indirect tax credits resulting from a favorable court ruling (of which $28 million relates to recoveries covering the past 20 years and is adjusted out of Americas' segment results). The nine months ended June 30, 2021 reflects a one-time gain of $38 million associated with the retrospective recoveries of Brazil indirect tax credits resulting from a favorable court ruling (of which $36 million relates to recoveries covering the past 20 years and is adjusted out of Americas' segment results), a $5 million gain on previously held interest at YFAS in an affiliate, and $13 million of transaction costs.

Geographic Information

Revenue by geographic area is as follows:

Net Sales
	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Americas
United States	$	1,501	$	1,298	$	4,276	$	4,332
Mexico	628		558		1,756		1,783
Other Americas	106		64		284		238
Regional elimination	(562)		(480)		(1,549)		(1,532)
	1,673		1,440		4,767		4,821
EMEA
Germany	258		261		737		891
Czech Republic	257		276		757		964
Other EMEA	1,030		1,144		3,170		3,918
Regional elimination	(330)		(353)		(1,001)		(1,205)
	1,215		1,328		3,663		4,568
Asia
Thailand	101		113		370		357
China	274		171		1,004		525
Japan	59		60		183		253
Other Asia	200		177		597		539
Regional elimination	(7)		(5)		(20)		(16)
	627		516		2,134		1,658
Inter-segment elimination	(30)		(42)		(93)		(138)
Total	$	3,485	$	3,242	$	10,471	$	10,909

The increase in net sales in China is attributable to the consolidation of CQADNT beginning October 1, 2021. Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for additional information.

XML

Nonconsolidated Partially-Owned Affiliates

9 Months Ended

Jun. 30, 2022

Equity Method Investments and Joint Ventures [Abstract]

Nonconsolidated Partially-Owned Affiliates

16. Nonconsolidated Partially-Owned Affiliates

Investments in the net assets of nonconsolidated partially-owned affiliates are reported in the "Investments in partially-owned affiliates" line in the consolidated statements of financial position as of June 30, 2022 and September 30, 2021. Equity in the net income of nonconsolidated partially-owned affiliates are reported in the "Equity income (loss)" line in the consolidated statements of income (loss) for the three and nine months ended June 30, 2022 and 2021, respectively.

Adient maintains total investments in partially-owned affiliates of $348 million and $335 million at June 30, 2022 and September 30, 2021, respectively. Operating information for nonconsolidated partially-owned affiliates is as follows:

	Nine Months Ended June 30,
(in millions)	2022		2021
Income statement data:
Net sales	$	2,993	$	6,795
Gross profit	$	291	$	717
Net income	$	132	$	418
Net income attributable to the entity	$	131	$	413

The decrease in net sales and profitability at Adient's nonconsolidated partially-owned affiliates are primarily attributable to the 2021 Yanfeng Transaction. Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for transactions involving Adient's investments in nonconsolidated partially-owned affiliates. Further, Adient is pursing a sale of a portion of a partially-owned affiliate in South Africa for $2 million. As a result, Adient concluded that indicators of other-than-temporary impairment were present related to this joint venture and recorded a non-cash impairment charge of $6 million during the second quarter of fiscal 2022.

An affiliate of Yanfeng has asserted that, in its capacity as a customer of KEIPER, it is entitled to a payment in the amount of approximately $46 million. Adient believes there is no basis for such payment by KEIPER and is disputing that such Yanfeng affiliate is entitled to any payment by KEIPER. Payment of such claim by KEIPER could have an approximate $17 million impact on Adient’s equity income after taxes from the KEIPER joint venture. KEIPER is also currently disputing the payment obligation.

XML

Commitments and Contingencies

9 Months Ended

Jun. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

17. Commitments and Contingencies

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product liability, casualty environmental, safety and health, intellectual property, employment, commercial and contractual matters, and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Costs related to such matters were not material to the periods presented.

Adient accrues for potential environmental liabilities when it is probable a liability has been incurred and the amount of the liability is reasonably estimable. Reserves for environmental liabilities totaled $6 million and $8 million at June 30, 2022 and September 30, 2021, respectively. Adient reviews the status of its environmental sites on a quarterly basis and adjusts its reserves accordingly. Such potential liabilities accrued by Adient do not take into consideration possible recoveries of future insurance proceeds. They do, however, take into account the likely share other parties will bear at remediation sites. It is difficult to estimate Adient's ultimate level of liability at many remediation sites due to the large number of other parties that may be involved, the complexity of determining the relative liability among those parties, the uncertainty as to the nature and scope of the investigations and remediation to be conducted, the uncertainty in the application of law and risk assessment, the various choices and costs associated with diverse technologies that may be used in corrective actions at the sites, and the often quite lengthy periods over which eventual remediation may occur. Nevertheless, Adient does not currently believe that any claims, penalties or costs in connection with known environmental matters will have a material adverse effect on Adient's financial position, results of operations or cash flows.

XML

Related Party Transactions

9 Months Ended

Jun. 30, 2022

Related Party Transactions [Abstract]

Related Party Transactions

18. Related Party Transactions

In the ordinary course of business, Adient enters into transactions with related parties, such as equity affiliates. Such transactions consist of the sale or purchase of goods and other arrangements.

The following table sets forth the net sales to and purchases from related parties included in the consolidated statements of income:

		Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)		2022		2021		2022		2021
Net sales to related parties	Net sales	$	53	$	70	$	175	$	209
Purchases from related parties	Cost of sales	95		139		298		433

The following table sets forth the amount of accounts receivable due from and payable to related parties in the consolidated statements of financial position:

(in millions)		June 30, 2022		September 30, 2021
Accounts receivable due from related parties	Accounts receivable	$	34	$	30
Accounts payable due to related parties	Accounts payable	69		41

Average receivable and payable balances with related parties remained consistent with the period end balances shown above.

XML

Basis of Presentation and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Jun. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The consolidated financial statements of Adient have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"). During the second half of fiscal 2021 and continuing into the first nine months of fiscal 2022, Adient faced, along with the entire global automotive industry, widespread supply chain disruptions primarily related to semiconductor chip shortages. Although Adient’s seating products are not highly dependent directly on semiconductor chips, Adient is directly impacted by the lower production levels at OEM’s as a direct result of these supply chain disruptions. These disruptions have led to unplanned down time at Adient’s production facilities, often with very little warning, which creates operating inefficiencies and limits Adient’s ability to adequately mitigate such inefficiencies. Further, the Russia/Ukraine conflict has created additional risks to the macroeconomic environment of the global automotive industry by restricting availabilities of certain key raw material components. Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information on the impacts from the Russia/Ukraine conflict.

The automotive industry has also experienced price increases for commodities, utilities and shipping costs throughout fiscal 2022 which have negatively impacted Adient's results. These cost increases may continue into the future as demand increases and supply may remain constrained, which has resulted in, and may continue to result in, increased costs for Adient that may not be, or may only be partially, offset. Adient has also experienced wage inflationary pressures as a result of constrained labor availability in fiscal 2022.

Additionally, the impact of COVID-19, and related variants and sub-variants, continues to be present throughout the world, including in all global and regional markets served by Adient. The elevated COVID-19 rates in China led to widespread lockdowns during the second and third quarters of fiscal 2022, negatively impacting the automotive production levels in that region, along with creating further supply chain disruptions. Although vaccines have been introduced that are expected to have the result of reducing the effect of COVID-19 and COVID-19 has waned in certain geographic areas, governmental authorities continue to implement numerous measures attempting to contain and mitigate the effects of COVID-19, including travel bans and restrictions, quarantines, social distancing orders, shelter in place orders and shutdowns of non-essential activities. Adient's manufacturing facilities are located in areas that continue to be affected by the pandemic.

Principles of Consolidations

Principles of Consolidation

Adient consolidates its wholly-owned subsidiaries and those entities in which it has a controlling interest. Investments in partially-owned affiliates are accounted for by the equity method when Adient's interest exceeds 20% and does not have a controlling interest.

Consolidated VIEs

Consolidated VIEs

Based upon the criteria set forth in the Financial Accounting Standards Board (the FASB) Accounting Standards Codification (ASC) 810, "Consolidation," Adient has determined that it was the primary beneficiary in two variable interest entities (VIEs) for the reporting periods ended June 30, 2022, and September 30, 2021, respectively, as Adient absorbs significant economics of the entities and has the power to direct the activities that are considered most significant to the entities.

The two VIEs manufacture seating products in North America for the automotive industry. Adient funds the entities' short-term liquidity needs through revolving credit facilities and has the power to direct the activities that are considered most significant to the entities through its key customer supply relationships.

New Accounting Pronouncements

New Accounting Pronouncements

Standards Adopted During Fiscal 2022

On October 1, 2021, Adient adopted Accounting Standards Codification (ASU) 2018-14 Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20). ASU 20218-14 eliminates, adds, and modifies certain disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The guidance is to be applied on a retrospective basis. The adoption of this guidance on October 1, 2021 did not significantly impact Adient's consolidated financial statements for the nine months ended June 30, 2022.

On October 1, 2021, Adient adopted ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 modifies ASC 740, Income Taxes, by simplifying accounting for income taxes. As part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements, the FASB’s amendments may impact both interim and annual reporting periods. The adoption of this guidance on October 1, 2021 did not significantly impact Adient's consolidated financial statements for the nine months ended June 30, 2022.

Standards Effective After Fiscal 2022

Adient has considered the ASUs summarized below, effective after fiscal 2022, none of which are expected to significantly impact the consolidated financial statements:

Standard Adopted	Description	Date Effective
ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40)	ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity by reducing the number of accounting models for convertible debt and convertible preferred stock.	October 1, 2022
ASU 2021-10, Government Assistance (Topic 832) - Disclosures by Business Entities about Government Assistance	The ASU requires annual disclosures of: i) information about the nature of government assistance transactions and the related accounting policy used to account for the transactions, ii) the balance sheet and income statement line items affected by the transactions, and the amounts for each financial statement line item, and iii) significant transaction terms and conditions.	October 1, 2022

XML

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Jun. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Carrying Amounts and Classifications of Assets and Liabilities for Consolidated VIEs

The carrying amounts and classification of assets (none of which is restricted) and liabilities included in Adient's consolidated statements of financial position for the consolidated VIEs are as follows:

(in millions)	June 30, 2022		September 30, 2021
Current assets	$	223	$	158
Noncurrent assets	105		88
Total assets	$	328	$	246
Current liabilities	$	193	$	143
Noncurrent liabilities	13		8
Total liabilities	$	206	$	151

Schedule of Computation of Basic and Diluted Earnings (Loss) Per Share

The following table shows the computation of basic and diluted earnings (loss) per share:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions, except per share data)	2022		2021		2022		2021
Numerator:
Net income (loss) attributable to Adient	$	(30)	$	(71)	$	(165)	$	148
Denominator:
Shares outstanding	94.8		94.2		94.7		94.1
Effect of dilutive securities	—		—		—		1.5
Diluted shares	94.8		94.2		94.7		95.6
Earnings (loss) per share:
Basic	$	(0.32)	$	(0.75)	$	(1.74)	$	1.57
Diluted	$	(0.32)	$	(0.75)	$	(1.74)	$	1.55

Schedule of New Accounting Pronouncements

Standards Effective After Fiscal 2022

Adient has considered the ASUs summarized below, effective after fiscal 2022, none of which are expected to significantly impact the consolidated financial statements:

Standard Adopted	Description	Date Effective
ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40)	ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity by reducing the number of accounting models for convertible debt and convertible preferred stock.	October 1, 2022
ASU 2021-10, Government Assistance (Topic 832) - Disclosures by Business Entities about Government Assistance	The ASU requires annual disclosures of: i) information about the nature of government assistance transactions and the related accounting policy used to account for the transactions, ii) the balance sheet and income statement line items affected by the transactions, and the amounts for each financial statement line item, and iii) significant transaction terms and conditions.	October 1, 2022

XML

Acquisitions and Divestitures (Tables)

9 Months Ended

Jun. 30, 2022

Business Combination and Asset Acquisition [Abstract]

Schedule of Purchase Price Adjustments and Allocation

Adient recorded a purchase price allocation for the assets acquired and liabilities assumed based on their estimated fair values as of the September 30, 2021 acquisition date. The preliminary purchase price adjustments and allocation is as follows:

	Fair value allocation
(in millions)	CQADNT		LFADNT
Cash	$	55	$	5
Accounts receivable	296		2
Inventory	37		5
Property, plant and equipment	86		8
Other assets	46		2
Goodwill	180		8
Intangible assets	234		6
Accounts payable	(252)		(19)
Other liabilities	(127)		(4)
Subtotal	555		13
Less: Interest already owned	103		—
Less: Redeemable noncontrolling interest	194		—
Total purchase consideration	258		13
Less: cash acquired	55		5
Net cash paid	$	203	$	8

XML

Inventories (Tables)

9 Months Ended

Jun. 30, 2022

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories consisted of the following:

(in millions)	June 30, 2022		September 30, 2021
Raw materials and supplies	$	765	$	750
Work-in-process	24		29
Finished goods	164		197
Inventories	$	953	$	976

XML

Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Jun. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Changes in Carrying Amount of Goodwill

The changes in the carrying amount of goodwill are as follows:

(in millions)	Americas		EMEA		Asia		Total
Balance at September 30, 2021	$	607	$	354	$	1,251	$	2,212
Currency translation and other	1		(38)		(53)		(90)
Balance at June 30, 2022	$	608	$	316	$	1,198	$	2,122

Schedule of Other Intangible Assets

Adient's other intangible assets, primarily from business acquisitions valued based on independent appraisals, consisted of:

	June 30, 2022						September 30, 2021
(in millions)	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Intangible assets
Patented technology	$	86	$	(24)	$	62	$	86	$	(19)	$	67
Customer relationships	627		(201)		426		649		(178)		471
Trademarks	18		(16)		2		26		(21)		5
Miscellaneous	26		(12)		14		24		(12)		12
Total intangible assets	$	757	$	(253)	$	504	$	785	$	(230)	$	555

XML

Product Warranties (Tables)

9 Months Ended

Jun. 30, 2022

Product Warranties Disclosures [Abstract]

Schedule of Product Warranty Liability

The changes in Adient's total product warranty liability are as follows:

	Nine Months Ended June 30,
(in millions)	2022		2021
Balance at beginning of period	$	23	$	24
Accruals for warranties issued during the period	7		7
Changes in accruals related to pre-existing warranties (including changes in estimates)	—		(1)
Settlements made (in cash or in kind) during the period	(7)		(6)
Currency translation	(1)		—
Balance at end of period	$	22	$	24

XML

Leases (Tables)

9 Months Ended

Jun. 30, 2022

Leases [Abstract]

Schedule of Lease Cost

The components of lease costs included in the consolidated statement of income (loss) for the three and nine months ended June 30, 2022 and 2021 were as follows:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Operating lease cost	$	32	$	32	$	90	$	94
Short-term lease cost	2		4		14		16
Total lease cost	$	34	$	36	$	104	$	110

Supplemental cash flow information related to leases is as follows:

	Nine Months Ended June 30,
(in millions)	2022		2021
Right-of-use assets obtained in exchange for lease obligations:
Operating leases (non-cash activity)	$	38	$	102
Operating cash flows:
Cash paid for amounts included in the measurement of lease liabilities	$	89	$	96

Schedule of Operating Lease Right of Use Assets and Operating Lease Liabilities

Operating lease right-of-use assets and lease liabilities included in the consolidated statement of financial position were as follows:

(in millions)		June 30, 2022			September 30, 2021
Operating leases:
Operating lease right-of-use assets	Other noncurrent assets	$	293		$	335
Operating lease liabilities - current	Other current liabilities	$	85		$	89
Operating lease liabilities - noncurrent	Other noncurrent liabilities	209			246
		$	294		$	335
Weighted average remaining lease term:
Operating leases		6 years			6 years
Weighted average discount rate:
Operating leases		5.4		%	5.2		%

Schedule of Operating Lease Liabilities and Minimum Payments

Maturities of operating lease liabilities and minimum payments for operating leases having initial or remaining non-cancelable terms in excess of one year as of June 30, 2022 are as follows:

	Operating leases
Fiscal years (in millions)	June 30, 2022
2022 (excluding the nine months ended June 30, 2022)	$	26
2023	89
2024	66
2025	47
2026	31
Thereafter	81
Total lease payments	340
Less: imputed interest	(46)
Present value of lease liabilities	$	294

XML

Debt and Financing Arrangements (Tables)

9 Months Ended

Jun. 30, 2022

Debt Disclosure [Abstract]

Schedule of Debt

Debt consisted of the following:

(in millions)	June 30, 2022		September 30, 2021
Long-term debt:
Term Loan B - LIBOR plus 3.25% due in 2028	$	990	$	998
4.875% Notes due in 2026	795		795
3.50% Notes due in 2024	860		1,161
9.00% Notes due in 2025	92		600
European Investment Bank Loan - EURIBOR plus 1.58% due in 2022	—		156
Finance lease obligations	1		1
Less: debt issuance costs	(20)		(32)
Gross long-term debt	2,718		3,679
Less: current portion	11		167
Net long-term debt	$	2,707	$	3,512
Short-term debt:
Other bank borrowings	$	9	$	17
Total short-term debt	$	9	$	17

Schedule of Net Financing Charges

Adient's net financing charges in the consolidated statements of income (loss) contained the following components:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Interest expense, net of capitalized interest costs	$	36	$	46	$	121	$	162
Banking fees and debt issuance cost amortization	6		14		20		27
Interest income	(2)		(2)		(5)		(6)
Premium paid on repurchase of debt	—		4		34		49
Derivative loss on Yanfeng transaction	—		24		3		24
Net foreign exchange	(1)		1		(1)		—
Net financing charges	$	39	$	87	$	172	$	256

XML

Derivative Instruments and Hedging Activities (Tables)

9 Months Ended

Jun. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Fair Values of Derivative Instruments and Other Amounts

The following table presents the location and fair values of derivative instruments and other amounts used in hedging activities included in Adient's consolidated statements of financial position:

	Derivatives and Hedging Activities Designated as Hedging Instruments under ASC 815				Derivatives and Hedging Activities Not Designated as Hedging Instruments under ASC 815
(in millions)	June 30, 2022		September 30, 2021		June 30, 2022		September 30, 2021
Other current assets
Foreign currency exchange derivatives	$	9	$	8	$	1	$	—
Other noncurrent assets
Foreign currency exchange derivatives	—		—		—		1
Total assets	$	9	$	8	$	1	$	1
Other current liabilities
Foreign currency exchange derivatives	$	17	$	11	$	—	$	13
Other noncurrent liabilities
Foreign currency exchange derivatives	3		4		—		—
Long-term debt
Foreign currency denominated debt	860		1,161		—		—
Total liabilities	$	880	$	1,176	$	—	$	13

Schedule of Gross and Net Amounts of Derivative Instruments and Other Amounts

The gross and net amounts of derivative instruments and other amounts used in hedging activities are as follows:

	Assets				Liabilities
(in millions)	June 30, 2022		September 30, 2021		June 30, 2022		September 30, 2021
Gross amount recognized	$	10	$	9	$	880	$	1,189
Gross amount eligible for offsetting	(10)		(9)		(10)		(9)
Net amount	$	—	$	—	$	870	$	1,180

Schedule of Effective Portion of Pretax Gains (Losses)

The following table presents the effective portion of pretax gains (losses) recorded in other comprehensive income related to cash flow hedges:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Foreign currency exchange derivatives	$	(6)	$	21	$	—	$	40

The following table presents the location and amount of the effective portion of pretax gains (losses) on cash flow hedges reclassified from AOCI into Adient's consolidated statements of income:

(in millions)		Three Months Ended June 30,				Nine Months Ended June 30,
		2022		2021		2022		2021
Foreign currency exchange derivatives	Cost of sales	$	2	$	1	$	5	$	(2)

The following table presents the location and amount of pretax gains (losses) on derivatives not designated as hedging instruments recognized in Adient's consolidated statements of income (loss):

(in millions)		Three Months Ended June 30,				Nine Months Ended June 30,
		2022		2021		2022		2021
Foreign currency exchange derivatives	Cost of sales	$	(2)	$	—	$	(1)	$	(2)
Foreign currency exchange derivatives	Net financing charges	(5)		(24)		(24)		(22)
Total		$	(7)	$	(24)	$	(25)	$	(24)

XML

Fair Value Measurements (Tables)

9 Months Ended

Jun. 30, 2022

Fair Value Disclosures [Abstract]

Schedule of the Fair Value Hierarchy for Assets and Liabilities

The following tables present Adient's fair value hierarchy for those assets and liabilities measured at fair value:

	Fair Value Measurements Using:
(in millions)	Total as of June 30, 2022		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Other current assets
Foreign currency exchange derivatives	$	10	$	—	$	10	$	—
Total assets	$	10	$	—	$	10	$	—
Other current liabilities
Foreign currency exchange derivatives	$	17	$	—	$	17	$	—
Other noncurrent liabilities
Foreign currency exchange derivatives	3		—		3		—
Total liabilities	$	20	$	—	$	20	$	—

	Fair Value Measurements Using:
(in millions)	Total as of September 30, 2021		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Other current assets
Foreign currency exchange derivatives	$	8	$	—	$	8	$	—
Other noncurrent assets
Interest rate cap	1		—		1		—
Total assets	$	9	$	—	$	9	$	—
Other current liabilities
Foreign currency exchange derivatives	$	24	$	—	$	24	$	—
Other noncurrent liabilities
Foreign currency exchange derivatives	4		—		4		—
Total liabilities	$	28	$	—	$	28	$	—

XML

Equity and Noncontrolling Interests (Tables)

9 Months Ended

Jun. 30, 2022

Equity [Abstract]

Schedule of Stockholders Equity

For the nine months ended June 30, 2022:

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at September 30, 2021	$	—	$	3,991	$	(988)	$	(627)	$	2,376	$	342	$	2,718
Net income (loss)	—		—		(165)		—		(165)		29		(136)
Foreign currency translation adjustments	—		—		—		(110)		(110)		(10)		(120)
Realized and unrealized gains (losses) on derivatives	—		—		—		(5)		(5)		—		(5)
Dividends attributable to noncontrolling interests	—		—		—		—		—		(19)		(19)
Purchase of subsidiary shares from noncontrolling interest	—		12		—		—		12		(12)		—
Share based compensation and other	—		15		—		—		15		—		15
Balance at June 30, 2022	$	—	$	4,018	$	(1,153)	$	(742)	$	2,123	$	330	$	2,453

For the three months ended June 30, 2022:

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at March 31, 2022	$	—	$	4,008	$	(1,123)	$	(600)	$	2,285	$	340	$	2,625
Net income (loss)	—		—		(30)		—		(30)		6		(24)
Foreign currency translation adjustments	—		—		—		(135)		(135)		(13)		(148)
Realized and unrealized gains (losses) on derivatives	—		—		—		(7)		(7)		—		(7)
Dividends attributable to noncontrolling interests	—		—		—		—		—		(3)		(3)
Share based compensation and other	—		10		—		—		10		—		10
Balance at June 30, 2022	$	—	$	4,018	$	(1,153)	$	(742)	$	2,123	$	330	$	2,453

For the nine months ended June 30, 2021:

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at September 30, 2020	$	—	$	3,974	$	(2,096)	$	(665)	$	1,213	$	322	$	1,535
Net income (loss)	—		—		148		—		148		51		199
Foreign currency translation adjustments	—		—		—		53		53		9		62
Realized and unrealized gains (losses) on derivatives	—		—		—		34		34		—		34
Dividends attributable to noncontrolling interests	—		—		—		—		—		(40)		(40)
Change in noncontrolling interest share	—		—		—		—		—		(3)		(3)
Share based compensation and other	—		19		—		—		19		1		20
Balance at June 30, 2021	$	—	$	3,993	$	(1,948)	$	(578)	$	1,467	$	340	$	1,807

For the three months ended June 30, 2021:

(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable  to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at March 31, 2021	$	—	$	3,985	$	(1,877)	$	(619)	$	1,489	$	353	$	1,842
Net income (loss)	—		—		(71)		—		(71)		16		(55)
Foreign currency translation adjustments	—		—		—		24		24		3		27
Realized and unrealized gains (losses) on derivatives	—		—		—		17		17		—		17
Dividends attributable to noncontrolling interests	—		—		—		—		—		(29)		(29)
Change in noncontrolling interest share	—		—		—		—		—		(3)		(3)
Share based compensation and other	—		8		—		—		8		—		8
Balance at June 30, 2021	$	—	$	3,993	$	(1,948)	$	(578)	$	1,467	$	340	$	1,807

Schedule of AOCI

The following table presents changes in AOCI attributable to Adient:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Foreign currency translation adjustments
Balance at beginning of period	$	(592)	$	(605)	$	(617)	$	(634)
Aggregate adjustment for the period, net of tax	(135)		24		(110)		53
Balance at end of period	$	(727)	$	(581)	$	(727)	$	(581)
Realized and unrealized gains (losses) on derivatives
Balance at beginning of period	$	(6)	$	(11)	$	(8)	$	(28)
Current period changes in fair value, net of tax	(5)		18		—		33
Reclassification to income, net of tax	(2)		(1)		(5)		1
Balance at end of period	$	(13)	$	6	$	(13)	$	6
Pension and postretirement plans
Balance at beginning of period	$	(2)	$	(3)	$	(2)	$	(3)
Balance at end of period	$	(2)	$	(3)	$	(2)	$	(3)
Accumulated other comprehensive income (loss), end of period	$	(742)	$	(578)	$	(742)	$	(578)

Schedule of Changes in Redeemable Noncontrolling Interest

The following table presents changes in the redeemable noncontrolling interests:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Beginning balance	$	48	$	44	$	240	$	43
Net income	4		6		26		19
Dividends	—		—		(33)		(14)
Change in redeemable noncontrolling interest	—		—		(186)		—
Foreign currency translation adjustments	(7)		(2)		(2)		—
Ending balance	$	45	$	48	$	45	$	48

XML

Retirement Plans (Tables)

9 Months Ended

Jun. 30, 2022

Retirement Benefits [Abstract]

Schedule of Net Periodic Benefit Cost

The following table contains the components of net periodic benefit cost:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Service cost	$	1	$	2	$	5	$	6
Interest cost	2		3		8		7
Expected return on plan assets	(3)		(6)		(11)		(14)
Net actuarial and settlement/curtailment (gain) loss	(3)		(1)		(3)		(1)
Net periodic benefit cost	$	(3)	$	(2)	$	(1)	$	(2)

XML

Restructuring and Impairment Costs (Tables)

9 Months Ended

Jun. 30, 2022

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Reserve

The restructuring actions are expected to be substantially completed by fiscal 2023.

(in millions)	Employee Severance and Termination Benefits		Total
Original reserve	$	20	$	20
Utilized—cash	(5)		(5)
Noncash adjustment—other	(1)		(1)
Balance at June 30, 2022	$	14	$	14

The restructuring actions are expected to be substantially completed by fiscal 2023.

(in millions)	Employee Severance and Termination Benefits		Currency Translation		Total
Balance at September 30, 2021	$	22	$	—	$	22
Utilized—cash	(15)		—		(15)
Noncash adjustment—other	(1)		(1)		(2)
Balance at June 30, 2022	$	6	$	(1)	$	5

The following table summarizes the changes in Adient's 2020 Plan reserve:

(in millions)	Employee Severance and Termination Benefits		Currency Translation		Total
Balance at September 30, 2021	$	75	$	2	$	77
Utilized—cash	(23)		—		(23)
Noncash adjustment—underspend/other	(6)		(6)		(12)
Balance at June 30, 2022	$	46	$	(4)	$	42

The following table summarizes the changes in Adient's 2019 Plan reserve:

(in millions)	Employee Severance and Termination Benefits		Currency Translation		Total
Balance at September 30, 2021	$	8	$	1	$	9
Utilized—cash	(4)		—		(4)
Noncash adjustment—underspend/other	(1)		—		(1)
Balance at June 30, 2022	$	3	$	1	$	4

XML

Segment Information (Tables)

9 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Schedule of Financial Information for Reportable Segments

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Net Sales
Americas	$	1,673	$	1,440	$	4,767	$	4,821
EMEA	1,215		1,328		3,663		4,568
Asia	627		516		2,134		1,658
Eliminations	(30)		(42)		(93)		(138)
Total net sales	$	3,485	$	3,242	$	10,471	$	10,909

	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Adjusted EBITDA
Americas	$	70	$	23	$	125	$	219
EMEA	31		22		104		277
Asia	64		92		283		364
Corporate-related costs (1)	(22)		(19)		(64)		(61)
Restructuring and impairment costs (2)	(12)		(8)		(20)		(20)
Purchase accounting amortization (3)	(14)		(11)		(41)		(32)
Restructuring related charges (4)	(1)		—		(5)		(6)
Gain on sale / (impairment) of nonconsolidated partially-owned affiliates (5)	—		—		(9)		33
Depreciation	(72)		(71)		(223)		(210)
Stock based compensation	(7)		(10)		(21)		(36)
Other items (6)	(2)		26		(8)		28
Earnings (loss) before interest and income taxes	35		44		121		556
Net financing charges	(39)		(87)		(172)		(256)
Other pension income (expense)	4		4		6		8
Income (loss) before income taxes	$	—	$	(39)	$	(45)	$	308

Notes:

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects qualified restructuring charges for costs that are directly attributable to restructuring activities and meet the definition of restructuring under ASC 420 and non-recurring impairment charges. During the nine months ended June 30, 2022, an impairment charge of $2 million related to net assets in Russia, and a held-for-sale impairment charge of $6 million were recorded in EMEA. During the nine months ended June 30, 2021, a held-for-sale impairment charge of $8 million was recorded in EMEA.

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects restructuring related charges for costs that are directly attributable to restructuring activities, but do not meet the definition of restructuring under ASC 420.

(5) The nine months ended June 30, 2022 reflects $3 million and $6 million of non-cash impairments of certain of Adient's investments in nonconsolidated partially-owned affiliates in China and South Africa, respectively. The nine months ended June 30, 2021 reflects a pre-tax gain of $33 million on the sale of Adient's interest in SJA. Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for additional information.

(6) The three months ended June 30, 2022 primarily reflects $2 million of transaction costs. The nine months ended June 30, 2022 reflects $7 million of transaction costs and $2 million of loss on finalization of asset sale in Turkey. The three months ended June 30, 2021 reflects $2 million of transaction costs and a one-time gain of $30 million associated with retrospective recoveries of Brazil indirect tax credits resulting from a favorable court ruling (of which $28 million relates to recoveries covering the past 20 years and is adjusted out of Americas' segment results). The nine months ended June 30, 2021 reflects a one-time gain of $38 million associated with the retrospective recoveries of Brazil indirect tax credits resulting from a favorable court ruling (of which $36 million relates to recoveries covering the past 20 years and is adjusted out of Americas' segment results), a $5 million gain on previously held interest at YFAS in an affiliate, and $13 million of transaction costs.

Schedule of Reconciliation of Other Significant Reconciling Items from Segments to Consolidated

Revenue by geographic area is as follows:

Net Sales
	Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)	2022		2021		2022		2021
Americas
United States	$	1,501	$	1,298	$	4,276	$	4,332
Mexico	628		558		1,756		1,783
Other Americas	106		64		284		238
Regional elimination	(562)		(480)		(1,549)		(1,532)
	1,673		1,440		4,767		4,821
EMEA
Germany	258		261		737		891
Czech Republic	257		276		757		964
Other EMEA	1,030		1,144		3,170		3,918
Regional elimination	(330)		(353)		(1,001)		(1,205)
	1,215		1,328		3,663		4,568
Asia
Thailand	101		113		370		357
China	274		171		1,004		525
Japan	59		60		183		253
Other Asia	200		177		597		539
Regional elimination	(7)		(5)		(20)		(16)
	627		516		2,134		1,658
Inter-segment elimination	(30)		(42)		(93)		(138)
Total	$	3,485	$	3,242	$	10,471	$	10,909

XML

Nonconsolidated Partially-Owned Affiliates (Tables)

9 Months Ended

Jun. 30, 2022

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Operating Information of Nonconsolidated Partially-owned Affiliates

Operating information for nonconsolidated partially-owned affiliates is as follows:

	Nine Months Ended June 30,
(in millions)	2022		2021
Income statement data:
Net sales	$	2,993	$	6,795
Gross profit	$	291	$	717
Net income	$	132	$	418
Net income attributable to the entity	$	131	$	413

XML

Related Party Transactions (Tables)

9 Months Ended

Jun. 30, 2022

Related Party Transactions [Abstract]

Schedule of Related Party Transactions

The following table sets forth the net sales to and purchases from related parties included in the consolidated statements of income:

		Three Months Ended June 30,				Nine Months Ended June 30,
(in millions)		2022		2021		2022		2021
Net sales to related parties	Net sales	$	53	$	70	$	175	$	209
Purchases from related parties	Cost of sales	95		139		298		433

The following table sets forth the amount of accounts receivable due from and payable to related parties in the consolidated statements of financial position:

(in millions)		June 30, 2022		September 30, 2021
Accounts receivable due from related parties	Accounts receivable	$	34	$	30
Accounts payable due to related parties	Accounts payable	69		41

XML

Basis of Presentation and Summary of Significant Accounting Policies (Details) - entity	Jun. 30, 2022	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of VIE entities	2	2

XML

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Carrying Amounts and Classifications of Assets and Liabilities for Consolidated VIEs (Details) - USD ($) $ in Millions	Jun. 30, 2022	Sep. 30, 2021
Variable Interest Entity [Line Items]
Current assets	$ 4,062	$ 5,086
Total assets	9,315	10,778
Current liabilities	3,387	3,511
Noncurrent liabilities	3,430	4,309
VIEs
Variable Interest Entity [Line Items]
Current assets	223	158
Noncurrent assets	105	88
Total assets	328	246
Current liabilities	193	143
Noncurrent liabilities	13	8
Total liabilities	$ 206	$ 151

XML

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Numerator:
Net income (loss) attributable to Adient	$ (30)	$ (71)	$ (165)	$ 148
Denominator:
Shares outstanding (in shares)	94.8	94.2	94.7	94.1
Effect of dilutive securities (in shares)	0.0	0.0	0.0	1.5
Diluted shares (in shares)	94.8	94.2	94.7	95.6
Earnings (loss) per share:
Basic (in usd per share)	$ (0.32)	$ (0.75)	$ (1.74)	$ 1.57
Diluted (in usd per share)	$ (0.32)	$ (0.75)	$ (1.74)	$ 1.55

XML

Acquisitions and Divestitures - Acquisitions (Details) ¥ in Millions, ¥ in Millions, $ in Millions									1 Months Ended					3 Months Ended						6 Months Ended	9 Months Ended		12 Months Ended
	Oct. 31, 2021	Oct. 21, 2021 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2021 CNY (¥)	Apr. 01, 2021 USD ($)	Mar. 31, 2021 USD ($)	Mar. 12, 2021 USD ($)	Mar. 12, 2021 CNY (¥)	Apr. 30, 2022 USD ($)	Apr. 30, 2022 JPY (¥)	Dec. 31, 2021 USD ($)	Dec. 31, 2021 CNY (¥)	Nov. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2021 CNY (¥)	Mar. 31, 2021 USD ($)	Sep. 30, 2022 venture	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Sep. 30, 2021 USD ($)
Business Acquisition [Line Items]
Proceeds from business divestitures																					$ 740	$ 72
Gain (loss) on sale of investment																					(8)	33
Non-cash impairment charges																					12	11
Net sales														$ 3,485			$ 3,242				10,471	10,909
Assets held for sale			$ 49											0							0		$ 49
EMEA
Business Acquisition [Line Items]
Non-cash impairment charges																					6	8
Customer Relationships And Patented Technologies
Business Acquisition [Line Items]
Useful life			10 years	10 years
Minimum | Customer Relationships And Patented Technologies
Business Acquisition [Line Items]
Useful life			3 years	3 years
Maximum | Customer Relationships And Patented Technologies
Business Acquisition [Line Items]
Useful life			12 years	12 years
CQYFAS
Business Acquisition [Line Items]
Net purchase consideration			$ 271
Acquisition of businesses, net of cash acquired			211
Cash acquired			60
CQADNT
Business Acquisition [Line Items]
Acquisition of businesses, net of cash acquired			203
Cash acquired			55
Intangible assets			234																				234
LFADNT
Business Acquisition [Line Items]
Acquisition of businesses, net of cash acquired			8
Cash acquired			5
Intangible assets			6																				6
YFAT
Business Acquisition [Line Items]
Business combination, deposit to acquire interest in joint venture									$ 6	¥ 37
Percent of total consideration									50.00%	50.00%
Percent of price paid at closing									50.00%	50.00%
Russia | EMEA
Business Acquisition [Line Items]
Non-cash impairment charges														2							2
Asset impairment charge and allowance for credit loss														3
Allowance for doubtful accounts														1
Net sales																$ 7
Foreign currency transaction loss																					3
Turkey
Business Acquisition [Line Items]
Proceeds from sale of property held-for-sale		$ 36													$ 10						$ 46
Turkey | Selling, general and administrative
Business Acquisition [Line Items]
Loss on sale of asset														2
France And Turkey
Business Acquisition [Line Items]
Non-cash impairment charge																							9
Assets held for sale			$ 11																				$ 11
Yanfeng
Business Acquisition [Line Items]
License revenue payment							$ 59	¥ 385
KEIPER | YFAT
Business Acquisition [Line Items]
Net purchase consideration									$ 24	¥ 150
Entities in China and Properties in U.S. | Assets Held For Sale
Business Acquisition [Line Items]
Non-cash impairment charge														1		$ 7
Rate of return
Business Acquisition [Line Items]
Measurement input			0.135																				0.135
YFAS
Business Acquisition [Line Items]
Proceeds from divestiture of interest in joint venture			$ 519	¥ 3,446			1,210	8,064			$ 691	¥ 4,618
Potential payments to acquire Interest in joint venture							271	1,754
Proceeds from sale of limited partnership investments													$ 41
YFM
Business Acquisition [Line Items]
Proceeds from divestiture of interest in joint venture							11	71
YFAT
Business Acquisition [Line Items]
Proceeds from business divestitures							17	113
YFAT | KEIPER
Business Acquisition [Line Items]
Proceeds from divestiture of interest in joint venture							6	38
CQADNT | The Boxun Agreement
Business Acquisition [Line Items]
Proceeds from divestiture of interest in joint venture							200				$ 15			$ 185	32
Net cash payment | ¥								194
GZDFAS | YFAS
Business Acquisition [Line Items]
Proceeds from divestiture of interest in joint venture							56	371
YHAS | YFAS
Business Acquisition [Line Items]
Proceeds from business divestitures							$ 2	¥ 13
Two Joint Ventures | Yanfeng
Business Acquisition [Line Items]
Proceeds from sale of equity method investments									$ 3
Non-cash impairment on investment															$ 3
Two Joint Ventures | Yanfeng | Subsequent event | Forecast
Business Acquisition [Line Items]
Investment ownership																				25.00%
Number of joint ventures transferred | venture																				2
SJA
Business Acquisition [Line Items]
Proceeds from divestiture of interest in joint venture					$ 53	$ 58
Gain (loss) on sale of investment																	33		$ 33			$ 33
Yanfeng | YFAS
Business Acquisition [Line Items]
Investment ownership							50.01%	50.01%
Yanfeng | AYM
Business Acquisition [Line Items]
Investment ownership							50.00%	50.00%
YFAS
Business Acquisition [Line Items]
Distributed earnings			$ 199	¥ 1,359			$ 635	¥ 4,168
Dividends and interest paid																	$ 436	¥ 2,809
Adient | AYM
Business Acquisition [Line Items]
Investment ownership							50.00%	50.00%
Adient | YFAT | KEIPER
Business Acquisition [Line Items]
Ownership interest							25.00%	25.00%
Adient | CQYFAS
Business Acquisition [Line Items]
Ownership interest							100.00%	100.00%
Adient | GZDFAS | YFAS
Business Acquisition [Line Items]
Ownership interest							25.00%	25.00%
Adient | YHAS | YFAS
Business Acquisition [Line Items]
Ownership interest							10.00%	10.00%
Adient | YFAI
Business Acquisition [Line Items]
Ownership interest	30.00%
Adient | YFAS
Business Acquisition [Line Items]
Ownership interest							49.99%	49.99%
YFAS | YFAS
Business Acquisition [Line Items]
Ownership interest							49.99%	49.99%
YFAS | YFM
Business Acquisition [Line Items]
Investment ownership							70.00%	70.00%
YFAS | YFAT
Business Acquisition [Line Items]
Ownership interest							75.00%	75.00%
YFAS | CQYFAS
Business Acquisition [Line Items]
Ownership interest							50.00%	50.00%
Yanfeng | YFAI
Business Acquisition [Line Items]
Ownership interest	70.00%
Yanfeng | YFAS
Business Acquisition [Line Items]
Ownership interest							50.01%	50.01%
Boxun | CQYFAS | The Boxun Agreement
Business Acquisition [Line Items]
Ownership interest							25.00%	25.00%
SJA
Business Acquisition [Line Items]
Ownership interest						50.00%

XML

Acquisitions and Divestitures - Fair Value Allocation (Details) - USD ($) $ in Millions	Sep. 30, 2021	Jun. 30, 2022
Business Acquisition [Line Items]
Goodwill	$ 2,212	$ 2,122
CQADNT
Business Acquisition [Line Items]
Cash	55
Accounts receivable	296
Inventory	37
Property, plant and equipment	86
Other assets	46
Goodwill	180
Intangible assets	234
Accounts payable	(252)
Other liabilities	(127)
Subtotal	555
Less: Interest already owned	103
Less: Redeemable noncontrolling interest	194
Total purchase consideration	258
Less: cash acquired	55
Net cash paid	203
LFADNT
Business Acquisition [Line Items]
Cash	5
Accounts receivable	2
Inventory	5
Property, plant and equipment	8
Other assets	2
Goodwill	8
Intangible assets	6
Accounts payable	(19)
Other liabilities	(4)
Subtotal	13
Less: Interest already owned	0
Less: Redeemable noncontrolling interest	0
Total purchase consideration	13
Less: cash acquired	5
Net cash paid	$ 8

XML

Inventories - Schedule of Inventories (Details) - USD ($) $ in Millions	Jun. 30, 2022	Sep. 30, 2021
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 765	$ 750
Work-in-process	24	29
Finished goods	164	197
Inventories	$ 953	$ 976

XML

Goodwill and Other Intangible Assets - Goodwill (Details) $ in Millions	9 Months Ended
	Jun. 30, 2022 USD ($)
Goodwill [Roll Forward]
Balance at September 30, 2021	$ 2,212
Currency translation and other	(90)
Balance at June 30, 2022	2,122
Americas
Goodwill [Roll Forward]
Balance at September 30, 2021	607
Currency translation and other	1
Balance at June 30, 2022	608
EMEA
Goodwill [Roll Forward]
Balance at September 30, 2021	354
Currency translation and other	(38)
Balance at June 30, 2022	316
Asia
Goodwill [Roll Forward]
Balance at September 30, 2021	1,251
Currency translation and other	(53)
Balance at June 30, 2022	$ 1,198

XML

Goodwill and Other Intangible Assets - Intangible Assets (Details) - USD ($) $ in Millions	Jun. 30, 2022	Sep. 30, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 757	$ 785
Accumulated Amortization	(253)	(230)
Net	504	555
Patented technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	86	86
Accumulated Amortization	(24)	(19)
Net	62	67
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	627	649
Accumulated Amortization	(201)	(178)
Net	426	471
Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	18	26
Accumulated Amortization	(16)	(21)
Net	2	5
Miscellaneous
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	26	24
Accumulated Amortization	(12)	(12)
Net	$ 14	$ 12

XML

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangibles	$ 40	$ 29

XML

Product Warranties - Schedule of Product Warranty Liability (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at beginning of period	$ 23	$ 24
Accruals for warranties issued during the period	7	7
Changes in accruals related to pre-existing warranties (including changes in estimates)	0	(1)
Settlements made (in cash or in kind) during the period	(7)	(6)
Currency translation	(1)	0
Balance at end of period	$ 22	$ 24

XML

Leases - Lease Cost (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Leases [Abstract]
Operating lease cost	$ 32	$ 32	$ 90	$ 94
Short-term lease cost	2	4	14	16
Total lease cost	$ 34	$ 36	$ 104	$ 110

XML

Leases - Schedule of Operating Lease Right of Use Assets and Operating Lease Liabilities (Details) - USD ($) $ in Millions	Jun. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Operating lease right-of-use assets	$ 293	$ 335
Operating lease liabilities - current	85	89
Operating lease liabilities - noncurrent	209	246
Present value of lease liabilities	$ 294	$ 335
Weighted average remaining lease term:
Operating leases	6 years	6 years
Weighted average discount rate:
Operating leases	5.40%	5.20%
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other noncurrent assets	Other noncurrent assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other current liabilities	Other current liabilities
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent

XML

Leases - Schedule of Operating Lease Liabilities and Minimum Payments (Details) - USD ($) $ in Millions	Jun. 30, 2022	Sep. 30, 2021
Operating leases
2022 (excluding the nine months ended June 30, 2022)	$ 26
2023	89
2024	66
2025	47
2026	31
Thereafter	81
Total lease payments	340
Less: imputed interest	(46)
Present value of lease liabilities	$ 294	$ 335

XML

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Right-of-use assets obtained in exchange for lease obligations:
Operating leases (non-cash activity)	$ 38	$ 102
Operating cash flows:
Cash paid for amounts included in the measurement of lease liabilities	$ 89	$ 96

XML

Debt and Financing Arrangements - Schedule of Long-term Debt (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2022	Feb. 28, 2022	Sep. 30, 2021	Sep. 30, 2020
Long-term debt:
Finance lease obligations	$ 1		$ 1
Less: debt issuance costs	(20)		(32)
Gross long-term debt	2,718		3,679
Less: current portion	11		167
Net long-term debt	2,707		3,512
Short-term debt:
Other bank borrowings	9		17
Total short-term debt	$ 9		17
EURIBOR
Short-term debt:
Basis spread	1.58%
Term Loan B - LIBOR plus 3.25% due in 2028
Long-term debt:
Long-term debt, gross	$ 990		998
Term Loan B - LIBOR plus 3.25% due in 2028 | LIBOR
Short-term debt:
Interest rate	3.25%
Unsecured Debt | 4.875% Notes due in 2026
Long-term debt:
Long-term debt, gross	$ 795		795	$ 797
Short-term debt:
Interest rate	4.875%
Unsecured Debt | 3.50% Notes due in 2024
Long-term debt:
Long-term debt, gross	$ 860		1,161
Short-term debt:
Interest rate	3.50%	3.50%
Unsecured Debt | 9.00% Notes due in 2025
Long-term debt:
Long-term debt, gross	$ 92		600
Short-term debt:
Interest rate	9.00%
Unsecured Debt | European Investment Bank Loan - EURIBOR plus 1.58% due in 2022
Long-term debt:
Long-term debt, gross	$ 0		$ 156
Unsecured Debt | European Investment Bank Loan - EURIBOR plus 1.58% due in 2022 | EURIBOR
Short-term debt:
Basis spread	1.58%

XML

Debt and Financing Arrangements - Narrative (Details)				1 Months Ended				3 Months Ended				9 Months Ended		12 Months Ended
	Jun. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Apr. 20, 2020 USD ($)	Feb. 28, 2022 USD ($)	Feb. 28, 2022 EUR (€)	May 31, 2021 USD ($)	Apr. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Sep. 30, 2020 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Sep. 30, 2021 USD ($)	Jun. 30, 2022 EUR (€)	Feb. 28, 2022 EUR (€)
Debt Instrument [Line Items]
ABL credit facility springing maturity period												91 days
Total loans outstanding							$ 1,000,000,000
Deferred financing costs	$ 20,000,000	$ 32,000,000										$ 20,000,000		$ 32,000,000
Total interest paid												$ 126,000,000	$ 183,000,000
Proceeds from sale and collection of receivables	262,000,000	126,000,000
EURIBOR
Debt Instrument [Line Items]
Basis spread												1.58%
Unsecured Debt
Debt Instrument [Line Items]
Face amount of debt (up to)	150,000,000											$ 150,000,000
Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	1,250,000,000											1,250,000,000
Credit facility expansion												250,000,000
Remaining borrowing capacity	780,000,000											$ 780,000,000
Revolving Credit Facility | Minimum
Debt Instrument [Line Items]
Commitment fee on unused portion of commitments												0.25%
Revolving Credit Facility | Maximum
Debt Instrument [Line Items]
Commitment fee on unused portion of commitments												0.375%
Revolving Credit Facility | EURIBOR | Minimum
Debt Instrument [Line Items]
Basis spread												1.50%
Revolving Credit Facility | EURIBOR | Maximum
Debt Instrument [Line Items]
Basis spread												2.00%
Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	150,000,000											$ 150,000,000
Letter of Credit
Debt Instrument [Line Items]
Remaining borrowing capacity	42,000,000											$ 42,000,000
Term Loan B - LIBOR plus 3.25% due in 2028
Debt Instrument [Line Items]
First lien secured net leverage ratio												1.75
Term Loan B - LIBOR plus 3.25% due in 2028 | Term Loan
Debt Instrument [Line Items]
Basis spread												4.25%
Debt instrument term												5 years
Face amount of debt (up to)	800,000,000						$ 214,000,000					$ 800,000,000
Debt periodic payment												1.00%
Step down rate							0.25%					0.25%
Payment for debt amendment costs							$ 7,000,000
Deferred financing costs							$ 8,000,000
Term Loan B - LIBOR plus 3.25% due in 2028 | Term Loan | EURIBOR
Debt Instrument [Line Items]
Basis spread							3.50%
Interest decrease during period							0.75%
Term Loan B - LIBOR plus 3.25% due in 2028 | Term Loan | Base Rate
Debt Instrument [Line Items]
Basis spread							2.50%
Incremental Term Loan | Term Loan
Debt Instrument [Line Items]
Face amount of debt (up to)	750,000,000											$ 750,000,000
Notes Due in 2026 | Senior Notes
Debt Instrument [Line Items]
Face amount of debt (up to)	$ 800,000,000											$ 800,000,000
Interest rate	7.00%											7.00%			7.00%
Repurchased face amount								$ 160,000,000	$ 640,000,000				160,000,000
Redemption percentage								103.00%	107.00%
Accrued and unpaid interest								$ 4,000,000	$ 17,000,000				4,000,000
Write off of deferred debt issuance cost									$ 9,000,000
Notes Due in 2026 | Term Loan
Debt Instrument [Line Items]
Deferred financing costs								$ 3,000,000					$ 3,000,000
4.875% Notes due in 2026 | Unsecured Debt
Debt Instrument [Line Items]
Face amount of debt (up to)	$ 900,000,000											$ 900,000,000
Interest rate	4.875%											4.875%			4.875%
Repayments of unsecured debt											$ 103,000,000			2,000,000
Long-term debt, gross	$ 795,000,000	795,000,000									$ 797,000,000	$ 795,000,000		795,000,000
3.50% Notes due in 2024 | Senior Notes
Debt Instrument [Line Items]
Interest rate			3.50%
Prior maturity period			91 days
3.50% Notes due in 2024 | Unsecured Debt
Debt Instrument [Line Items]
Face amount of debt (up to) | €															€ 1,000,000,000
Interest rate	3.50%			3.50%								3.50%			3.50%	3.50%
Repurchased face amount				$ 198,000,000												€ 177,000,000
Redemption percentage				102.00%	102.00%
Accrued and unpaid interest	$ 860,000,000			$ 19,000,000								$ 860,000,000			€ 823,000,000	€ 17,000,000
Write off of deferred debt issuance cost				$ 1,000,000	€ 1,000,000
Long-term debt, gross	860,000,000	1,161,000,000										860,000,000		1,161,000,000
European Investment Bank Loan - EURIBOR plus 1.58% due in 2022 | Unsecured Debt
Debt Instrument [Line Items]
Face amount of debt (up to) | €															€ 135,000,000
Repayments of unsecured debt						$ 20,000,000				$ 16,000,000
Long-term debt, gross	0	156,000,000										$ 0		156,000,000
European Investment Bank Loan - EURIBOR plus 1.58% due in 2022 | Unsecured Debt | EURIBOR
Debt Instrument [Line Items]
Basis spread												1.58%
9.00% Notes due in 2025 | Senior Notes
Debt Instrument [Line Items]
Face amount of debt (up to)			$ 600,000,000
Interest rate				9.00%												9.00%
Repurchased face amount				$ 508,000,000
Redemption percentage				105.875%	105.875%
Accrued and unpaid interest	$ 92,000,000			$ 15,000,000								$ 92,000,000
Write off of deferred debt issuance cost				$ 6,000,000
Proceeds from debt, net			591,000,000
Debt issuance costs, gross			$ 10,000,000
9.00% Notes due in 2025 | Unsecured Debt
Debt Instrument [Line Items]
Interest rate	9.00%											9.00%			9.00%
Long-term debt, gross	$ 92,000,000	$ 600,000,000										$ 92,000,000		$ 600,000,000
North American Subfacility | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	950,000,000											950,000,000
European Subfacility | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 300,000,000											$ 300,000,000

XML

Debt and Financing Arrangements - Schedule of Net Financing Charges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Debt Disclosure [Abstract]
Interest expense, net of capitalized interest costs	$ 36	$ 46	$ 121	$ 162
Banking fees and debt issuance cost amortization	6	14	20	27
Interest income	(2)	(2)	(5)	(6)
Premium paid on repurchase of debt	0	4	34	49
Derivative loss on Yanfeng transaction	0	24	3	24
Net foreign exchange	(1)	1	(1)	0
Net financing charges	$ 39	$ 87	$ 172	$ 256

XML

Derivative Instruments and Hedging Activities - Narrative (Details)	3 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 EUR (€) instrument	Jun. 30, 2022 USD ($) instrument	Feb. 28, 2022	Sep. 30, 2021 USD ($)
Derivative [Line Items]
Percentage of foreign exchange rate exposure hedged, minimum			70.00%	70.00%
Percentage of foreign exchange rate exposure hedged, maximum			90.00%	90.00%
Cash collateral received				$ 0		$ 0
Cash collateral pledged				$ 0		$ 0
3.50% Notes due in 2024 | Unsecured Debt
Derivative [Line Items]
Interest rate			3.50%	3.50%	3.50%
Interest rate cap
Derivative [Line Items]
Number of instruments held | instrument			2	2
Notional amount of derivative asset				$ 200,000,000
Net Investment Hedging | Cross-currency interest rate swaps | Japan
Derivative [Line Items]
Number of instruments held | instrument			0	0
Net Investment Hedging | Foreign currency exchange derivatives
Derivative [Line Items]
Effective portion of pretax gains (loss) related to net investment hedges	$ 59,000,000	$ (17,000,000)
Gains (losses) reclassified into income for net investment hedges	0	0
Cash Flow Hedging
Derivative [Line Items]
Ineffectiveness recognized from cash flow hedges	$ 0	$ 0
Derivatives and Hedging Activities Designated as Hedging Instruments under ASC 815 | 3.50% Notes due in 2024 | Unsecured Debt
Derivative [Line Items]
Notional value of derivative liability			€ 823,000,000	$ 860,000,000
Interest rate			3.50%	3.50%

XML

Derivative Instruments and Hedging Activities - Schedule of Fair Values of Derivative Instruments and Other Amounts (Details) - USD ($) $ in Millions	Jun. 30, 2022	Sep. 30, 2021
Derivatives, Fair Value [Line Items]
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other noncurrent assets	Other noncurrent assets
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other current liabilities	Other current liabilities
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Foreign currency exchange derivatives
Derivatives, Fair Value [Line Items]
Derivative asset	$ 10	$ 8
Foreign currency exchange derivatives | Other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	17	24
Foreign currency exchange derivatives | Other noncurrent liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	3	4
Derivatives and Hedging Activities Designated as Hedging Instruments under ASC 815
Derivatives, Fair Value [Line Items]
Derivative asset	9	8
Derivative liability, noncurrent	860	1,161
Derivative liability	880	1,176
Derivatives and Hedging Activities Designated as Hedging Instruments under ASC 815 | Foreign currency exchange derivatives
Derivatives, Fair Value [Line Items]
Derivative asset, current	9	8
Derivative asset, noncurrent	0	0
Derivative liability, current	17	11
Derivative liability, noncurrent	3	4
Derivatives and Hedging Activities Not Designated as Hedging Instruments under ASC 815
Derivatives, Fair Value [Line Items]
Derivative asset	1	1
Derivative liability, noncurrent	0	0
Derivative liability	0	13
Derivatives and Hedging Activities Not Designated as Hedging Instruments under ASC 815 | Foreign currency exchange derivatives
Derivatives, Fair Value [Line Items]
Derivative asset, current	1	0
Derivative asset, noncurrent	0	1
Derivative liability, current	0	13
Derivative liability, noncurrent	$ 0	$ 0

XML

Derivative Instruments and Hedging Activities - Schedule of Gross and Net Amounts of Derivative Instruments and Other Amounts (Details) - USD ($) $ in Millions	Jun. 30, 2022	Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gross amount recognized, asset	$ 10	$ 9
Gross amount eligible for offsetting, asset	(10)	(9)
Net amount, asset	0	0
Gross amount recognized, liability	880	1,189
Gross amount eligible for offsetting, liability	(10)	(9)
Net amount, liability	$ 870	$ 1,180

XML

Derivative Instruments and Hedging Activities - Schedule of Effective Portion of Pretax Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ (7)	$ (24)	$ (25)	$ (24)
Foreign currency exchange derivatives | Cost of sales
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax gain (loss) on foreign currency exchange derivatives not designated as hedging instrument	(2)	0	(1)	(2)
Foreign currency exchange derivatives | Net financing charges
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax gain (loss) on foreign currency exchange derivatives not designated as hedging instrument	(5)	(24)	(24)	(22)
Foreign currency exchange derivatives | Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency exchange derivatives	(6)	21	0	40
Foreign currency exchange derivatives | Cash Flow Hedging | Cost of sales
Derivative Instruments, Gain (Loss) [Line Items]
Effective portion of pretax gain (loss) reclassified from AOCI into income	$ 2	$ 1	$ 5	$ (2)

XML

Fair Value Measurements - Schedule of the Fair Value Hierarchy for Assets and Liabilities (Details) - USD ($) $ in Millions	Jun. 30, 2022	Sep. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other noncurrent assets	Other noncurrent assets
Total assets	$ 10	$ 9
Total liabilities	$ 20	$ 28
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	$ 10	$ 8
Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset		1
Other current liabilities | Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	17	24
Other noncurrent liabilities | Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	3	4
Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	0	0
Total liabilities	0	0
Quoted Prices in Active Markets (Level 1) | Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	0	0
Quoted Prices in Active Markets (Level 1) | Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset		0
Quoted Prices in Active Markets (Level 1) | Other current liabilities | Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Quoted Prices in Active Markets (Level 1) | Other noncurrent liabilities | Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	10	9
Total liabilities	20	28
Significant Other Observable Inputs (Level 2) | Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	10	8
Significant Other Observable Inputs (Level 2) | Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset		1
Significant Other Observable Inputs (Level 2) | Other current liabilities | Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	17	24
Significant Other Observable Inputs (Level 2) | Other noncurrent liabilities | Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	3	4
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	0	0
Total liabilities	0	0
Significant Unobservable Inputs (Level 3) | Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset	0	0
Significant Unobservable Inputs (Level 3) | Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset		0
Significant Unobservable Inputs (Level 3) | Other current liabilities | Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	0	0
Significant Unobservable Inputs (Level 3) | Other noncurrent liabilities | Foreign currency exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	$ 0	$ 0

XML

Fair Value Measurements - Narrative (Details)	Jun. 30, 2022 USD ($) instrument	Jun. 30, 2022 CNY (¥) instrument	Sep. 30, 2021 USD ($)
Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of instruments held | instrument	2	2
Notional amount of derivative asset | $	$ 200,000,000
Net Investment Hedging | Cross-currency interest rate swaps | China
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of instruments held | instrument	1	1
Notional amount of derivative asset	$ 23,000,000	¥ 150,000,000
Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of long-term debt | $	$ 2,500,000,000		$ 3,800,000,000

XML

Equity and Noncontrolling Interests - Schedule of Stockholders Equity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	$ 2,625	$ 1,842	$ 2,718	$ 1,535
Net income (loss)	(24)	(55)	(136)	199
Foreign currency translation adjustments	(148)	27	(120)	62
Realized and unrealized gains (losses) on derivatives	(7)	17	(5)	34
Dividends attributable to noncontrolling interests	(3)	(29)	(19)	(40)
Purchase of subsidiary shares from noncontrolling interest			0
Change in redeemable noncontrolling interest		(3)		(3)
Share based compensation and other	10	8	15	20
Stockholders' equity, ending balance	2,453	1,807	2,453	1,807
Shareholders' Equity Attributable to Adient
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	2,285	1,489	2,376	1,213
Net income (loss)	(30)	(71)	(165)	148
Foreign currency translation adjustments	(135)	24	(110)	53
Realized and unrealized gains (losses) on derivatives	(7)	17	(5)	34
Purchase of subsidiary shares from noncontrolling interest			12
Share based compensation and other	10	8	15	19
Stockholders' equity, ending balance	2,123	1,467	2,123	1,467
Ordinary Shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	0	0	0	0
Stockholders' equity, ending balance	0	0	0	0
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	4,008	3,985	3,991	3,974
Purchase of subsidiary shares from noncontrolling interest			12
Share based compensation and other	10	8	15	19
Stockholders' equity, ending balance	4,018	3,993	4,018	3,993
Retained Earnings (Accumulated Deficit)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	(1,123)	(1,877)	(988)	(2,096)
Net income (loss)	(30)	(71)	(165)	148
Stockholders' equity, ending balance	(1,153)	(1,948)	(1,153)	(1,948)
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	(600)	(619)	(627)	(665)
Foreign currency translation adjustments	(135)	24	(110)	53
Realized and unrealized gains (losses) on derivatives	(7)	17	(5)	34
Stockholders' equity, ending balance	(742)	(578)	(742)	(578)
Shareholders' Equity Attributable to Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' equity, beginning balance	340	353	342	322
Net income (loss)	6	16	29	51
Foreign currency translation adjustments	(13)	3	(10)	9
Dividends attributable to noncontrolling interests	(3)	(29)	(19)	(40)
Purchase of subsidiary shares from noncontrolling interest			(12)
Change in redeemable noncontrolling interest		(3)		(3)
Share based compensation and other	0	0	0	1
Stockholders' equity, ending balance	$ 330	$ 340	$ 330	$ 340

XML

Equity and Noncontrolling Interests - Schedule of AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Stockholders' equity, beginning balance	$ 2,625	$ 1,842	$ 2,718	$ 1,535
Aggregate adjustment for the period, net of tax	(162)	42	(127)	96
Stockholders' equity, ending balance	2,453	1,807	2,453	1,807
Accumulated Other Comprehensive Income (Loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Stockholders' equity, beginning balance	(600)	(619)	(627)	(665)
Stockholders' equity, ending balance	(742)	(578)	(742)	(578)
Foreign currency translation adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Stockholders' equity, beginning balance	(592)	(605)	(617)	(634)
Aggregate adjustment for the period, net of tax	(135)	24	(110)	53
Stockholders' equity, ending balance	(727)	(581)	(727)	(581)
Realized and unrealized gains (losses) on derivatives
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Stockholders' equity, beginning balance	(6)	(11)	(8)	(28)
Current period changes in fair value, net of tax	(5)	18	0	33
Reclassification to income, net of tax	(2)	(1)	(5)	1
Stockholders' equity, ending balance	(13)	6	(13)	6
Pension and postretirement plans
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Stockholders' equity, beginning balance	(2)	(3)	(2)	(3)
Stockholders' equity, ending balance	$ (2)	$ (3)	$ (2)	$ (3)

XML

Equity and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interest (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Beginning balance			$ 342
Dividends	$ (3)	$ (29)	(19)	$ (40)
Change in redeemable noncontrolling interest		(3)		(3)
Ending balance	330		330
Redeemable Noncontrolling Interest
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Beginning balance	48	44	240	43
Net income	4	6	26	19
Dividends	0	0	(33)	(14)
Change in redeemable noncontrolling interest	0	0	(186)	0
Foreign currency translation adjustments	(7)	(2)	(2)	0
Ending balance	$ 45	$ 48	$ 45	$ 48

XML

Retirement Plans - Schedule of Net Periodic Benefit Cost (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Retirement Benefits [Abstract]
Service cost	$ 1	$ 2	$ 5	$ 6
Interest cost	2	3	8	7
Expected return on plan assets	(3)	(6)	(11)	(14)
Net actuarial and settlement/curtailment (gain) loss	(3)	(1)	(3)	(1)
Net periodic benefit cost	$ (3)	$ (2)	$ (1)	$ (2)

XML

Retirement Plans - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Retirement Benefits [Abstract]
Mark-to-market gain	$ 4	$ 1
Curtailment loss	$ 1

XML

Restructuring and Impairment Costs - Narrative (Details) employee in Thousands, $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2022 USD ($) employee	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) plant employee	Jun. 30, 2021 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)
Restructuring Cost and Reserve [Line Items]
Noncash adjustment—underspend/other						$ 20
Restructuring reserve	$ 70		$ 70		$ 115
Restructuring and impairment costs	$ 12	$ 8	$ 20	$ 20
Number of positions eliminated to date | employee	15		15
Number of positions eliminated | employee			14
Number of plants expected to close | plant			29
Number of plants closed | plant			21
2022 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Expected restructuring costs	$ 20		$ 20
Noncash adjustment—underspend/other			(1)
Restructuring reserve	14		14		20
Utilized—cash			5
Restructuring and Related Cost, Expected Cost Adjustment	8		8
2021 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Expected restructuring costs					27
Noncash adjustment—underspend/other			(2)		16
Restructuring reserve	5		5		22
Utilized—cash			15
2021 Restructuring Plan | EMEA
Restructuring Cost and Reserve [Line Items]
Expected restructuring costs					23
2021 Restructuring Plan | Americas
Restructuring Cost and Reserve [Line Items]
Restructuring reserve					3
2021 Restructuring Plan | Asia
Restructuring Cost and Reserve [Line Items]
Expected restructuring costs					1
2020 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Noncash adjustment—underspend/other			(12)
Restructuring reserve	42		42		$ 77
Restructuring and impairment costs						205
Utilized—cash			23
2020 Restructuring Plan | EMEA
Restructuring Cost and Reserve [Line Items]
Restructuring and impairment costs						175
2020 Restructuring Plan | Americas
Restructuring Cost and Reserve [Line Items]
Restructuring and impairment costs						20
2020 Restructuring Plan | Asia
Restructuring Cost and Reserve [Line Items]
Restructuring and impairment costs						$ 10
Restructuring Plan 2018, 2017, 2016
Restructuring Cost and Reserve [Line Items]
Utilized—cash			2
2018 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	2		2
2017 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	2		2
2016 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	$ 1		$ 1

XML

Restructuring and Impairment Costs - Changes in Reserve (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Jun. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	$ 115
Noncash adjustment—underspend/other			$ 20
Restructuring reserve ending balance	70	$ 115
2022 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	20
Utilized—cash	(5)
Noncash adjustment—underspend/other	(1)
Restructuring reserve ending balance	14	20
2021 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	22
Utilized—cash	(15)
Noncash adjustment—underspend/other	(2)	16
Restructuring reserve ending balance	5	22
2020 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	77
Utilized—cash	(23)
Noncash adjustment—underspend/other	(12)
Restructuring reserve ending balance	42	77
2019 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	9
Utilized—cash	(4)
Noncash adjustment—underspend/other	(1)
Restructuring reserve ending balance	4	9
Employee Severance and Termination Benefits | 2022 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	20
Utilized—cash	(5)
Noncash adjustment—underspend/other	(1)
Restructuring reserve ending balance	14	20
Employee Severance and Termination Benefits | 2021 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	22
Utilized—cash	(15)
Noncash adjustment—underspend/other	(1)
Restructuring reserve ending balance	6	22
Employee Severance and Termination Benefits | 2020 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	75
Utilized—cash	(23)
Noncash adjustment—underspend/other	(6)
Restructuring reserve ending balance	46	75
Employee Severance and Termination Benefits | 2019 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	8
Utilized—cash	(4)
Noncash adjustment—underspend/other	(1)
Restructuring reserve ending balance	3	8
Currency Translation | 2021 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	0
Utilized—cash	0
Noncash adjustment—underspend/other	(1)
Restructuring reserve ending balance	(1)	0
Currency Translation | 2020 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	2
Utilized—cash	0
Noncash adjustment—underspend/other	(6)
Restructuring reserve ending balance	(4)	2
Currency Translation | 2019 Restructuring Plan
Restructuring Reserve [Roll Forward]
Restructuring reserve beginning balance	1
Utilized—cash	0
Noncash adjustment—underspend/other	0
Restructuring reserve ending balance	$ 1	$ 1

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Jun. 30, 2022	Jun. 30, 2021
Income Tax Contingency [Line Items]
Income tax provision (benefit)	$ 20			$ 10			$ 65	$ 90
Income (loss) before income taxes	0			$ (39)			$ (45)	$ 308
Effective tax rate				(26.00%)			(144.00%)	(29.00%)
Income tax expense, decrease in deferred tax asset	12
Unrecognized tax benefits	463						$ 463
Unrecognized tax benefits that would impact effective tax rate	124						124
Net accrued interest	22						22
Interest and penalties accrued	$ 2						7
Pre-tax gain							(8)	$ 33
Retrospective recoveries of Brazil indirect tax credits							$ 0	38
SJA
Income Tax Contingency [Line Items]
Pre-tax gain				$ 33	$ 33			$ 33
Tax on gain on disposal of equity method investment					$ 5
Foreign Tax Authority | State Administration of Taxation, China
Income Tax Contingency [Line Items]
Tax benefit from temporary indirect tax rate reduction		$ 4
Foreign Tax Authority | Secretariat of the Federal Revenue Bureau of Brazil
Income Tax Contingency [Line Items]
Income tax provision (benefit)				10		$ 3
Indirect foreign tax credit			$ 3	11
Retrospective recoveries of Brazil indirect tax credits				$ 30		$ 8

XML

Segment Information (Details) $ in Millions	3 Months Ended					9 Months Ended
	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Jun. 30, 2022 USD ($) segment	Jun. 30, 2021 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment						3
Net sales	$ 3,485			$ 3,242		$ 10,471	$ 10,909
Corporate-related costs	(2)			26		(8)	28
Restructuring and impairment costs	(12)			(8)		(20)	(20)
Purchase accounting amortization	(14)			(11)		(41)	(32)
Restructuring related charges	(1)			0		(5)	(6)
Gain on sale / (impairment) of nonconsolidated partially-owned affiliates	0			0		(9)	33
Depreciation	(72)			(71)		(223)	(210)
Stock based compensation	(7)			(10)		(21)	(36)
Earnings (loss) before interest and income taxes	35			44		121	556
Net financing charges	(39)			(87)		(172)	(256)
Other pension income (expense)	4			4		6	8
Income (loss) before income taxes	0			(39)		(45)	308
Non-cash impairment charges						12	11
Pre-tax gain						(8)	33
Integration-related costs	2			2		7	13
China
Segment Reporting Information [Line Items]
Net sales	274			171		1,004	525
Non-cash impairment on investment						3
South Africa
Segment Reporting Information [Line Items]
Non-cash impairment on investment		$ 6				6
Turkey | Selling, general and administrative
Segment Reporting Information [Line Items]
Loss on sale of asset	2
BRAZIL
Segment Reporting Information [Line Items]
One-time gain				30			38
SJA
Segment Reporting Information [Line Items]
Pre-tax gain				33	$ 33		33
YFAS
Segment Reporting Information [Line Items]
Gain on previously held interest							5
Americas
Segment Reporting Information [Line Items]
One-time gain				$ 28			$ 36
Tax credits recovery period				20 years			20 years
EMEA
Segment Reporting Information [Line Items]
Non-cash impairment charges						6	$ 8
EMEA | Russia
Segment Reporting Information [Line Items]
Net sales			$ 7
Non-cash impairment charges	2					2
Operating Segments | Americas
Segment Reporting Information [Line Items]
Net sales	1,673			$ 1,440		4,767	4,821
Adjusted EBITDA	70			23		125	219
Operating Segments | EMEA
Segment Reporting Information [Line Items]
Net sales	1,215			1,328		3,663	4,568
Adjusted EBITDA	31			22		104	277
Operating Segments | Asia
Segment Reporting Information [Line Items]
Net sales	627			516		2,134	1,658
Adjusted EBITDA	64			92		283	364
Eliminations
Segment Reporting Information [Line Items]
Net sales	(30)			(42)		(93)	(138)
Corporate-related costs
Segment Reporting Information [Line Items]
Corporate-related costs	$ (22)			$ (19)		$ (64)	$ (61)

XML

Segment Information - Disaggregation of Revenue by Geographical Market (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Disaggregation of Revenue [Line Items]
Net sales	$ 3,485	$ 3,242	$ 10,471	$ 10,909
Americas
Disaggregation of Revenue [Line Items]
Net sales	1,673	1,440	4,767	4,821
United States
Disaggregation of Revenue [Line Items]
Net sales	1,501	1,298	4,276	4,332
Mexico
Disaggregation of Revenue [Line Items]
Net sales	628	558	1,756	1,783
Other Americas
Disaggregation of Revenue [Line Items]
Net sales	106	64	284	238
EMEA
Disaggregation of Revenue [Line Items]
Net sales	1,215	1,328	3,663	4,568
Germany
Disaggregation of Revenue [Line Items]
Net sales	258	261	737	891
Czech Republic
Disaggregation of Revenue [Line Items]
Net sales	257	276	757	964
Other EMEA
Disaggregation of Revenue [Line Items]
Net sales	1,030	1,144	3,170	3,918
Asia
Disaggregation of Revenue [Line Items]
Net sales	627	516	2,134	1,658
Thailand
Disaggregation of Revenue [Line Items]
Net sales	101	113	370	357
China
Disaggregation of Revenue [Line Items]
Net sales	274	171	1,004	525
Japan
Disaggregation of Revenue [Line Items]
Net sales	59	60	183	253
Other Asia
Disaggregation of Revenue [Line Items]
Net sales	200	177	597	539
Inter-segment elimination
Disaggregation of Revenue [Line Items]
Net sales	(30)	(42)	(93)	(138)
Inter-segment elimination | Americas
Disaggregation of Revenue [Line Items]
Net sales	(562)	(480)	(1,549)	(1,532)
Inter-segment elimination | EMEA
Disaggregation of Revenue [Line Items]
Net sales	(330)	(353)	(1,001)	(1,205)
Inter-segment elimination | Asia
Disaggregation of Revenue [Line Items]
Net sales	$ (7)	$ (5)	$ (20)	$ (16)

XML

Nonconsolidated Partially-Owned Affiliates - (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Mar. 31, 2022	Jun. 30, 2022	Sep. 30, 2021
Schedule of Equity Method Investments [Line Items]
Investments in partially-owned affiliates		$ 348	$ 335
South Africa
Schedule of Equity Method Investments [Line Items]
Proceeds from sale of equity method investments		2
Non-cash impairment on investment	$ 6	6
KEIPER
Schedule of Equity Method Investments [Line Items]
Estimated possible claim amount		17
Affiliate Of Yangeng | KEIPER
Schedule of Equity Method Investments [Line Items]
Estimated possible claim amount		$ 46

XML

Nonconsolidated Partially-Owned Affiliates - Schedule of Operating Information of Nonconsolidated Partially-owned Affiliates (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Schedule of Equity Method Investments [Line Items]
Gross profit	$ 173	$ 150	$ 524	$ 789
Equity Method Investment, Nonconsolidated Investee or Group of Investees
Schedule of Equity Method Investments [Line Items]
Net sales			2,993	6,795
Gross profit			291	717
Net income			132	418
Net income attributable to the entity			$ 131	$ 413

XML

Commitments and Contingencies (Details) - USD ($) $ in Millions	Jun. 30, 2022	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Reserves for environmental liabilities	$ 6	$ 8

XML

Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Sep. 30, 2021
Related Party Transactions [Abstract]
Net sales to related parties	$ 53	$ 70	$ 175	$ 209
Purchases from related parties	95	$ 139	298	$ 433
Accounts receivable due from related parties	34		34		$ 30
Accounts payable due to related parties	$ 69		$ 69		$ 41